ANTI CARIOGENIC (Protecting From Tooth Decay)
April 30, 2022HSP70, THE ANTI-AGING PROTEIN
May 10, 2022- Regulation of inflammatory responses by natural anticoagulants
- natural anticoagulants and the liver
- Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?
- natural anticoagulants, aging, and thromboembolism
- natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies
- Changes in the natural anticoagulants following bone marrow transplantation.
- The role of natural anticoagulants in the pathogenesis and management of systemic activation of coagulation and inflammation in critically ill patients
- Deficiencies of natural anticoagulants, protein C, protein S, and antithrombin
- The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S
- natural anticoagulants: A missing link in mild to moderate bleeding tendencies
- Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants
- The influence of tamoxifen in vivo on the main natural anticoagulants and fibrinolysis.
- natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation
- Predictors of stroke outcome: the role of hemorheology, natural anticoagulants, and serum albumin
- Prognostic significance of D-dimer, natural anticoagulants and routine coagulation parameters in acute pancreatitis
- Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients …
- 5 The natural anticoagulants
- Plasma concentrations of the natural anticoagulants protein C and protein S in patients with proteinuria
- Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial …
- … , protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on natural anticoagulants Study I Group
- natural anticoagulants can be useful predictors of severity in chronic liver disease
- natural anticoagulants (antithrombin III, protein C, and protein S) in patients with mild to moderate ischemic stroke
- natural anticoagulants in systemic lupus erythematosus. Deficiency of protein S bound to C4bp associates with recent history of venous thromboses, antiphospholipid …
- The fibrinolytic response to venous occlusion and the natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus …
- Differential kinetics of coagulation factors and natural anticoagulants in patients with liver cirrhosis: potential clinical implications
- Thrombophilic abnormalities of natural anticoagulants in patients with ulcerative colitis.
- Coagulopathy of childhood nephrotic syndrome–a reappraisal of the role of natural anticoagulants and fibrinolysis
- Do age and anticoagulants affect the naturalhistory of acute subdural hematomas?
- Interactions between naturalhealth products and oral anticoagulants: spontaneous reports in the Italian Surveillance System of naturalHealth Products
- Origin of the gender differences of the naturalresistance to antivitamin K anticoagulants in rats
- Determinants of elevated levels of natural anticoagulants in healthy subjects
- Characterization of the coagulation system in healthy dolphins: the coagulation factors, natural anticoagulants, and fibrinolytic products
- VTE recurrence in patients with inherited deficiencies of natural anticoagulants
- Superficial venous thrombosis: role of inherited deficiency of natural anticoagulants in extension to deep veins
- natural anticoagulants and their pathways
- Deficiencies of the natural anticoagulants–novel clinical laboratory aspects of thrombophilia testing
- Sulfated polysaccharide anticoagulants suppress naturalkiller cell activity in vitro
- Heparinase: II. Distribution of enzyme in various tissues and its action on naturalheparins and certain synthetic anticoagulants
- … disease in pediatric patients after hematopoietic stem cell transplantation: relevance of activated coagulation and fibrinolysis markers and natural anticoagulants
- natural anticoagulants in disseminated intravascular coagulation and sepsis
- Normal levels of the natural anticoagulants (proteins C & S and antithrombin III) and the fibrinolytic factors (tPA and PAI) in Arab children
- The level of natural anticoagulants in transfusion dependent thalassemia patients in Kelantan, Northeastern Malaysia
- The effect of delayed analysis or freeze-thawing on the measurement of natural anticoagulants, resistance to activated protein C and markers of activation of the …
- natural anticoagulants and fibrinolytic activity following interferon therapy in chronic viral hepatitis
- ST-elevation myocardial infarction, pulmonary embolism, and cerebral ischemic stroke in a patient with critically low levels of natural anticoagulants
- Principal coagulation factors and natural anticoagulants in the armadillo Chaetophractus villosus (Mammalia, Xenarthra, Dasypodidae)
- Recombinant natural anticoagulants: a review.
- The evaluation of natural anticoagulants in systemic lupus erythematosus in children
- Coordinated responses of natural anticoagulants to allogeneic stem cell transplantation and acute GVHD–A longitudinal study
- Cerebral infarctions in young patients related to deficiency of natural anticoagulants. Protein C and protein S
- Deficiency of natural anticoagulants: how should we manage cardiovascular prevention?
- A survey of the clinical course and management of Japanese patients deficient in natural anticoagulants
- Genetic variation and natural anticoagulants
- Protein Z and natural anticoagulants in children on peritoneal dialysis and hemodialysis
- Anticuagulants: An overview of naturaland Synthetic Therapeutic anticoagulants
- Stability of prothrombin times in sheep dosed with naturaland synthetic anticoagulants
- naturalregulatory anticoagulants proteins among Sudanese patients with dengue virus infection
- Comparison of plasma levels of natural anticoagulants (protein C and protein S) among Jordanian smokers and non-smokers
- Alteration of some natural anticoagulants in dogs with chronic renal failure
- The interactions among B2-glycoprotein I, natural anticoagulants, and complement: significance for the antiphospholipid syndrome
- Assessment of risk factors for deep vein thrombosis associated with natural anticoagulants and fibrinolytic regulatory proteins.
- Levels of natural anticoagulants Protein C, Protein S and Antithrombin III in Patients with Solid Malignancies
- Deficiency of natural anticoagulants
- Predictive role of natural anticoagulants in Prognosis of Chronic Liver Disease in Pediatric Age Group
- PB2232 THE natural anticoagulants IN PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
- natural anticoagulants in sepsis—Too much of a good thing?
- natural anticoagulants deficiencies and transient ischemic attacks
- CHANGES IN THE LEVEL OF natural anticoagulants BLOOD PRETERM POSTNATAL.
- Experimental and clinical research on the interaction between inflammation and coagulation and its control by natural anticoagulants
- Coagulation factors and natural anticoagulants in polycythemia vera patients, relation with JAK2V617F mutation load
- Genetic thrombophilia and natural anticoagulants: importance of polymorphisms within and outside the genes
- Levels of natural anticoagulants, antithrombin III and protein C in diabetic vascular disease
- Effects of living at 300 meters below sea level on coagulation and natural anticoagulants.
- natural anticoagulants protein c and protein s in acute ischemic stroke in young adults
- An evaluation of natural anticoagulants and coagulation factors in patients with congenital disorders of glycosylation type I
- Inhibition of Pulmonary Coagulopathy by Nebulized natural anticoagulants during Streptococcus Pneumoniae Pneumonia in Rats
- natural anticoagulants and activated protein C resistance in patients with antiphospholipid antibodies (aPL) and in patients with pirmary venous thrombosis without …
- Preliminary Characterization of Occipodins, naturalProduct anticoagulants from Hematophagous Marine Parasites, Isopod Elthusa vulgaris and Copepod …
- Epoxidation of some skin-photosensitizes and anticoagulants of naturalcoumarin and furocoumarins as potential alkylating agents of DNA
- … open abdomen: an analysis of physiologic subgroups. The anticoagulated trauma patient: the Ontario experience in the era of direct oral anticoagulants. The effect of …
- naturalanticoagulant mechanisms.
- The regulation of naturalanticoagulant pathways
- A pharmacological review of dicoumarol: An old naturalanticoagulant agent
- New mechanisms for vascular control of inflammation mediated by naturalanticoagulant proteins
- Biochemistry of heparin antithrombin interactions, and the physiologic role of this naturalanticoagulant mechanism
- Profile of naturalanticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients
- Beta2‐glycoprotein I in thrombosis: evidence for a role as a naturalanticoagulant
- Interaction between interleukin-6 and the naturalanticoagulant system in acute stroke
- Genome wide association study for plasma levels of naturalanticoagulant inhibitors and protein C anticoagulant pathway: the MARTHA project
- Deficiency of naturalanticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon?
- Contribution of naturalanticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients
- Modulation of monocyte function by activated protein C, a naturalanticoagulant
- The role of naturalanticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis
- naturalanticoagulant pathways in normal and transplanted human hearts.
- … (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a naturalanticoagulant
- naturalanticoagulant protein levels in Turkish patients with inflammatory bowel disease
- Studies of naturalanticoagulant proteins and anticardiolipin antibodies in patients with the lupus anticoagulant
- naturalanticoagulant inhibitors: activated Protein C
- Activated protein C, a naturalanticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation
- Antithrombin III in fresh and cultured human endothelial cells: a naturalanticoagulant from the vascular endothelium
- Age-specific onset and distribution of the naturalanticoagulant deficiency in pediatric thromboembolism
- Colloid transfusion, naturalanticoagulant depletion, and symmetric peripheral gangrene
- Targeting protease nexin-1, a naturalanticoagulant serpin, to control bleeding and improve hemostasis in hemophilia
- naturalanticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus.
- Increased risk of venous thrombosis in carriers of naturalanticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia …
- Analysis of inherited thrombophilic mutations and naturalanticoagulant deficiency in patients with idiopathic portal hypertension
- Alterations in naturalanticoagulant levels during allogeneic bone marrow transplantation: a prospective study in 27 patients.
- Targeted gene disruption of naturalanticoagulant proteins in mice
- The endothelial heparan sulfate-antithrombin III naturalanticoagulant pathway in normal and transplanted human kidneys.
- Anticoagulant drugs increase naturalkiller cell activity in lung cancer
- naturalanticoagulant deficiencies in Thais: A population-based study
- Anticoagulant and antiprotease profiles of a novel naturalheparinomimetic mannopentaose phosphate sulfate (PI-88)
- naturalanticoagulant and fibrinolytic pathways in renal allograft failure.
- The naturalanticoagulant protein S is decreased in male smokers
- Uncovering the genetic background of naturalanticoagulant deficiencies: time to look behind the scenes
- Chemically sulfated naturalgalactomannans with specific antiviral and anticoagulant activities
- naturalanticoagulant proteins in the regulation of autoimmunity: potential role of protein S
- A review on anticoagulant/antithrombotic activity of naturalplants used in traditional medicine
- Structural features and anticoagulant activities of a novel naturallow molecular weight heparin from the shrimp Penaeus brasiliensis
- Association of the urine homocysteine/creatinine ratio to proinflammatory cytokine, naturalanticoagulant, and nitric oxide levels in cerebrovascular disease
- Effect of pulmonary tuberculosis on naturalanticoagulant activity in therapy-naïve Ghanaian adults; a case-control study
- naturalanticoagulant system in children with beta-thalassemia major
- … a new liquid chromatography-tandem mass spectrometry ion-trap technique for the simultaneous determination of thirteen anticoagulant rodenticides, drugs, or natural…
- … structural studies of two naturalisoforms of ammodytoxin, phospholipases A2 from Vipera ammodytes ammodytes which differ in neurotoxicity and anticoagulant …
- Type II protein C deficiency: identification and molecular modelling of two naturalmutants with low anticoagulant and normal amidolytic activity.
- Cerebral microbleeds in murine amyloid angiopathy: naturalcourse and anticoagulant effects
- Effects of anticoagulant, serum, and temperature on the naturalkiller activity of human peripheral blood mononuclear cells stored overnight
- Anticoagulant activity of a naturalprotein purified from Hypomesus olidus
- Anticoagulant activity screening of an in-house database of naturalcompounds for discovering novel selective factor Xa inhibitors; a combined in silico and in vitro …
- Additive thrombin inhibition by fast moving heparin and dermatan sulfate explains the anticoagulant effect of sulodexide, a naturalmixture of glycosaminoglycans
- Bioactive naturalCompounds with Antiplatelet and Anticoagulant Activity and Their Potential Role in the Treatment of Thrombotic Disorders
- Purification of Protein C, a naturalAnticoagulant, from Human Plasma by Affinity Chromatography with Convanavalin A
- naturalinhibitors of blood coagulation and fibrinolysis in patients with lupus anticoagulant.
- Pulmonary hypertension in adult Egyptian patients with b-thalassemia major: correlation with naturalanticoagulant levels
- Functional characterization of twelve naturalPROS1 mutations associated with anticoagulant protein S deficiency
- Activity levels of naturalanticoagulant proteins in childhood acute lymphoblastic leukemia: relation to thromboembolic complications and treatment
- Impact of sustained virus elimination on naturalanticoagulant activity in patients with chronic viral hepatitis C
- Membrane binding and anticoagulant properties of protein S naturalvariants
- Molecular modelling, 3D-QSAR, and drug docking studies on the role of naturalanticoagulant compounds in antithrombotic therapy
- Analysis of levels of naturalanticoagulant proteins and activated protein C resistance in venous thromboembolism patients referred to Iranian Blood …
- Congenital deficiencies of naturalanticoagulant systems responsible for recurrent thromboembolism
- Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, naturalinhibitors and molecular markers of thrombosis.
- Impact of erythrocytapheresis on naturalanticoagulant levels in children with sickle cell disease: A pilot study
- IN VITRO AND IN VIVO ANTICOAGULANT ACTIVITY OF IMPERATA CYLINDRICA A NOVEL ANTICOAGULANT LEAD FROM naturalORIGIN.
- 3 The Heparan Sulfate-Antithrombin Pathway: A naturalAnticoagulant Mechanism of the Blood Vessel Wall
- Mechanisms of the antimetastatic effects of anticoagulant drugs: dependence on naturalkiller (NK) cell activity
- Haemorheological, naturalAnticoagulant and Homocysteine Profiles in Coeliac Disease: a Case-control Study
- Effects of acrolein, a naturaloccurring aldehyde, on the anticoagulant serpin antithrombin
- Effects of pulse-therapy on naturalanticoagulant system of the endothelium in nonspecific aortoarteritis
- A STUDY OF naturalOCCURRING ANTICOAGULANT AND ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH HISTORY OF THROMBOSIS IN TEHRAN
- THE POTENTIAL OF NYAMPLUNG LEAF EXTACT AS A naturalANTICOAGULANT
- Extraction of Sulphated Polysaccharides (SPs) from Different Species of Marine Macroalgae and Studying their Role as naturalAnticoagulant
- Pathogenetic Substantiation of the Usability of the naturalAnticoagulant Sulodexide in a Combine Treatment of Pregnant Women with Premature Delivery
- The anticoagulant, hepatic lipase-releasing and lipoprotein lipase-releasing activities of several naturaland chemically modified heparins differ
- naturalanticoagulant and antifibrinolysis in patients with chronic renal failure with and without hemodialysis
- Haemorheological, naturalAnticoagulant and Homocysteine Profiles in Coeliac Disease: A Case-control Study
- naturalANTICOAGULANT-PROTEIN S DEFICIENCY AND PREGNANCY OUTCOME-A RARE CASE REPORT
- Zinc Binds and Regulates the Activity of the naturalAnticoagulant Protein Z
- Anticoagulant and Antiprotease Profiles of a Novel naturalHeparinomimetic Mannopentaose Phosphate Sulfate (PI-88)
- Marine Sulfated Polysaccharides with Unusual Anticoagulant Action through an Additional Unrelated naturalInhibitors Mechanism
- Hereditary deficiency of all vitamin K‐dependent procoagulants and anticoagulants
- Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus.
- < The> natural anticoagulants
- The effects of alcohol on coagulation and fibrinolytic factors: a controlled trial.
- Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies.
- Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome.
- Prothrombotic states in young people with idiopathic stroke. A prospective study.
- Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation.
- Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism.
- Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study
- High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma.
- Postoperative changes in coagulant and anticoagulant factors following abdominal aortic surgery
- High levels of factor VIII and venous thrombosis
- Coagulation factors in nephrotic syndrome
- Changes in blood coagulation, platelet function, and plasminogen-plasmin system in diabetes
- Risk factors for thromboembolism: pathophysiology and detection
- Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection
- Thrombophilia in pregnancy
- Decline of proteins C and S and factors II, VII, IX and X during the initiation of warfarin therapy
- The Significance of TFPI in Clotting Assays–Gomparison and Combination with other anticoagulants
- Nature’s anticoagulants: controlling the clotting cascade
- Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver
- Are there markers of the blood-vessel wall interaction and of thrombus formation that can be used clinically?
- Arg506–Gln mutation in factor V and risk of thrombosis during pregnancy
- Epidemiology of coagulation disorders
- Familial coagulation-inhibiting and fibrinolytic protein deficiencies in juvenile transient ischaemic attacks.
- Congenital deficiency of histidine-rich glycoprotein: failure to identify abnormalities in routine laboratory assays of hemostatic function, immunologic function, and trace …
- Factors in xenograft rejection
- Relevance of proteins C and S, antithrombin III, von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing …
- Risk of thromboembolic complications in patients with inflammatory bowel disease
- Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate.
- Factor Vila and other haemostatic variables following bone marrow transplantation
- Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden
- Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia
- Factor V Cambridge: A New Mutation (Arg306→Thr) Associated With Resistance to Activated Protein C
- Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′‐untranslated region of the prothrombin gene
- Protein C, isolation and potential use in prevention of thrombosis.
- Disseminated intravascular coagulation findings in 100 patients.
- The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial
- Changes in the plasma levels of proteins C and S in young women on low-dose oestrogen oral contraceptives.
- Thrombosis promoting changes in chronic liver diseases.
- Markers of thrombin and plasmin generation in patients with inherited thrombophilia.
- Protein S deficiency associated to anti-protein S antibodies in a patient with mixed connective-tissue disease and its reversal by danazol
- Relationship between vitamin K dependent coagulation factors and anticoagulants (protein C and protein S) in neonatal vitamin K deficiency.
- Significant elevation of protein C and protein S levels in thrombotic disorders by low dose danazol.
- Antiphospholipid antibody and antiphospholipid antibody syndrome.
- A prospective evaluation of atherosclerotic risk factors and hypercoagulability in young adults with premature lower extremity atherosclerosis
- Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism
- Reduction of antithrombin III, protein C, and protein S levels and activated protein C resistance in polycythemia vera and essential thrombocythemia patients with …
- Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid
- Changes of hemostatic factors in patients with hemoglobinopathies.
- The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss
- Overtight nappy precipitating thrombosis in antithrombin III deficiency.
- EFFECT OF PORCINE ENDOTHELIAL TISSUE FACTOR PATHWAY INHIBITOR ON HUMAN COAGULATION FACTORS1
- Alpha2-macroglobulin levels are high in adult patients with congenital antithrombin deficiency
- Activated protein C and antithrombin-III activity during arterial thrombolysis with recombinant tissue-type plasminogen activator in rabbits.
- Protein C deficiency: summary of the 1995 database update
- Effect of thymalin on blood coagulation and fibrinolysis
- Acute fibrinolysis following craniotomy and removal of metastatic tumor of the cerebellum: case report
- Hypercoagulable states in arterial thromboembolism
- Treatment of deep vein thrombosis using temporary vena caval filters after allogeneic bone marrow transplantation
- Hypercoagulability in patients with veno-occlusive disease after bone marrow transplantation
- Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
- Hemostasis activation in patients with liver cirrhosis
- The impact of the search for thrombophilia risk factors among antiphospholipid syndrome patients with thrombosis
- Hereditary protein S deficiency and familial thrombosis. A review with description of a Danish family with protein S deficiency
- Effect of intravenous infusions of thrombin and heterogenous blood on lymph coagulability
- Protein C, protein S and heparin cofactor II–their significance as the regulatory factors in the blood coagulation cascade
- A search for autoantibodies to thrombomodulin in patients with documented thrombosis
- Venous thrombosis: antithrombin III deficiency.
- Hemostatic changes in Rocky Mountain spotted fever and Mediterranean spotted fever
- AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state
- Naturally occurring anticoagulants and bone marrow transplantation
- Thrombophilia: some recent advances in understanding.
- Hypercoagulability syndrome due to heparin co-factor deficiency
- Ischemic stroke due to deficiency of coagulation inhibitors. Report of 10 young adults.
- Laboratory test utilization in the diagnosis of hypercoagulability
- Correlation of haemostatic variables and structural changes of major arteries of the head in ischemic stroke patients
- Effects of recombinant human erythropoietin [rHuEPo] on haemostasis in patients maintained on chronic hemodialysis
- Role of the parasympathetic division of the autonomic nervous system in regulating blood coagulation and fibrinolysis following intravenous injection of thrombin
- A Case of Congenital Vitamin K Dependent Coaguation Factor Defeciency
- Hemostatic Abnormalities Related to Bone Marrow Transplantation
- New agents for the treatment of thrombosis
- EXPRESSION OF HUMAN THROMBOMODULIN COFACTOR ACTIVITY IN PORCINE AORTIC ENDOTHELIAL CELLS.
- PCR screening method to detect factor v leiden mutation in tia and stroke
- Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation
- Is inherited thrombophilia a risk factor for arterial stroke?
- Inherited fibrinogen abnormality causing thrombophilia
- Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis
- Infrequency of stroke caused by specific coagulation disorders
- Organization of a Randomized Clinical Trial for the Prevention of Recurrent Thrombosis in the Antiphospholipid Syndrome: the WAPS Project (Warfarin in …
- Fortnightly review: Disseminated intravascular coagulation: Diagnosis and treatment
- Cerebral infarction and familial protein S deficiency.
- Effect of vitamin-E-modified dialysers on dialyser clotting, erythropoietin and heparin dosage: a comparative crossover study
- Budd‐chiari syndrome associated with factor V leiden mutation: A report of 6 patients
- FV-ARG-506-GLN-mutation-associated resistance to activated protein C in ischemic stroke
- Antiphospholipid syndrome patients’ monocytes are “primed” to express tissue factor
- Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis of 238 patients with congenital deficiency of …
- Disseminated intravascular coagulation (DIC)
- Protein S deficiency and factor V Leiden gene in pregnancy
- L-asparaginase treatment reduces the anticoagulant potential of the protein C system without affecting vitamin K-dependent carboxylation
- The Methylenetetrahydrofolate Reductase TT677 Genotype Is Associated with Venous Thrombosis Independently of the Coexistence of the FV Leiden and the …
- Fibrinolysis, inhibitors of blood coagulation, and monocyte derived coagulant activity in acute malaria
- The investigation of patients with retinal vascular occlusion
- Use of protein-C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans
- Comparison of coagulation parameters for healthy subjects and Behçet disease patients with and without vascular involvement
- The therapeutic potential of novel anticoagulants
- Isolated familial plasminogen deficiency may not be a risk factor for thrombosis
- preparation: pre-analytical variation
- The Biologic Impact of Hereditary Defects that Cause Thrombosis
- Anticoagulation in patients with acute renal failure treated with continuous renal replacement therapies
- EXPRESSION OF HUMAN THROMBOMODULIN COFACTOR ACTIVITY IN PORCINE ENDOTHELIAL CELLS1, 2
- Cerebral Infarction in PeopleUnder 40 Years I
- Inhibition of endothelial cell thromboresistance by homocysteine
- Progressive intracranial occlusive disease associated with deficiency of protein S. Report of two cases.
- Thrombophilia testing: what do we think the tests mean and what should we do with the results?
- Blood coagulation and its alterations in hemorrhagic and thrombotic disorders.
- Obstetric Complications: Consumption Coagulopathy
- Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients
- Factor V Leiden is associated with repeated and recurrent unexplained fetal losses
- Changes in the plasma levels of vitamin K‐dependent proteins C and S and of C4b‐binding protein during pregnancy and oral contraception
- The molting cycle of the spiny lobster, Panulirus argus Latreille. III. Physiological changes which occur in the blood and urine during the normal molting cycle
- Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of …
- A Rapid and reliable PCR based method for detecting the blood coagulation Factor V Leiden mutation
- Acquired protein S deficiency with multiple thrombotic complications after orthotopic liver transplant
- Hemostatic and metabolic abnormalities in diabetes mellitus. The search for a link
- Recombinant tissue plasminogen activator (rt‐PA) for veno‐occlusive liver disease in pediatric autologous bone marrow transplant patients
- Hypercoagulable abnormalities and postoperative failure of arterial reconstruction
- Prevalence of anti–protein S antibodies in patients with systemic lupus erythematosus
- Protein C and S response to danacrine in end-stage renal disease
- Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment
- Diffuse arterial thrombosis in a young man with elevated lipoprotein (a) and minimal atherosclerosis
- Relationship between maternal antithrombin III and protein C/protein S levels before, during and after delivery
- Prothrombotic risk factors and acute kidney transplant rejection
- Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation
- The diagnosis and clinical management of thrombophilia
- Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study
- Thromboelastography identifies sex-related differences in coagulation
- Cardiovascular materials
- In‐vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with β‐thalassaemia major
- Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis
- Protein C deficiency related to valproic acid therapy: a possible association with childhood stroke
- The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit
- Mathematical Model of Serine Protease Inhibition in the Tissue Factor Pathway to Thrombin (∗)
- The thrombophilic state induced by therapeutic agents in the cancer patient
- The prothrombin gene G20210A variant: prevalence in a UK anticoagulant clinic population
- Hypercoagulable states: molecular genetics to clinical practice
- Inherited thrombophilia and pregnancy
- Cerebral venous sinus thrombosis associated with hepatic cirrhosis
- Prothrombotic states associated with retinal venous occlusion in young adults
- An abnormal plasma distribution of protein S occurs in functional protein S deficiency
- Increased platelet activation and abnormal membrane glycoprotein content and redistribution in myeloproliferative disorders
- Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment
- Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke …
- Hypercoagulable states in patients with leg ischaemia
- Multiple organ dysfunction syndrome in bone marrow transplantation
- Early hemostatic alterations following bone marrow transplantation: a prospective study
- Evaluation of the hypercoagulable state: whom to screen, how to test and treat
- Thrombin inhibition in discordant xenograft rejection
- Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L …
- Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters
- THROMBOSIS IN CHURG—STRAUSS SYNDROME. BEYOND VASCULITIS?
- Hereditary protein C deficiency and portal-vein thrombosis.
- Cancer, thrombosis, and anticoagulants
- Why do patients with antiphospholipid antibody clot?
- Does thrombophilia play an aetiological role in Legg-Calvé-Perthes disease?
- Age-related differences in outcome and severity of DIC in children with septic shock and purpura
- Post-chemotherapy Sweet’s syndrome in three patients with AML
- Coagulation abnormalities in sepsis: relation with inflammatory responses
- Physiologic changes in coagulation and fibrinolysis during normal pregnancy
- Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus
- Investigations for thrombotic tendencies
- Thrombophilia: a genetic predisposition to thrombosis.
- High level of protein C and protein S in nephrotic syndrome
- Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis
- Presence of serum antibodies to coagulation protein C in patients with systemic lupus erythematosus is not associated with antigenic or functional protein C …
- Arterial thrombosis in nephrotic syndrome due to minimal change glomerulonephritis
- Prevalence of protein C deficiency in the healthy population
- Neurology and the blood: haematological abnormalities in ischaemic stroke
- Mesenteric venous thrombosis: a case report
- Reduced blood levels of coagulation inhibitors in chronic hemodialysis compared to CAPD
- Detection of the prethrombotic state due to procoagulant imbalance
- Effect of acetylcholine and atropine on the secretion of blood clotting compounds into the blood stream by the kidneys
- Efficacy of danazol in a patient with congenital protein s deficiency: Paradoxical evidence for decreased platelet activation with increased thrombin generation
- Veno‐occlusive disease of the liver after hemopoietic cell transplantation
- Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study
- Lower extremity arterial occlusions in young patients with Crohn’s colitis and premature atherosclerosis: report of six cases.
- Influence of demographic factors on antithrombin III activity in a healthy population
- Warfarin-induced skin necrosis
- Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial [see …
- Coexistence of factor V Leiden and factor II A20210 mutations and recurrent venous thromboembolism
- Pathogenesis of Thrombotic Complications of Haematological Malignancies
- Laboratory markers of coagulation activation
- A hirudin catching ELISA for quantitating the anticoagulant in biological fluids
- Basic analytical parameters as the predictive factors for 30‐day case fatality rate in stroke
- The role of platelets in the coagulopathy of heatstroke a study of platelet aggregation in heatstroke patients during the Makkah pilgrimage (Haj) to
- Hydroxylation of styrene-diene triblock copolymers in solution and on the surface
- Reversal of thrombocytopenia following oral anticoagulation in two patients with primary antiphospholipid syndrome
- Sustained bleeding after a leech bite in the apparent absence of hirudin
- Antiphospholipid antibodies, prethrombotic states, and stroke.
- Protein C pathway, antiphospholipid antibodies and thrombosis
- Antiphospholipid antibodies, haemostatic variables and thrombosis–a survey of 144 patients
- Lower extremity amputations in adults less than forty years of age: an underestimated risk from premature atherosclerosis
- High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria
- Strokes in Thai children: etiology and outcome.
- Stroke in relapsing thrombotic thrombocytopenic purpura.
- Disseminated intravascular coagulation
- Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation
- Hypercoagulability and the management of anticoagulant therapy in surgical patients: review and recommendations
- Benign intracranial hypertension: a non-thrombotic complication of the primary antiphospholipid syndrome?
- Effects of annexin V on the activity of the anticoagulant proteins C and S
- Contraceptive choices in women with coagulation disorders
- Frequency of protein S deficiency in general Japanese population
- 7 Antiphospholipid antibodies and thrombosis
- Basic, laboratory and clinical aspects of thromboembolic diseases
- Increased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagulability factors
- Is there a need for antithrombin III substitution early after burn injury?
- Enhancement of protein S anticoagulant function by β2-glycoprotein I, a major target antigen of antiphospholipid antibodies
- Acidosis induced disseminated intravascular microthrombosis and its dissolution by streptokinase
- A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?
- Efficacy and safety of weight-adapted nadroparin calcium vs. heparin sodium in prevention of clinically evident thromboembolic complications in 1,190 general …
- Hemostasis in dentistry, with special reference to hemocoagulation: I. The basic theory of hemostasis
- Immunology: Antiphospholipid antibodies and β2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach
- Transient global amnesia in a young woman on prolonged treatment with oral contraceptive drugs
- The antiphospholipid/cofactor syndromes: a primary variant with antibodies to β2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays
- Association of osteonecrosis in systemic lupus erythematosus with abnormalities of fibrinolysis
- Risk of recurrent venous thromboembolism in patients with the factor V Leiden (FVR506Q) mutation: effect of warfarin and prediction by precipitating factors
- Recent advances in understanding clotting and evaluating patients with recurrent thrombosis
- An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans–associated meningococcemia
- Preparation for regional anaesthesia induces changes in thrombelastography
- The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?
- Thrombotic risk during pregnancy and puerperium in women with APC-resistance–effective subcutaneous heparin prophylaxis in a pregnant patient
- Superior sagittal sinus and inferior vena cava thrombosis with acute Budd-Chiari syndrome.
- Coagulation and anticoagulation systems in newborns–correlation with their mothers at delivery
- Cells and the activation of factor VII
- Diagnosis and management of pulmonary embolism in pregnancy
- Factor V Leiden and the risk of proximal venous thrombosis after total hip arthroplasty
- Passive smoking adversely affects the haemostasis/fibrinolytic parameters in healthy non-smoker offspring of healthy smokers
- Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis
- Enhancement of plasminogen binding and fibrinolysis by chloropeptin I
- Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies-a crucial role for acquired free protein S deficiency
- Is testing for inherited coagulation inhibitor deficiencies in young stroke patients worthwhile?
- Pharmacokinetic study of the low-molecular-weight heparin fraxiparin in patients with nephrotic syndrome
- Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud’s phenomenon and thrombosis
- Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism
- The antiphospholipid syndrome
- Oral anticoagulation in the community
- A hypercoagulable state in activated protein C resistant patients with ischemic stroke
- Childhood stroke associated with protein C or S deficiency and primary antiphospholipid syndrome
- Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation (HSCT)?
- Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts
- Familial thrombophilia and activated protein C resistance: thrombotic risk in pregnancy?
- Blood collection and sample preparation: pre-analytical variation
- Recurrent renal vein thrombosis and renal failure associated with antithrombin-III deficiency
- The nephrotic syndrome and its complications
- Risk factors for venous thromboembolism in pregnancy
- Disseminated intravascular coagulation in elective primary total hip replacement
- Prothrombotic changes in children with sickle cell disease: relationships to cerebrovascular disease and transfusion
- Clotting for the clinician: an overview of thrombosis and antithrombotic therapy
- Placental pathology in antiphospholipid antibody syndrome
- Effects of recombinant human erythropoietin on physiological inhibitors of coagulation in children on continuous ambulatory peritoneal dialysis
- Arterial thrombosis associated with immune thrombocytopenia: presence of a platelet aggregating IgG synergistic with thrombin and adrenalin
- Warfarin and heparin-induced skin necrosis and the purple toe syndrome: infrequent complications of anticoagulant treatment
- Aprotinin in deep hypothermic circulatory arrest
- Endothelial cell injury in cardiovascular surgery
- Arterial thrombosis of the arm in infant of diabetic mother
- Circulating anticoagulants: physiologic and pathophysiologic
- Hypercoagulable state and graft rejection—is there a link?
- The role of heparin in intrinsic blood coagulation
- Haematological manifestations of systemic lupus erythematosus
- Hepatic veno-occlusive disease after bone marrow transplant
- Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism
- Patient management of pulmonary embolism
- Changes in plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) by the interferon treatment for chronic hepatitis C
- Study of the Pharmacological Effect of the Bile Salt, Sodium Scymnol Sulfate, from Rhizoprionodon acutus. II.: Prophylactic Effect of Scymnol on Lesion Development …
- Low‐dose warfarin decreases coagulability without affecting prothrombin complex activity
- A comparative study of the clotting power of the blood and lymph
- Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients
- Free protein S deficiency: a possible association with cerebrovascular occlusion.
- Effect of tamoxifen on measurements of hemostasis in healthy women
- Clinical Associations of Antibodies to Phospholipids and/or
- Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis
- Hyperhomocysteinemia: a risk factor for arterial and venous thrombotic disease
- Interleukin-1 in haemophilic arthritis
- Portal vein thrombosis associated to prothrombin G20210A mutation and protein C deficiency
- Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden
- Coumarin necrosis, neonatal purpura fulminans, and protein C deficiency
- Effect of acupuncture on monoamines and adenosine triphosphatase activity in lateral hypothaiamic area of obese rats
- Cutaneous necrosis associated with the antiphospholipid syndrome and mycosis fungoides
- Cranial sinus thrombosis and preeclampsia.
- The effect of n-3 fatty acids on blood coagulation
- Response to activated protein C upon storage of whole blood and plasma
- Vascular-bed–specific hemostasis and hypercoagulable states
- Visual scotomata resulting from lupus anticoagulant in a patient with lymphoma in remission
- Disseminated Intravascular Coagulation in Individuals with Cancer
- Prevalence of mutated factor V ARG506 to GLN in Italians
- Polyion sensors as liquid junction‐free reference electrodes
- Cerebral venous thrombosis in the nephrotic syndrome
- Relation of the changes in hemorheologic indices and the site and size of cerebral infarction
- Effect of hemodialysis on protein C, protein S, and antithrombin III levels
- Venous surgery in patients with congenital antithrombin III deficiency
- Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile
- 35 LABORATORY INVESTIGATION OF HAEMOSTASIS
- Effect of subcutaneous administration of recombinant human erythropoietin on plasma protein C, protein S, and antithrombin III levels in patients on continuous …
- Functional activity of protein C in liver cirrhosis and acute viral hepatitis on the Ivory Coast.
- Transcranial Doppler patterns in patients with anticardiolipin antibodies
- Retinal vein thrombosis associated with chronic hepatitis C: a case series and review of the literature
- The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome
- Analysis of blood coagulation in the zebrafish
- Sagittal sinus thrombosis associated with transient free protein S deficiency after L-asparaginase treatment: case report and review of the literature
- Thromboembolic disease in pregnancy
- Protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis and hemodialysis
- The antiphospholipid-protein syndrome
- Overview of the Hypercoagulable States
- The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow …
- The syndrome of hepatic veno-occlusive disease after marrow transplantation
- Department of Dermatology
- Transient correction of partial congenital factor V deficiency in nephrotic syndrome
- Anticuerpos antifosfolipido: Valoracion de los sistemas de la hemostasia.
- Classification of Pressure Ulcers-Reply
- Venous thromboembolism and cancer: a two-way clinical association
- Antithrombotics/serine proteases
- Pulmonary embolism in a patient with coagulopathy from end-stage liver disease
- The prothrombin response to the parenteral administration of large doses of vitamin K in subjects with normal liver function and in cases of liver disease: a …
- Venous thromboembolism after hip fracture surgery in a patient with haemophilia B and factor V Arg506Gln (factor V Leiden)
- Treatment of patients with antiphospholipid antibodies during pregnancy
- Hypercoagulable state in patients with antiphospholipid syndrome is related to high induced tissue factor expression on monocytes and to low free protein S
- A comparison of postoperative thrombotic potential following abdominal aortic surgery, carotid endarterectomy, and femoro-popliteal bypass
- Tissue factor pathway inhibitor and the revised theory of coagulation
- Computer-aided design of thrombin inhibitors
- Current concepts of anticoagulant therapy in pregnancy
- Resolution of Budd‐Chiari syndrome following bone marrow transplantation for paroxysmal nocturnal haemoglobinuria
- Evaluation of the haemostatic system during ketoacidotic deterioration of diabetes mellitus
- The expression of coagulation factors during murine development
- Fundamental research in molecular biology: relevance to medicine
- How to detect activated coagulation
- Splenomegaly, hypersplenism and coagulation abnormalities in liver disease
- Thrombosis and hemostasis in renal disease
- Vascular homeostasis, adhesion molecules, and macrovascular disease in non‐insulin‐dependent diabetes mellitus
- Clinical trials for the antiphospholipid syndrome
- Protein S deficiency in lupus erythematosus secondary to hereditary angio‐oedema
- Arg sup 506-Gln Mutation in Factor V and Risk of Thrombosis During Pregnancy
- The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis
- Early prediction of stroke severity: role of the erythrocyte sedimentation rate
- The G20210A polymorphism in the 3′-untranslated region of the prothrombin gene in Mexican mestizo patients with primary antiphospholipid syndrome
- The effect of near‐normoglycaemic control on plasma levels of coagulation factor VII and the anticoagulant proteins C and S in insulin‐dependent diabetic patients
- Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes
- The effect of epidural blockade on postoperative hypercoagulability following abdominal aortic bypass surgery
- Cerebral venous thrombosis in patients with nephrotic syndrome
- The control of thrombin generation in haemoglobinopathies and other haemolytic red cell disorders in children
- Catastrophic antiphospholipid syndrome
- Thrombophilia: how far should a clotter be investigated?
- Hypercoagulable states and lower limb ischemia in young adults
- Administration of autologous fetal membranes: effects on the coagulation in pregnant mini-pigs
- Hemorheological and hemostatic parameters in children with nephrotic syndrome undergoing steroid therapy
- The prediction of thromboembolism
- Ischemic stroke in Korean young adults
- A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
- Isolation and characterization of americanin, a specific inhibitor of thrombin, from the salivary glands of the lone star tickAmblyomma americanum (L.)
- Protein C deficiency and portal thrombosis in liver transplantation in children
- Platelets abolish the profibrinolytic effect of activated protein C
- An investigation of the role of antiphospholipid antibodies and [beta] 2 glycoprotein-I in the modulation of haemostatic reactions
- Management of thrombophilia in pregnancy
- Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis
- Deep cerebral venous thrombosis and hereditary tissue plasminogen activator (t-PA) deficiency
- Premature closure of foramen ovale and renal vein thrombosis in a stillborn twin homozygous for methylene tetrahydrofolate reductase gene polymorphism: A …
- Lupus anticoagulant in patients with peripheral vascular disease: a prospective study
- Previous cytomegalovirus infection and risk of coronary thrombotic events after stent placement
- The effect of n‐3 polyunsaturated fatty acids on lipids, haemostasis, neutrophil and monocyte chemotaxis in insulin‐dependent diabetes mellitus
- Early pathophysiology of osteonecrosis
- Abnormalities in the protein C anticoagulant pathway detected by a novel assay using human thrombomodulin
- Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human α‐thrombin
- Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli
- New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy
- Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy
- A new blood-clotting theory
- Antiphospholipid syndrome
- Increased Risk for Venous Thrombosis in Carriers of the Prothrombin G→A20210 Gene Variant
- Medical Perspective Antiphospholipid Antibodies, Thrombosis and Atherosclerosis in Systemic Lupus Erythematosus: a Unifying’Membrane Stress Syndrome’ …
- Acute coronary syndromes: unstable angina and non–Q-wave myocardial infarction
- Heparin, its chemistry, pharmacology and clinical use
- Acquired free protein S deficiency in children with steroid resistant nephrosis
- The role of thrombosis in severe pulmonary hypertension
- Analysing early liver dysfunction after bone marrow transplantation
- Rapid detection of anticardiolipin antibodies
- Warfarin-induced complete bilateral breast necrosis
- Serum anti-β2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients
- Meconium and amniotic fluid embolism: effects on coagulation in pregnant mini-pigs
- Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings
- α-Thalassemia among pediatric Nb S homozygotes
- On the nature of hypercoagulability
- Absence of thrombosis in subjects with heterozygous protein C deficiency
- Plasma and urinary heparin cofactor II levels in patients with nephrotic syndrome
- Contents, Vol. 26, 1996
- Anticardiolipin and acquired protein S deficiency in early childhood
- Drug Treatment of Stroke in Patients with Antiphospholipid Antibodies
- Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases
- Protein C levels as a prognostic indicator of outcome in sepsis and related diseases
- Pregnancy outcome in women with antiphospholipid antibodies
- Coagulation cascade, fibrinolytic system, antithrombin III, protein C and protein S in patients maintained on continuous ambulatory peritoneal dialysis
- Haemostatic abnormalities persist despite glycaemic improvement by insulin therapy in lean type 2 diabetic patients
- Recombinant Hirudin
- Effectiveness and safety of blood transfusion: have we lost the plot?
- Practical haemodialysis began with cellophane and heparin: the crucial role of William Thalhimer (1884–1961)
- THE SEQUENTIAL IN UTERO DEATH OF HETEROKARYOTIC MONOZYGOTIC TWINS. A CASE REPORT AND LITERATURE REVIEW
- anticoagulants in women
- Plasma thrombin-antithrombin complexes, latent coagulation disorders and metastatic spread in lung cancer: a longitudinal study
- LOW MOLECULAR WEIGHT HEPARIN FOR THE PREVENTION OF VENO-OCCLUSIVE DISEASE OF THE LIVER IN BONE MARROW TRANSPLANTATION …
- Protein S deficiency occurs in the nephrotic syndrome
- Human genetic diseases of proteolysis
- Protein S and protein C anticoagulant activity in acute and chronic cardiac ischemic syndromes. Relationship to inflammation, complement activation and in vivo …
- Multicenter comparison of five functional and two immunological assays for protein C
- Prevalence of the prothrombin gene variant 20210 G→ A among patients with myocardial infarction
- Hypercoagulable states in patients with retinal venous occlusion
- Prothrombotic and antithrombotic factors are elevated in patients with type 1 diabetes complicated by microalbuminuria
- anticoagulants in pregnancy
- Protein S and C antigen levels in proteinuric patients: Dependence on type of glomerular pathology
- Cerebral venous thrombosis in patients with nephrotic syndrome
- Classification of pressure ulcers
- Cerebral venous thrombosis and procoagulant factors: a case study
- The Arg506Gln mutation (FV Leiden) among a cohort of 4188 unselected Danish newborns
- Haemostatic factors in human peripheral afferent lymph
- The endothelium and thrombosis
- Primary thrombophilia in Mexico: a prospective study
- State-of-the-Art Review: Chemotherapy and Thrombosis in Gynecologic Malignancy
- The thrombotic diathesis associated with the presence of phospholipid antibodies may be due to low levels of free protein S
- Hypercoaguable State Associated with a Deficiency of Protein C in a Thoroughbred Colt
- Fibrinolytic Abnormalities and Antiphospholipid Antibodies
- Lower extremity ischemia in adults younger than forty years of age: a community-wide survey of premature atherosclerotic arterial disease
- The Effect of n-3 Fatty Acids on Lipids and Haemostasis in Patients with Type lla and Type IV Hyperlipidaemia
- Thrombin signalling and protease-activated receptors
- α1-antitrypsin, an inhibitor for thrombin and plasmin
- Production of phospholipid antibodies in selected thrombophilic women differing in genotype at the 506 site of factor V
- Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation
- Early drop in protein C and antithrombin III is a predictor for the development of venoocclusive disease in patients undergoing hematopoietic stem cell transplantation
- Anticoagulation in pregnancy
- Endothelial cell injury in cardiovascular surgery: an overview
- Anticoagulation in
- Circulating levels of endothelial function are modulated by dietary monounsaturated fat
- Prothrombotic abnormalities in inflammatory bowel disease
- Significance of glomerular deposition of protein S in various glomerulopathies
- The kaleidoscope of autoimmunity
- Endothelial dysfunction in critically ill patients: the effect of haemofiltration
- Gender differences in IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion.
- Management of the Septic Patient in the Operating Room
- Stroke in childhood
- 2 Congenital thrombophilia
- Fibrinolysis and coagulation abnormalities in systemic lupus erythematosus
- Problems with anticoagulation for continuous renal replacement therapies
- Low-dose oral contraceptive usage and coagulation
- Cerebrovascular disease with antiphospholipid antibodies: immune mechanisms, significance, and therapeutic options
- Plasma levels of D‐dimer and circulating endothelial adhesion molecules in veno‐occlusive disease of the liver following allogeneic bone marrow transplantation
- Cerbral venous thrombosis in ulcerative colitis and review of the literature
- Thromboembolic risks and complications in nephrotic children
- A familial hemorrhagic diathesis due to an antithrombin
- A missense mutation in γ-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors
- Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives
- Muscle infarction in diabetes: Clinical manifestations and course
- The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects
- Advances in antithrombotic drug therapy for coronary artery disease
- Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range
- Guidelines for the management of thrombophilia. Department of Haematology, The Royal London Hospital, Whitechapel, London, UK.
- An overview of thrombolytic agents
- An experimental investigation into the causes of disseminated intravascular coagulation in hemorrhagic shock
- Deep venous thrombosis and pulmonary embolism in pregnancy
- Hemostasis in malignancy
- The effects of human thrombomodulin on the inactivation of thrombin by its serum inhibitors
- Turbulent Mass Transport and Flame Spreading Rates Within Turbulent Flames Confined in a Variable Area Duct
- Central venous catheters for hemodialysis: How to overcome the problems
- Prothrombotic abnormalities in children with venous thromboembolism
- Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus
- Broadsheet number 53: activated protein c resistance: diagnosis and clinical management
- Homocysteine, coagulation, platelet function, and thrombosis
- Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease
- Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation
- Dealing with Drug-Induced Thrombocytopenia: Case Commentary
- The serial hemostasis-related changes in patients with cerebral infarction: comparison between progressing and non-progressing stroke
- Potentiation of the Action of Warfarin by Bezafibrate in Patients with the Nephrotic Syndrome
- Hypercoagulability in vascular surgery patients
- Young women with advanced aortoiliac occlusive disease: new insights
- Antithrombin: the principal inhibitor of thrombin
- The alterations of the activities of coagulation inhibitors and fibrinolytic factors in stored cord blood could affect the yield of progenitor cells during processing
- Coagulation for blood bankers
- Pathogenic role of antiprotein-phospholipid antibodies
- Mechanisms of hypercoagulation in malignancy and during chemotherapy
- Blood cardiolipin in haemodialysis patients. Its implication in the biological action of platelet-activating factor
- Thromboembolic complications of polycythemia: Polycythemia vera versus smokers’ polycythemia
- Arterial thrombosis in the nephrotic syndrome.
- Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening, and treatment
- Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism.
- Prevalence of antiphospholipid antibodies in deep vein thrombosis and their relationship to blood coagulation and fibrinolysis
- The changing epidemiology of asthma
- Hysterectomy techniques and their effect on the blood markers of thrombogenicity
- Sequential treatment of recurrent mesenteric desmoid tumor
- Serum antibodies to distinct epitopes of the tissue‐type plasminogen activator (t‐PA) in patients with systemic lupus erythematosus
- Proposed classification and pathologic mechanisms of purpura fulminans and skin necrosis
- Homocysteine and oxidized low density lipoprotein enhance platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic …
- Normal fetal growth in women with antiphospholipid syndrome treated with high‐dose intravenous immunoglobulin (IVIG)
- Lupus anticoagulant testing with optical end point automation
- Thromboembolism after hip and knee arthroplasty: diagnosis and treatment
- Coagulation changes in the neonatal period and in early infancy
- Prevalence of factor V Leiden in young adults with retinal vein occlusion
- The Subcutaneous Use of Heparin: A Summary of Observations
- Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells
- Vascular endothelium, haemostasis and thrombosis
- Stroke and antiphospholipid antibodies
- Antiphospholipid antibodies: lupus anticoagulant and anticardiolipin antibody
- Acute aortic thrombosis associated with spinal cord infarction in nephrotic syndrome
- Familial coexistence of primary antiphospholipid syndrome and factor VLeiden
- Clinical and biological aspects of juvenile thrombophilia
- Evaluation of Ischemic Stroke and Recurrent Ischemic Attack
- Oral contraceptives and blood coagulation: a critical review
- Topical diagnosis: prechiasmal visual pathways
- Variations in hemostatic parameters after near-maximum exercise and specific tests in athletes
- Venous thrombosis and women’s health: Identification of risk factors and long terms effects
- 3 Megakaryocytic cell lines
- Increased levels of protein C activity, protein C concentration, total and free protein S in nephrotic syndrome
- Management of Antepartum Fetal Death
- Coagulation studies and fistula blood flow during erythropoietin therapy in haemodialysis patients
- Fibrinolysis in patients with the 1691 G→ A mutation in factor V gene and history of deep vein thrombosis
- Thromboembolism in obstetrics
- Structure and function of endothelial cell integrins
- Thrombosis risk in the trauma patient: prevention and treatment
- Blood coagulation from the beginning until to-day
- Hypercoagulability following multiple trauma
- Effect of xuefu zhuyu decoction on the function of platelets and human umbilical vein endothelial cell
- Postpartum pyometra: a case report
- ACUTE CORONAR’Y SYNDROMES
- Strategies for the design of novel thrombolytic and antithrombolytic agents
- Antiphospholipid syndrome and the skin
- β2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis
- Venous thromboembolism
- Intravascular agglutination of the formed elements of blood
- Effect of plasma from patients with primary antiphospholipid syndrome on platelet function in a collagen rich perfusion system
- Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation in nonhuman primates
- Pathogenesis of and potential therapies for delayed xenograft rejection
- 11a Thrombosis and embolism
- Factor V Leiden: should all women be screened prior to commencing the contraceptive pill?
- A sensitized clotting time
- Antiphospholipid antibodies and the antiphospholipid antibody syndrome
- Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells
- Hemostasis in renal disease: pathophysiology and management
- Modulation of hemostatic mechanisms in bacterial infectious diseases
- Randomized comparison of two different schedules of granulocyte colony-stimulating factor administration after allogeneic bone marrow transplantation
- Comparison of functional testing for resistance to activated protein C and molecular biological testing for factor V R506Q in 370 patients
- Deep vein thrombosis in pregnancy and the puerperium: a comprehensive review
- Protein C and protein S clinical perspectives
- CLINICO-PATHOLOGICAL EVALUATION OF PREGNANCY INDUCED HYPERTENSION
- PACU and ICU care: Evaluation and management of postoperative cardiovascular complications
- Protein C activity and antigen
- Prevalence of the C677T methylenetetra-hydrofolate reductase mutation in Thai patients with deep vein thrombosis
- Prevention and treatment of hepatic venocclusive disease after high-dose cytoreductive therapy
- A Summary of Observations
- Regulation of blood coagulation
- Hereditary protein S deficiency in a large New Jersey kindred
- The prognostic value of the acute‐phase response in stroke recurrence
- Animal studies clearly indicate that dietary marine oils have antithrombotic effects, especially when they replace saturated fany acids in the diet. This chapter reviews …
- Fibromyalgia and interleukin-2 therapy for malignancy
- The syndrome of veno-occlusive disease after blood or marrow transplantation
- The progressive nature of peripheral arterial disease in young adults: a prospective analysis of white men referred to a vascular surgery service
- Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation
- State-of the-Art Review: Prevention of Thrombosis in Gynecologic Malignancy
- Sex hormone binding globulins and atherosclerotic risk in systemic lupus
- Pharmacological actions of sulodexide
- Pulmonary embolism: diagnosis and treatment
- Analysis of hemostasis in the zebrafish
- Antiphospholipid Syndromes and the Nervous System Clinical Features, Mechanisms, and Treatment
- Pre-and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease-a preliminary study
- Studies on Thrombin Formation
- Deep venous thrombosis and pulmonary embolism
- Antithrombotic and thrombolytic therapy for coronary heart disease: consensus and controversy
- A review of tissue plasminogen activator in the treatment of veno‐occlusive liver disease after bone marrow transplantation
- Plasma levels of lipoprotein (a) are elevated in patients with the antiphospholipid antibody syndrome
- Endothelium-derived haemostatic factors and the antiphospholipid syndrome
- Physiology of blood coagulation
- Poly‐(2‐hydroxyethyl methacrylate) particles for preoprative endovascular occulusion of extensive angiodysplasias
- Intensive Treatment of the Patient with Hepatic Trauma
- Venocclusive disease of the liver after bone marrow transplantation: the role of hemostasis
- Newer strategies for the treatment of heparin‐induced thrombocytopenia
- Bleeding in Transplantation Surgery
- Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity
- Anticoagulant activity of sulfated polysaccharides isolated from Codium fragile
- Genetic markers: genes involved in thrombosis
- Interactions Between Malignancy and Coagulation
- The pathogenesis, diagnosis and treatment of strokes: a progress report
- Prothrombin G20210A gene mutation, heparin cofactor II defects, primary (essential) thrombocythemia, and thrombohemorrhagic manifestations
- Estimating true fractional calcium absorption
- The anticoagulant properties of a modified form of protein S
- Resistance to activated protein C and a novel factor V gene mutation
- Protein C in acute stroke.
- Mechanism of blood coagulation in normal and pathologic conditions
- Risk factors for stroke in young Indonesian women
- The retinoic acid and cAMP-dependent up-regulation of 3-O-sulfotransferase-1 leads to a dramatic augmentation of anticoagulantly active heparan sulfate …
- Combination oral contraceptives and cardiovascular disease
- Anti-phospholipid antibody syndrome: medical zebra: or, just the stripes
- Acute ischemic stroke: update on treatment and prevention
- Rheumatoid arthritis and connective tissue diseases
- Fibrinogen Bellingham: A γ‐chain R275C substitution and a β‐promoter polymorphism in a thrombotic member of an asymptomatic family
- Coagulation parameters in maternal and cord blood at delivery
- The physiological significance of phospholipase A (2) activity in the saliva of the lone star tick, Amblyomma americanum (L.)
- Inhibitory mechanism of blood coagulation by the anticoagulant polysaccharide from Coriolus versicolor
- Adsorption of proteins in the processes of interaction of polymers with blood and model solutions
- Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno …
- Extrahepatic expression and regulation of protein C in the mouse
- Recurrent TIPS failure associated with biliary fistulae: treatment with PTFE-covered stents
- Thrombophilic state in breast cancer
- Dietary fish oil and experimental atherosclerosis
- Enalapril and pregnancy-induced hypertension
- Primary sclerosing cholangitis associated with membranous nephropathy
- Pentasa in lieu of sulfasalazine
- Risks of coronary heart disease in women: current understanding and evolving concepts
- Tamoxifen-Induced Changes in the Plasma Fibrinolytic Factors in Menopausal Women with Breast Cancer.
- Fibrositis and the chronic fatigue syndrome
- COAGULACIÓN FIBRINÓLISIS
- Formestane is feasible and effective in elderly breast cancer patients with comorbidity and disability
- Fish oils in rheumatoid arthritis
- Nonbacterial thrombotic endocarditis associated with gold-induced pulmonary disease
- Blood: physical characteristics, formed elements, hemoglobin, and coagulation
- Protein S deficiency and skin necrosis associated with continuous ambulatory peritoneal dialysis
- Kala-azar and the acquired immunodeficiency syndrome (AIDS)
- Resistance to Activated Protein C and Inherited Thrombosis—Molecular Mechanism, Diagnosis and Clinical Management
- Preventive treatment for tuberculosis in elderly persons
- Guidelines for infection with the human immunodeficiency virus (HIV) and health care workers
- The genetic dynamics of disease
- The pathogenesis, prevention and medical management of peripheral arterial thrombosis
- Vasoactive peptides and the carcinoid syndrome
- Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions
- The early dumping syndrome and propranolol
- New antithrombotics for the intensive care unit setting: GP IIb/IIIa inhibitors, low-molecular-weight heparins, and direct thrombin inhibitors
- Varicella-Zoster Virus Infection
- Perioperative Nutrition
- Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients
- The molecular mechanism of factor Va inactivation by activated protein C
- Immunologic abnormalities in the antiphospholipid syndrome
- Stopping Antibiotics in Neutropenic Patients
- Correction: Intravenous Verapamil and Multifocal Atrial Tachycardia
- Pulse Methotrexate Therapy in Rheumatoid Arthritis
- Asymptomatic Cardiac Ischemia in Diabetic Persons
- Testing for the Human Immunodeficiency Virus (HIV) by Insurance Carriers
- Migratory Erythema and Glucagonoma: Descriptive Nomenclature
- The Doctor-Patient Relationship
- Omissions from A Library for Internists
- Antithrombin III in hematopoietic stem cell transplantation
- Venous Thromboembolism and Advanced Cancer
- Stroke: antithrombin versus antiplatelet therapy
- cated as a mechanism in the development of the disease (1-3). Nonbacterial thrombotic endocarditis can occur in gold-in-duced lung disease and may be a …
- Neurological complications of organ transplantation
- Selective transcriptional augmentation of hepatic gene expression in the rat with Heymann nephritis
- Bispectral index (BIS) monitoring of ICU patients on continuous infusion of sedatives and paralytics reduces sedative drug utilization and cost
- Antithrombotic therapy in high-risk pregnancy
- Beverly J. Pennell
- Functional food science and the cardiovascular system
- An investigation of antiphospholipid antibody associated obstetric complications
- Activated protein C resistance in pregnancy
- Anticoagulation and hemostasis in cardiac surgical patients
- Abnormalities of coagulation in experimental nephrotic syndrome
- Plasminogen Activation and Fibrinolysis in the Antiphospholipid Syndrome
- Blood clotting and hemostasis
- Genetics and ischaemic stroke
- Abdominal sepsis in patients 65-onwards after non-scheduled laparotomy
- Case 11-1990: A 38-Year-Old Woman with Fever, Skin Lesions, Thrombocytopenia, and Venous Thromboses
- Antiphospholipid antibodies or not? The role of β2 glycoprotein 1 in autoantibody-mediated pregnancy loss
- Severity evaluation in acute pancreatitis: the role of SOFA score and general severity scores
- Plasma composition in the nephrotic syndrome
- Therapeutic Intervention Scoring System (TISS)-a method for calculating costs in the intensive care unit (ICU) and intermediate care unit (IMCU)
- The fibrinolytic system in neoplasia
- Thrombosis and atherosclerosis
- The clinical relevance of the fluid balance in critically ill patients
- Structure-function relationships in histidine-rich glycoprotein, a putative plasma pH-sensor
- Stress in nursing staff: a comparative analysis between intensive care units and general medicine units
- Changes in vascularization of human breast cancer xenografts responding to antiestrogen therapy
- Myocardial Infarction
- Comorbidity risk parameters associated with advanced breast cancer and systemic disease: Management of nonbreast disease
- Tamoxifen induces hypoxia in MCF-7 xenografts
- PROTEIN C AND PROTEIN S: METHODOLOGICAL
- Role of hyperbaric oxygen therapy (HBOT) in recovery of cardiopulmonary function: survival of patients developing ARDS following closed chest trauma (CCT)
- Bacteremia and systemic inflammatory response syndrome (SIRS) in confirmed post-partum endometritis
- Collaborative practice and clinical outcomes in the ICU
- Effects of artificial changes in chest wall compliance on respiratory mechanics and gas exchange in patients with acute lung injury (ALI)
- Bacterial versus viral meningitis: comparison of the old and the new clinical prediction models
- Decreased protein C, protein S and antithrombin III levels are predictive of poor outcome in gram-negative sepsis caused by Burkholderia pseudomallei
- Frequency, mortality and risk factors of candidemia at a tertiary care hospital
- The incidence of ARDS, interim results of the East Anglian ARDS Registry
- Relationship between superimposed pressure and pleural pressure gradient in an experimental model of ARDS
- Laboratory diagnosis of inherited protein S deficiency
- Incidence of cortisol deficiency in patients with traumatic brain injury
- ARDS before and after the start of mechanical ventilation
- Anxiety and depression in family members of ICU patients: ethical considerations regarding decision-making capacity
- Translaryngeal tracheostomy: prospective experience in two Canadian tertiary intensive care units
- Glutamine-enriched parenteral nutrition during postoperative catabolic state
- Serum albumin and mortality risk in critically ill patients
- Hemostasis
- Hypoglycemia masquerading as acute psychosis in young age
- Organization and staffing of intensive care units in Brazil
- Propofol-induced inhibition of intestinal peristalsis involves enteric opioidergic pathways
- Induced moderate hypothermia markedly exacerbates pulmonary hypertension and dysoxia in a neonatal piglet model of elevated pulmonary vascular resistance
- A comparison between oesophageal Doppler and continuous thermodilution for the measurement of cardiac output in critically ill patients
- An audit of unplanned extubations in a medical intensive care unit
- Cytokines and sepsis-just black smoke?
- Immediate complications of central venous cannulation in ICU
- Continuous monitoring of gastric carbon dioxide with optical fibers: European project COMOCADOF, in vitro evaluation
- Renal disease in the elderly
- Are IL-6, IL-10 and PCT plasma concentrations more reliable than APACHE-III or SAPS-II for the individual mortality risk prediction in severe sepsis?
- Evaluation of thoracic fluid contents in patients with acute myocardial infarction
- Delivery of parenteral nutrition byall in one bag'(AIO) versus single bottle system (SBS) in critically ill patients: a prospective randomized trial
- Decrease of red blood cell sialic acid membrane content in septic patients
- Respiratory mechanics studied by multiple regression and the end-inspiratory pause technique during mechanical ventilation
- 13C-stable isotope analyses technique for ICU patients
- Evaluation of a new wireless ECG electrode built in a telemeter in critically ill patients
- Transthoracic cardioversion with damped biphasic waveform shocks
- A prospective trial of surgical resident performed focused abdominal sonography for trauma (FAST): an easy training method
- Evaluation of PCO2 measurements using a gastric air tonometer located in non-mixing solution
- Gastric-arterial pCO2 gradient, but not lactate levels, is related to multiple organ dysfunction assessed by SOFA score in septic patients
- Interleukin-17 stimulates intraperitoneal neutrophil infiltration through the release of the chemokine GROα from peritoneal mesothelial cells
- Epidemiology of cardiac arrhythmias in a medical-cardiologic intensive care unit: single center experience
- Endotoxin-induced pulmonary hyporesponsiveness to inhaled nitric oxide is improved by nitric oxide synthase 2 inhibition
- Hemostasis and coagulation
- Meeting the needs of ICU patient families: a multicentre study
- The change in Bispectral Index with stimulation indicates depth of sedation in intensive care
- Therapeutic activity in elderly medical intensive care patients
- Comparison of pressure-related performance data with data measured by thermodilution in heart failure and sepsis
- Selected biochemical values and organ dysfunction assessment in prediction of difficult to wean patients
- Timing of extubation after esophagectomy
- The predictive value of serial acute physiology score (APS) and simplified acute physiology score II (SAPS II) in post-operative liver transplant patients
- Use of Combitube airway to protect the airway from methylene blue dye
- Secretory phospholipase A2 (sPLA2), procalcitonin (PCT) and C-reactive protein (CRP) for the diagnosis and differentiation of septic shock and non-septic shock
- Dexmedetomidine for sedation in the medical ICU
- Phagocytosis of granulocytes is decreased in most patients with severe sepsis or septic shock
- Newly developed thrombocytopenia in medical intensive care patients
- The influence of empiric antimicrobial therapy on acquired pulmonary infection in patients with a chest injury on ICU
- Severe mushroom poisoning due to amatoxin in children
- Measurement of gastric emptying in ICU patients with 13C-acetate
- Would the blood volume analyzer-100 (BVA-100) be an alternative to pulmonary artery catheter (PAC) in critically ill patients
- The effect of using a heparin-free flush system for central venous and pulmonary artery catheters on a general medical and surgical intensive care unit
- Antithrombin (AT) improves inflammation induced microcirculatory disturbance in rat mesentery
- G-protein-and phosphodiesterase-dependent regulation of neutrophil migration by antithrombin III involving CXC-receptor 1
- Automatic tube compensation combined with pressure support ventilation-improved work of breathing pattern and less work
- Lipopolysaccharide induced procoagulant activity and cytokine production: influence of antithrombin
- Proportional pressure support in acute lung injury: an observational study
- Systemic and splanchnic hemodynamics, metabolism and PCO2-gap during septic shock induced by live E. coli infusion in dogs
- Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory …
- Triiodothyronine (T3) ameliorates the cytokine storm in rats with sepsis
- Influence of enoximone and dobutamine upon liver perfusion and function in fluid optimized septic patients
- Timing and incidence density of upper gastrointestinal bleeding acquired by critically ill children
- Procalcitonin concentrations in blood after long-distance running
- Effects of a lung recruitment maneuver keeping PEEP before and after L-Pflex on gas exchange in child ARDS patients
- Effects of PEEP and tidal volume on elastances and distribution of volume changes of the different chest wall compartments
- The Effect of Tourniquet Application On Systemic Coagulation
- TISS 76 and TISS 28: outcome discrimination and correlation with length of ICU/hospital stay in 303 consecutive patients of a medical intensive care unit
- Clinical and economic study of the use of somatostatin 14 AA (amino-acids) in the treatment of enterocutaneous and pancreatic fistulas
- Prognostic factors in severe ARDS-patients
- A comparison of pulmonary artery occlusion pressure (PaOP) measurements using pressure controlled ventilation (PCV) versus airway pressure release ventilation …
- Management and outcome of symptomatic hyponatremia in emergency department
- The role of gallium-67 scintigraphy in diagnosing sources of fever in critically ill patients in ICU
- Central neuroaxial blockade improves case-mix adjusted mortality of the critically ill surgical patient
- Comparison of pulmonary arterial and arterial trans-cardiopulmonary thermodilution cardiac output in porcine septic shock
- Decrease in urine output during mesenteric traction syndrome is an early predictor of multiorgan dysfunction
- Treatment of hypophosphataemia in critically ill patients with a two day dosing regimen
- Effects of angiotensin II on the renal excretion of urodilatin in the isolated rat kidney
- A prospective study of the incidence of critical illness polyneuropathy
- Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
- Plasma endothelin-1 and natriuretic peptide levels and antioxidant capacity of heart transplanted patients
- CI/SVRI relationship during different phases of inflammatory response
- Earthquake, rescued victims, crush injury and their follow up
- Is the volume of a pleural effusion predictable using the thickness of the pleural lamella measured by sonography as a reference?
- The lower inflection point of the inspiratory pressure-volume curve overestimates optimal PEEP in surfactant-treated immature lambs
- Differences in phagocytosis by polymorphonuclear leucocytes (PMNs) and monocytes (Mos) in endotoxemia and endotoxin (ET) tolerance
- Inhibition of inducible nitric oxide synthase (iNOS) reduces multi-organ failure (MOF) in the thioacetamide (TAA) rat model
- Partial liquid ventilation combined with two different gas ventilation strategies in acute lung injury in piglets
- The combination of lactate and bicarbonate buffers in continuous venovenous hemodiafiltration and its impact on serum lactate levels and homeostasis
- Muscular mass and subcutaneous fat changes according to duration of ICU hospitalization with corticosteroid and muscle relaxant intake
- The ex vivo production of tumor necrosis factor-α (TNF-α) in men: relationship to cytokine balance during cardiopulmonary bypass
- Severity of illness, critical events, organ failure assessment and ICU outcome
- Relationship between systemic arterial pressure (SAP) and EtCO2 in patients with hemorrhagic shock
- Cardiopulmonary resuscitation with cardiopulmonary bypass after cardiac surgery
- Accidental hypothermia and active rewarming: the metabolic changes observed above and below 32° C
- Influence of prone position on gastric mucosal-arterial PCO2 gradient
- Effective pulmonary capillary pressure during hyperdynamic porcine endotoxemia
- Effects of mercaptoethylguanidine during long-term hyperdynamic porcine endotoxemia
- Effect of continuous hemofiltration (CVVHF) on inflammatory parameters
- A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
- Effect of different tidal volumes and PEEP levels on gas exchange and FRC
- Hospital urinary infection epidemic by Candida famata: reduction of mortality after therapy with fluconazole and identification of the risk factors related to the infection
- Heparin vs recombinant hirudin for anticoagulation in continuous renal replacement therapy
- Ileal microcirculation and mucosal acidosis during hyperdynamic porcine endotoxemia
- Experience with brain death and organ donation in a tertiary care hospital in Riyadh, Saudi Arabia
- Protection of spinal cord ischemic injury with the β-agonist Clenbuterol
- In contrast to CD64 expression, CD14 expression is persistently downregulated on polymorphonuclear cells (PMN) but not on monocytes of patients with septic shock
- Effects of epinephrine and norepinephrine on endotoxin-induced tissue factor expression in blood monocytes
- Managing cost in ICU-a report of an experience
- The new way of postoperative pulmonary complications prophylaxis in oesophageal cancer surgery
- Change in the provision of out-of-hours consultant cover improves case-mix adjusted mortality in a district general (university-affiliated) hospital intensive care unit
- Results of transplantation with kidneys from non-heart-beating donors
- Using fraxiparin in patients with gestosis
- Influence of different PEEP levels and tidal volumes on the regional nonaerated tissue: experimental study
- The changes in platelet function in SIRS, sepsis and MODS-a tight connection to the changes in the immune and hemostatic system
- Effects of PEEP above the L-Pflex on gas exchange, hemodynamic and gastric tonometry in ARDS patients
- Relationship between TNFα and IL10 release during cardiac operations and the development of apoptosis
- Pre-admission functional status and outcome in medical intensive care
- An alternative, and more sensitive, approach to detecting differences in outcome in sepsis
- Indocyanine green clearance monitoring during liver transplant for fulminant hepatic failure: preliminary results
- The use of percutaneous tracheostomy in patients with severe acute or chronic liver disease
- Impact of carrier solution on biological insulin availability
- Routine blood gas analysis does not provide information on regional metabolism of the stomach obtained by gastric tonometry in patients with left ventricular failure
- Is redistribution of microcirculatory blood flow within the small intestinal wall the cause of prolonged paralytic ileus in the critically ill?
- Alteration of current perception threshold in severely injured patients
- Effect of iNOS inhibition on exhaled NO and serum nitrate in hyperdynamic porcine endotoxemia
- Evaluation of different CPAP systems in ICU population
- Sepsis increases accumulation of cell-free hemoglobin in intima of submucosal arterioles in rats
- Epinephrine is more effective than other sympathomimetics in correcting cerebral hypoperfusion associated with mesenteric ischemic reperfusion insult
- Gastric mucosal tonometry: should we adjust PiCO2 and CO2-gap to temperature?
- Management of children with severe traumatic brain injury in an adult ICU: evaluation of outcome
- A comparison of the effects of conventional and balloon laryngoscopy on the sagittal dimensions of the space available for the cord at the level of the …
- An experience with surgical admissions to a Paediatric ICU (PICU) in Harare Zimbabwe
- The relationship between data of gastric tonometry by determination of polymorphonuclear leukocytes (PMNs, ie, myeloperoxidase activity) and gut mucosal …
- Mortality and outcome in different subgroups of patients admitted in an ICU
- Non-invasive two-point estimation of arterial PCO2 and alveolar deadspace
- Outcome after major trauma: 12-month follow-up
- Work up to rule out perioperative myocardial infarction: is it overused?
- Detection of perfusion failure during open heart surgery with sublingual PCO2
- Urgent orotracheal intubation induces transient bacteremia in critically ill patients
- Experience of medical examination and health consultation for public exposed to neutrons caused by criticality incident in Japan
- Clonidine concentration-dependently inhibits intestinal peristalsis in vitro
- Diaspirin cross-linked hemoglobin (DCLHb) ensures tissue oxygenation during hemodilution below the critical hematocrit
- Renal blood flow in critically ill cardiac patients: effect of dobutamine on total flow and selective redistribution of the cardiac index
- Endotoxin-induced capillary perfusion failure and leukocyte adhesion is not prevented by the thrombin inhibitor hirudin: an intravital microscopic study
- Are we allocating limited resources to patients in most need?
- Computer tomography of chest organs in the diagnosis of acute respiratory distress-syndrome of patients with severe brain injury
- The formation of platelet microvesicles in septic pigs treated with different kinds of volume replacement
- Elevated levels of adhesion molecules in septic patients with pre-existing coronary artery disease
- How does major abdominal surgery induce procalcitonin and IL-6 in the postoperative period?
- Ten years of blood cultures surveillance in an intensive care unit of a tertiary hospital in Israel
- Expression and regulation of procalcitonin in different human cells
- Is muscular mass affected by L-Carnitine levels in critically ill patients?
- A comparison between some standardized scales of evaluation of anxiety and depression in nursing staff
- Functional status and quality of life (QoL) in long-term survivors of cardiac arrest after cardiac surgery
- Effect of mechanical ventilation and respiratory tract colonization on bronchial immunoglobulin A and G levels in ICU patients
- Lactic acid clearance in the emergency department prognosticates multisystem organ failure and death
- In vitro study of a new vaporization humidifying device: DAR HC 2000®
- The Bair Hugger patient warming system in prolonged surgery
- Oxygenation response to prone positioning in pulmonary and extrapulmonary ARDS
- Procalcitonin helps to discriminate between septic and non-septic underlying disease at admission in ICU
- Health-related quality of life after heart surgery
- Effects of Antithrombin III on body cavity effusions, fluid balance, colloid osmotic pressure and hemodynamics in porcine septic shock
- High incidence of positive fungal DNA in the blood of critically ill patients
- Falciparum malaria in ICU
- Withdrawing life-prolonging medical treatment in 246 patients
- Usefulness of vancomycin serum concentration monitoring in the critically ill patient
- Quality of life 6 and 12 months after discharge from the intensive care unit
- Non invasive mechanical ventilation (NINMV) in cardiac surgery
- Risk factors associated with vancomycin-resistant enterococcal colonization in a general ICU and the effect of surveillance and prevention over respiratory tract and …
- Procalcitonin serum concentrations do not differentiate severity of septic shock in postoperative patients
- Evaluation of the logistic organ dysfunction system for the assessment of organ dysfunction and mortality
- Is postoperative ICU care needed for high-risk patients after major elective surgery?
- Open lung strategies in patients with intracranial lesions and acute lung injury
- Acute necrotizing pancreatitis—histological study focusing on necrosis and apoptosis
- Effects of volume replacement on plasma volume and albumin escape rate in a porcine model of fecal peritonitis
- Compliance or failure and improvement or deterioration diagnosis of patients from performance diagrams
- Acute psychological reactions in relatives of patients treated in the intensive care unit (ICU)
- The early management of pain in casualty wards
- Early enteral nutrition after Pancreas Kidney Transplantation (PKTx) with enteral drainage (a pilot study in five patients)
- Role of platelet activating factor (PAF) on leukocyte-independent plasma extravasation and mast cell activation during endotoxemia
- Plasma Cl: Na ratio: a simple alternative to Stewart’s Strong Ion equation for detection of elevated lactate or unmeasured anions in metabolic acidosis
- The GH/IGF-I axis in children with a meningococcal septic shock: striking differences between survivors and non-survivors
- Baseline audit of manipulation and management of intravenous therapy delivery systems
- Norepinephrine-induced blood pressure increase to pre-shock levels worsens regional flow distribution in porcine septic shock
- Assessment of a handy-type blood gas analyzer for measuring intramucosal pH (pHi)
- Intraluminal antibiotic treatment of central venous catheter infection in patients receiving total parenteral nutrition
- Is the ecarin clotting time (ECT) a valid monitoring parameter for r-hirudin-based anticoagulation in continuous renal replacement therapy?
- Hypocapnic and normocapnic ventilation in hepatic encephalopathy: a comparision
- Influence of iloprost on hepato splanchnic metabolic activity and energy balance in patients with septic shock
- Neurosurgical patients admitted to intensive care units (ICU) exhibit a systemic inflammatory response
- Inflammatory response, prognostic scores and mortality in acute pancreatitis
- Relationship between cardiac troponin I (cTnI) release during cardiac operations and myocardial cell death
- Treatment of severe heat stroke in an intensive care unit: clinical course, acute outcome and implications for management
- Risk factors of infection and molecular typing in ICU colonized patients with Enterobacter aerogenes
- Increased intestinal permeability accompanies the development of sepsis in ICU patients
- Vancomycin as a single daily dose in critically ill patients on an intensive care unit
- Beneficial effects of lung recruitment with PEEP after cardiac surgery
- Carbon dioxide elimination during continuous venovenous hemodiafiltration (CVVHD)-laboratory experiment
- Emergency department evaluation of orthotopic liver transplant recipients
- Respiratory burst activity of PMN is increased in most patients during septic shock
- Impact of CVVH on monocyte activation in the critically ill
- Efficacy of the endotoxin absorption method (PMX) in patients with septic shock associated with intraperitoneal infections
- Evolution of micro-organisms isolated in nosocomial bloodstream infections in Belgian Intensive Care Units, 1992-1999
- Hemodynamic effects of the inspiratory flow rate in patients with septic shock
- Effects of bronchoalveolar lavage (BAL) fluids of patients with ventilator-associated bronchopneumonia (VAP) on alveolar cells in culture
- Ward death following ICU discharge-can it be predicted? Development and validation of a predictive model
- Evaluation of transesophageal atrial pacing in the prone and lateral position
- Tetanus-following up 285 patients in ICU
- Prospective randomized study of hemodialysis membrane biocompatibility in acute renal failure
- The role of selected biochemical values in graft quality prediction in brain death organ donors
- Pseudocholinesterase and albumin in infants with cirrhosis
- Metabolism in abdominal organs, as evaluated by microdialysis, in experimental severe acute pancreatitis
- Data from the US Army field surgical hospital intensive care unit in post-war Kosovo
- Acute weakness in the ICU-electrophysiological and pathological findings
- Does metoclopramide prevent bacterial translocation (BT)?
- Leptospirosis in intensive care units: report of 33 cases
- Therapy of malignant intracranial hypertension by lumbar cerebrospinal fluid drainage
- Parenteral nutrition (PN) depresses hepatic albumin synthesis in septic rats
- The impact of late-onset ventilator-associated pneumonia on mortality in a Saudi-Arabian hospital
- Prolonging ICU stay reduces the number of ward deaths: evaluation of a model for triaging ICU discharges
- Respiratory effects of dexmedetomidine in the ICU
- Variation of early auditory evoked potentials (EAEP) in severe hyponatremia
- Preload assessment in septic shock
- Changes in the C-type Natriuretic peptide (CNP) and NO derivatives in the plasma and CSF of the patients with subarachnoid hemorrhage (SAH)
- Monitoring of sedation with BIS Index, comparison with Ramsay and Cook sedation scores
- Role of decisive markers in diagnosis and outcome of patients with septic shock
- The interactions between human antithrombin and heparin
- Tamoxifen and HRT: Synergistic or Antagonistic?
- Septic Shock with Purpura in Children: an experimental and clinical approach
- 21 Thromboembolic Disease
- Hemostasis and the surgical patient
- The intracellular serpin proteinase inhibitor 6 is expressed in monocytes and granulocytes and is a potent inhibitor of the azurophilic granule protease, cathepsin G
- Protein S and thrombotic disease
- Coagulation defects
- Childhood essential thrombocythaemia without evidence of myeloproliferation: how many investigations should be done?
- Physiology and Pathology of Blood Coagulation A Review of the Literature of 1961 (First Series)
- Fulminant meningococcemia (purpura fulminans)
- Oral contraceptives and arterial and venous thrombosis: a clinician’s formulation
- Physiology and Pathology of Blood Coagulation
- Selective estrogen receptor modulators: clinical spectrum
- Reproductive Physiology in the Human Female With Age
- Novel anticoagulant and prohemostatic strategies
- The effect of blood chemistry on the rheological properties of the fluid
- Role of cysteine proteinases in IGF-1R turnover, invasion and metastasis
- Studies on coagulation and acute-phase response in the horse
- Psychological aspects of gastrointestinal illness among Israeli medical outpatients
- A study of platelet aggregation in whole blood from normal and prothrombotic subjects
- Mechanisms of stimulus-response coupling in platelet-activating factor stimulated platelets
- Inflammation and thrombosis
- New anticoagulants for venous thromboembolic disease.
- Role of coagulation inhibitors in inflammation
- Activity of naturalcoagulation inhibitor proteins in the acute phase of ischaemic stroke
- The interactions between inflammation and coagulation
- What can we learn from the three megatrials using anticoagulants in severe sepsis?
- New aspects of the blood coagulation cascade, anticoagulants and vein thrombosis in Asia.
- Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis
- Recurrence rate after a first venous thrombosis in patients with familial thrombophilia
- New antithrombin‐based anticoagulants
- Frequency of thrombophilia in patients with adverse pregnancy outcome
- In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial†‡
- Coagulation disorders in uremia
- Thromboembolism in adults with acute lymphoblastic leukemia during induction with L-asparaginase-containing multi-agent regimens: incidence, risk factors, and …
- Why do animal models (sometimes) fail to mimic human sepsis?
- Veno-occlusive disease prophylaxis with fresh frozen plasma and heparin in bone marrow transplantation
- Drug intervention trials in sepsis: divergent results
- Interactions between the innate immune and blood coagulation systems
- Tifacogin, recombinant tissue factor pathway inhibitor
- Air travel and thrombosis.
- The relationship between protein C, protein S and cytokines in acute ischemic stroke
- Induction of a hypercoagulability state and endothelial cell activation by granulocyte colony-stimulating factor in peripheral blood stem cell donors
- High levels of factor VIIIc and risk of venous thrombosis: critical analysis of case-control studies
- Evaluation of the blood coagulation mechanism and platelet aggregation in individuals with mechanical or biological heart prostheses
- Understanding and preventing the coagulation disorders associated with xenograft rejection
- Thrombotic complications during induction chemotherapy of acute childhood lymphoblastic leukemia.
- The liver and the haemeostatic system
- Free protein S (PS) in normal pregnancy: a comparison between two analytical methods
- Central retinal vein occlusion and thrombophilia risk factors
- Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis
- Inflammation and coagulation
- Coagulation defects and platelets function in splenectomized and non-splenectomized beta-thalassemic children
- Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy …
- anticoagulants: to bleed or not to bleed, that is the question
- Thrombosis in children with acute lymphoblastic leukemia: Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and …
- Portal vein thrombosis after hematopoietic cell transplantation: frequency, treatment and outcome
- Thrombosis and a hypercoagulable state in HIV-infected patients
- Genetic polymorphisms associated with venous and arterial thrombosis: an overview
- A boy with Churg-Strauss syndrome and thrombosis associated with eosinophilia
- Gene polymorphism of factor V and variceal bleeding in infants and children
- Antithrombin III activity in the elderly–association with cardiovascular disease risk factors
- Portal vein thrombosis in pregnancy: case report and review of the literature
- The state of hemostasis in patients after mini-invasive aorta and coronary artery bypass surgery
- The state of hemostasis in patients after mini-invasive aorta and coronary artery bypass surgery
- Venous thromboembolism: which patients are truly at risk
- The blood coagulation system as a molecular machine
- Anti-thrombin III, Protein C, and Protein S deficiency in acute coronary syndrome
- The causes of early disorders of cerebral circulation in patients undergoing carotid endarterectomy.
- The complex nature of the prothrombotic state in acute lymphoblastic leukemia of childhood
- Hemostasis disorders in severe infections: state of the art
- Struggle for implementation of new strategies in intensive care medicine: anticoagulation, insulin, and lower tidal volumes
- Does letrozole have any place in adjuvant setting in breast cancer patients with documented hypercoagulability?
- Recurrent Thrombosis Is Frequently Associated with Increased Microparticle-Mediated Thrombin Generation.
- Antithrombin–Heparin Complexes
- Extracorporeal anticoagulation for intermittent and continuous forms of renal replacement therapy in the intensive care unit
- A Case of Protein S Deficiency with Cerebral Infarction
- Anticoagulant and Anti-Inflammatory Effects of Recombinant Human Antithrombin in Man after LPS Challenge.
- The liver and the haemeostatic system
- Frequency of thrombophilia in patients with adverse pregnancy outcome
- TWINS DEVELOPING ARTERIAL THROMBOSIS IN THE EARLY NEONATAL PERIOD: AN ELUSIVE DIAGNOSIS?
- Chronic Arterial Occlusion by Hypercoagulable State 2 cases report (Antiphospholipid syndrome and Polycythemia vera)
- Relation between thrombin activatable fibrinolysis inhibitor and haemostatic alterations in patients with chronic liver disease and portal vein thrombosis
- Coagulation and Innate Immunity
- Effect of CMF-chemotherapy on blood coagulation in patients with breast cancer
- Activation of Endothelial Cells, Coagulation and Fibrinolysis in Thai Children with Dengue Virus Infection.
- High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis
- Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis
- Platelets and anticoagulant capacity in patients with inflammatory bowel disease
- Masterclass series in peripheral arterial disease: Inherited thrombophilia
- Role of tissue factor in thrombosis. Coagulation-inflammation-thrombosis circuit
- Hematologic risk factors for stroke in Saudi children
- Diagnostic issues in thrombophilia: a laboratory scientist’s view
- “Baffled” by the conclusions
- Hemostasis and thrombosis: physiological and pathological aspects
- Variable effect of prothrombotic factors on fetomaternal circulation
- Anticoagulation for continuous renal replacement therapy
- Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based?
- Inherited thrombophilia in ischemic stroke and its pathogenic subtypes
- Clinical trials in sepsis.
- Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model
- Haemostatic disorders during liver transplantation
- Clinical trials in sepsis
- Coagulation in sepsis
- Coagulation and atherothrombotic disease
- Blood and bone marrow pathology
- The impact of the inflammatory response on coagulation
- Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis
- Hemostatic markers with bolus versus prolonged heparin after carotid artery stenting
- Hereditary thrombophilia in ethnic Omani patients
- Thrombophilia in coronary artery disease: A double jeopardy
- Indwelling catheter-related central venous thrombosis during bone marrow transplantation
- Acquired and inherited thrombophilia in women with unexplained fetal losses
- A novel anticoagulant purified from fish protein hydrolysate inhibits factor XIIa and platelet aggregation
- Tissue factor pathway inhibitor in childhood nephrotic syndrome
- Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome
- Platelet and endothelial-cell markers in meningococcal septicaemia: a report of two cases
- Associated thrombophilic defects in essential thrombocythaemia: their relationship with clinical manifestations
- A family history can display a synergistic effect of atherogenic and prothrombotic risk in pregnancy
- Abciximab inhibits procoagulant activity but not the release reaction upon collagen‐or clot‐adherent platelets
- Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation
- Year in review 2005: Critical Care–resource management
- Central nervous system listeriosis confused with leptomeningeal carcinomatosis in cancer patients
- Prospective assessment of risk factors for recurrent stroke during childhood-a 5-year follow-up study
- Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults …
- Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism
- Normal responses to injury prevent systemic inflammation and can be immunosuppressive
- CASE REPORT-MYOCARDIAL INFARCTION IN A YOUNG PATIENT WITH METHYLENE TETRAHYDROFOLATE REDUCTASE (MTHFR) GENE MUTATION
- CASE REPORT-MYOCARDIAL INFARCTION IN A YOUNG PATIENT WITH METHYLENE TETRAHYDROFOLATE REDUCTASE (MTHFR) GENE MUTATION
- The thrombophilic fetus
- Cerebral metastases in patients with advanced breast cancer treated with trastuzumab
- anticoagulants for acute respiratory distress syndrome: can they work?
- Plasminogen activator inhibitor‐1 is an independent diagnostic marker as well as severity predictor of hepatic veno‐occlusive disease after allogeneic bone marrow …
- Morphological and functional differences in haemostatic axis between kidney transplanted and end‐stage renal disease patients
- Hemostasis and thrombosis
- Management of sepsis
- On the need of biopsy confirmation at suspected first recurrence of cancer
- Cost effectiveness of aromatase inhibitors
- Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study
- Myocardial injury in meningococcus-induced purpura fulminans in children
- Management of preterm infants with intracardiac thrombi
- Inherited thrombophilic risk factors in a large cohort of individuals referred to Italian thrombophilia centers: distinct roles in different clinical settings
- Pathophysiological basis for anticoagulant and antithrombotic therapy in pulmonary hypertension
- A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state
- Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis
- Endothelial cell gene regulation
- Testing for thrombophilia: an evidence-based approach
- Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia
- Use of laserotherapy in multimodality treatment and prevention of obstetric pathology
- Familial thrombophilia and lifetime risk of venous thrombosis
- Dermatologic aspects of antiphospholipid antibody syndrome
- Microvascular thrombosis: What is the importance?
- Thrombocytopenia in the parturient
- What causes the antiphospholipid syndrome?
- Feasibility of lmw heparin prophylaxis for management of thrombophilia investigation in patients on oral anticoagulation therapy
- The nexus between systemic inflammation and disordered coagulation in sepsis
- Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors
- Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: case reports and review of the literature
- The pivotal role of the endothelium in haemostasis and thrombosis
- Direct thrombin inhibitors
- Premature lower extremity atherosclerosis: clinical aspects
- Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach
- Thrombophilia in sickle cell disease: the red cell connection
- Acute Dialysis Quality Initiative
- Disorders of Thrombosis and Haemostasis
- Effect of a combined oral contraceptive containing 20 μg ethinyl estradiol and 75 μg gestodene on hemostatic parameters
- Purpura fulminans in sepsis
- FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile
- Detection of an Ala601Thr mutation of plasminogen gene in 3 out of 36 Korean patients with deep vein thrombosis
- Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity
- The crucial role of systemic responses in the innate (non-adaptive) host defense
- Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis?
- Evaluation of coagulation, fibrinolysis and protein C in risk patients and patients presenting coronarian diseases
- Inflammation and the activated protein C anticoagulant pathway
- Paradoxical hyperfibrinolysis is associated with a more intensely haemorrhagic phenotype in severe congenital haemophilia
- Procoagulant activity on platelets adhered to collagen or plasma clot
- Anticoagulant 1, 2, 3, 4, 6-pentagalloyl-β-d-glucopyranose isolated from geranium (Pelargonium inquinans Ait)
- Hirudin as alternative anticoagulant-a historical review
- Combined antithrombin and protein C supplementation in meningococcal purpura fulminans: a pharmacokinetic study
- The effects of continuous venovenous hemofiltration on coagulation activation
- Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes
- High prevalence of combined thrombophilic abnormalities in patients with inflammatory bowel disease
- Importance of anticoagulant proteins in chronic liver diseases
- Elevated D-dimer level predicts recurrent VTE
- By what mechanism do leeches help to salvage ischaemic tissues?: A review
- Congenital and acquired hemorrhagic problems
- Pathophysiology of sepsis
- Hormone replacement therapy, thrombosis and thrombophilia
- Thrombosis and cancer: the role of screening for occult cancer and recognizing the underlying biological mechanisms
- Coagulopathy of sepsis
- Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia
- Designing and funding clinical trials of novel therapies
- Novel anticoagulants for the prevention and treatment of venous thromboembolism
- Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion
- Thrombophilia and Pregnancy Complications: Preeclampsia,(Late) Intrauterine Fetal Death, and Thrombosis
- Air Travel and Thrombosis
- Anti-Thrombin III in the Management of Hematopoietic Stem-Cell Transplantation—Associated Toxicity
- Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests?
- The elevated markers of hypercoagulability in children with Henoch–Schönlein purpura
- Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats
- Obesity and reproduction
- Haemostatic changes in pregnancy
- Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism
- The prevalence of protein C, protein S, and antithrombin III deficiency in non-APS/SLE Chinese adults with noncardiac cerebral ischemia
- Paradoxical neutrophil activation and coagulopathy during the recovery phase after endotoxemia
- Thrombin generation and mortality during Staphylococcus aureus sepsis
- Fatal deep vein thrombosis after allogeneic reduced intensity hematopoietic stem cell transplantation for the treatment of metastatic gastric cancer
- Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism
- Tissue factor in infection and severe inflammation
- anticoagulants in pregnancy
- Unraveling severe sepsis: why did OPTIMIST fail and what’s next?
- Effects of anticoagulant treatment on intestinal ischaemia and reperfusion injury in rats
- Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease…
- Blood Group Non-O May Be Associated with an Increased Risk of Venous Thrombosis: Taiwan Thrombophilia Study
- Improving pregnancy outcome in women with thrombophilia
- Fibrin(ogen)-αMβ2 Interactions Regulate Leukocyte Function and Innate Immunity In Vivo
- Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway
- Hypercoagulability risk factors in children with minimal change disease and the protective role of protein-C activity
- Disseminated intravascular coagulation syndrome and protein C
- Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia
- Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation
- Enhanced tissue factor pathway inhibitor response as a defense mechanism against ongoing local microvascular events of Legg-Calve-Perthes disease
- Inherited thrombophilia and obstetric complications
- The prothrombotic state in cancer: pathogenic mechanisms
- In uremia, plasma levels of anti-protein C and anti-protein S antibodies are associated with thrombosis
- Cocaine by internal mail: two surgical cases
- Neurological manifestations in severe acute respiratory syndrome
- Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-κB
- Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia—a review
- Cryoprecipitate-induced mesenteric venous thrombosis during L-asparaginase therapy for acute lymphoblastic leukaemia
- Upper extremity deep venous thrombosis
- Two-way interactions between inflammation and coagulation
- Low protein Z levels and risk of occurrence of deep vein thrombosis
- Antiphospholipid syndrome in a human immunodeficiency virus 1-infected child
- Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome
- The wheelchair thrombosis syndrome.
- The immunopathogenesis of sepsis
- Treatment of bleeding with recombinant factor VIIa in a patient with extensive burns
- Impact of screening on thrombophilia for patients with venous thrombosis
- New subsets of the antiphospholipid syndrome in 2006:“PRE-APS”(probable APS) and microangiopathic antiphospholipid syndromes (“MAPS”)
- Pre-eclampsia and thrombophilia
- Recurrent thromboembolism in infants and children suffering from symptomatic neonatal arterial stroke: a prospective follow-up study
- D-dimer predicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activity
- Effect of recombinant activated protein C and low-dose heparin on neutrophil-endothelial cell interactions in septic shock.
- Protein S and congenital protein S deficiency: the most frequent congenital thrombophilia in Japanese
- Evidence-based medicine in the ICU: important advances and limitations
- Antithrombin III inhibits nuclear factor κB activation in human monocytes and vascular endothelial cells
- Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation
- Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation
- MHC class II and III polymorphisms and the antiphospholipid syndrome
- C hapter 5 0 Management of Disseminated Intravascular Coagulation
- Calciphylaxis: a rare association with alcoholic cirrhosis. Are deficiencies in protein C and S the cause?
- Fetuses are exposed to a hypoxic environment in utero. The placenta delivers 35–40 mm
- Congenital thrombophilia associated to obstetric complications
- Intravascular thrombosis in discordant xenotransplantation
- Cardiovascular and thrombophilic risk factors for central retinal vein occlusion
- Role of the tissue factor pathway in the pathogenesis and management of multiple organ failure
- Emergent cardiovascular risk factor: Homocysteine
- Protein Z and vitamin K in kidney disease.
- Graft protein C entrapment is associated with reduced phagocyte activation during reperfusion in human liver transplantation
- Catastrophic antiphospholipid syndrome
- Thrombophilia and the risk of venous thromboembolism in cancer
- Genetic hyper-coagulation predisposition for myocardial infarction in the Newfoundland population
- A safety evaluation of drotrecogin alfa (activated) in hematopoietic stem cell transplant patients with severe sepsis: lessons in clinical research
- The normal role of Activated Protein C in maintaining homeostasis and its relevance to critical illness
- Magnetic resonance imaging of mouse spinal cord
- Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia
- Novel and usual associations
- Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status
- Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case …
- Haemostatic cardiovascular risk factors: differential effects of red wine and diet on healthy young
- Aggravation of endotoxin-induced disseminated intravascular coagulation and cytokine activation in heterozygous protein-C–deficient mice
- Warfarin induced massive and bilateral skin necrosis of the breasts: a case report and review of the literatures
- Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention
- Are D-dimer levels after aneurysmal subarachnoid hemorrhage predictive of outcome?
- Behçet’s disease and thrombophilia
- Pathogenesis of venous thromboembolism
- Some aspects of hemostasis in kidney transplant recipients maintained on cyclosporine, azathioprine, and prednisone in comparison to patients treated with …
- Distinctive effects of red wine and diet on haemostatic cardiovascular risk factors
- Continuous renal replacement therapy for liver disease
- Upregulation of hepatic LDL receptor-related protein in nephrotic syndrome: response to statin therapy
- Enhancement of study on hemostatic and thrombotic disorders
- Hyperhomocysteinemia and venous thromboembolism
- Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium
- Continued Investigation of Immune Competence in Navy Marine Mammals: Implications for Health Viability and Mission Readiness
- Paraoxonase 192 Gln→ Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults
- Procoagulant protein levels are differentially increased during human endotoxemia
- Mechanism of action of drotrecogin alfa activated (rhAPC)
- Surgery in Carriers of Blood-borne Infections
- Effect of short course high dose methylprednisolone on endothelin-1 and nitric oxide in children with acute lymphoblastic leukemia: a preliminary study
- Protein S deficiency is common in a healthy Thai population
- Practical tips for warfarin dosing and monitoring
- Hormone replacement therapy and coagulation
- Serial changes in markers measuring coagulation, fibrinolysis, and vasoactivity in patients with ischemic stroke
- An evaluation of thrombophilia screening in an urban tertiary care medical center: A “real world” experience
- Successful treatment of fulminant pneumococcal sepsis with recombinant tissue plasminogen activator
- The 21st international symposium on intensive care and emergency medicine, Brussels, Belgium, 20-23 March 2001
- Lipaemia: an overrated interference
- Deep vein thrombosis and air travel
- APC stripped bare
- Thromboprophylaxis after vaginal delivery: A district generalhospital experience
- Laboratory Testing and the Thrombophilia Workup
- P0238 ANTITHROMBIN SUPPLEMENTATION AFTER LIVER TRANSPLANTATION
- Hemostasis and aging
- Venous thromboembolism: disease burden, outcomes and risk factors
- Investigation of the Anticoagulant Activity of Several Low-Molecular-Weight Endogenous Ligands of Blood Plasma by Methods of Computer Simulation and Universal …
- Recurrent acute stent thrombosis associated with protein C and S deficiencies
- Should plasma be transfused prophylactically before invasive procedures?
- Genomic medicine and thrombotic risk: who, when, how and why?
- Pseudo-heparin-induced thrombocytopenia
- Tissue factor upregulation drives a thrombosis–inflammation circuit in relation to cardiovascular complications
- WARFARIN INDUCED MASSIVE AND BILATERAL SKIN NECROSIS OF THE BREASTS: A CASE REPORT AND REVIEW OF THE LITERATURES
- Neurological symptoms of Adamantiades–Behçet’s syndrome
- Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects
- Thrombosis of the portal venous system after splenectomy for trauma
- β2-glycoprotein I, anti-β2-glycoprotein I, and fibrinolysis
- Sepsis and disseminated intravascular coagulation
- Homocysteine and brain atrophy
- Does disseminated intravascular coagulation lead to multiple organ failure?
- Enhanced expression of plasminogen activator inhibitor 1 in patients with nephrotic syndrome
- Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening
- Physiologic inhibitors of coagulation in patients on chronic hemodialysis
- Dual antibody reactivity to β2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome
- Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke
- Hemostasis alterations in metabolic syndrome
- Hemostatic effects of tamoxifen in hereditary hemorrhagic telangiectasia
- Acute arterial thrombotic purpura complicating varicella and the role of hyperbaric oxygen as an adjunctive therapy
- Massive blood transfusion
- Hemostasys system disorders in acute pankreatitis
- Protein S modulates the anticoagulant action of recombinant human activated protein C: a comparison between neonates and adults
- Veno-occlusive disease: cytokines, genetics, and haemostasis
- Inherited thrombophilias
- Effects of replacement fluids on coagulation system used for therapeutic plasma exchange
- Unravelling the confusion about HRT in women
- Thrombophilia, clinical factors, and recurrent venous thrombotic events
- Hematologic changes in sepsis and their therapeutic implications
- Genetic susceptibility to venous thrombosis
- Hormone therapy and venous thromboembolism
- Evaluation of coagulation in pediatric bone marrow transplantation patients
- Thrombophilic risk factors in patients with central retinal vein occlusion
- Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management
- Management of sepsis in the critically ill patient: key aspects
- Immunologic manipulation for the threatened fetus
- Ximelagatran—promises and concerns
- Protease-activated receptors in vascular biology
- Antithrombin Modulates the Leukocyte–Endothelial Cell Interaction in the Staphylococcal Enterotoxin B-Challenged Mouse
- Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction
- Pediatric reference intervals for seven common coagulation assays
- The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation
- Mechanisms of the inflammatory response
- Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation
- State-of-the-Art Review: Thrombophilia and Pregnancy: Review of the Literature and Some Original Data
- Microcoagulation processes after xenotransplantation
- Thrombotic disorders in infancy and childhood
- Warfarin skin necrosis associated with protein S deficiency and a mutation in the methylenetetrahydrofolate reductase gene
- Antineoplastic treatment and venous thrombosis
- Genetic epidemiology of sepsis and septic shock
- Prothrombotic disorders in patients with mesenteric vein thrombosis
- Endothelial apoptosis: the missing link between atherosclerosis and SLE?
- Thrombophilia in pregnancy: maternal and fetal implications
- Pro-thrombotic states in stroke
- Stroke in sickle cell disease
- Diabetes mellitus: a hypercoagulable state
- Acute myelogenous leukemia associated with extreme symptomatic thrombocytosis and chromosome 3q translocation: case report and review of literature
- The future of plasma‐derived clotting factor concentrates
- Endothelium and allotransplantation
- Drug interactions between herbal and prescription medicines
- Serendipitous diagnosis of protein S deficiency
- Maternal issues in thrombosis and thrombophilia
- Does Ginkgo biloba Special Extract EGb 761® Provide Additional Effects on Coagulation and Bleeding when Added to Acetylsalicylic Acid 500mg Daily?
- Creepy crawly medicine–does it work?
- Antiphospholipid antibodies in a heterogeneous group of patients: experience from a central laboratory
- Factor V Leiden
- Traitements antitumoraux et complications thromboemboliques: thrombose et cancer
- New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology
- Moyamoya-like vasculopathy (moyamoya syndrome) in children
- Fever six weeks after trauma
- Pharmacodynamics of active site‐inhibited factor VIIa in endotoxin‐induced coagulation in humans
- Atypical warfarin‐induced skin necrosis
- Treating heparin-induced thrombocytopenia
- Con: antifibrinolytics are not safe and effective in patients undergoing liver transplantation
- The impact on coagulation of an intravenous loading dose in addition to a subcutaneousregimen of low-molecular-weight heparinin the initial treatment of acute …
- Spinal cord infarction as a severe complication of meningococcal meningitis
- Central venous line thrombosis in children and young adults with thalassemia major
- Haemostatic changes in pregnancy
- Female hormones and thrombosis
- Fibrinolysis in disseminated intravascular coagulation
- Overview of New Anticoagulant Drugs
- Hazards from naturalorigins
- Heparin-derived oligosaccharides as potential therapeutic agents in senile dementia and stroke
- Interactions between coagulation and inflammation
- Cerebral venous sinus thrombosis in a neonate with homozygous prothrombin G20210A genotype
- The incidence of venous thromboembolism in carriers of antithrombin, protein C or protein S deficiency associated with the HR2 haplotype of factor V: a family cohort …
- Antithrombin-III in Pediatric Systemic Lupus Erythematosus
- updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome
- Levels of plasma des-γ-carboxy protein C and prothrombin in patients with liver diseases
- Heparin cofactor II deficiency
- Platelet aggregation in children with acute lymphoblastic leukemia during induction of remission therapy
- Going with the flow of anticoagulant therapy
- Coagulation and inflammation in acute lung injury
- Molecular diagnostics in coagulation
- Benefit of recombinant human activated protein C beyond 28-day mortality: there is more to life than death
- Hikmat N. Abdel-Razeq, MD, ABIM (Hema&Onco)
- Design, synthesis and evaluation of graftable thrombin inhibitors for the preparation of blood-compatible polymer materials
- Protein C, protein S, and thrombomodulin in amniotic fluid. A preliminary study
- Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly
- Widespread cutaneous necrosis associated with antiphospholipid antibodies: report of four cases
- Thrombophilia in cancer
- Thrombin generation in platelet-poor plasma is normal in patients with hereditary mucocutaneous haemorrhages
- Impact of preoperative steroids administration on ischemia‐reperfusion injury and systemic responses in liver surgery: a prospective randomized study
- Editorial III: Inflammation and the coagulation system
- Thrombosis and haemorrhage in polycythaemia vera and essential thrombocythaemia
- Isquemia miocárdica y manejo postoperatorio
- Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD
- Importance of hemostatic gene polymorphisms for susceptibility to and outcome of severe sepsis
- Non-hemostatic activity of coagulation factor Xa: potential implications for various diseases
- Low protein Z levels in children with nephrotic syndrome
- Effects of high-dose methylprednisolone therapy on coagulation factors in patients with acute immune thrombocytopenic purpura
- Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene
- Influence of blood collection techniques on platelet function
- D-dimer is not a long-term prognostic marker following acute cerebral ischemia
- Efficacy and safety of a prothrombin complex concentrate (Octaplex®) for rapid reversal of oral anticoagulation
- Hemostatic alterations in patients with acute, unilateral vestibular paresis
- Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia
- The hematologic system as a marker of organ dysfunction in sepsis
- Effect of Nigella sativa on blood hemostatic function in rats
- Thromboelastograph in cardiac surgery: state of the art
- Antiphospholipid syndrome in an eight‐month‐old infant with sickle cell trait
- Mouse Models for Arterial Thrombosis: Does Clotting Make a Difference in Human Cardiovascular Disease?
- A prospective cohort study on the absolute incidence of venous thromboembolism and arterial cardiovascular disease in asymptomatic carriers of the prothrombin …
- Prenatal screening for thrombophilia: the background and the approach
- Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model
- Anticoagulant therapy for acute lung injury or pneumonia
- Coagulation inhibition for sepsis
- Thrombosis and cancer
- Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: Results from the thrombolysis in …
- Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment
- The antiphospholipid syndrome and atherosclerosis: clue to pathogenesis
- Prothrombin 20210 mutation (factor II mutation)
- The causes of coagulopathy are multiple and can be classified into congenital and acquired causes as follows
- Inherited thrombophilia, pregnancy, and oral contraceptive use: clinical implications
- High-dose antithrombin therapy for sepsis: mechanisms of action
- Effect of cyclosporine A on total homocysteine level in a rabbit model
- Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia
- The anatomy of the kidney and ureter
- Qualitative platelet disorders
- Linking the sepsis triad of inflammation, coagulation, and suppressed fibrinolysis to infants
- Multiorgan failure due to rapid occlusive vascular disease in antiphospholipid syndrome: the ‘catastrophic’antiphospholipid syndrome
- Cancer-related deep venous thrombosis: clinical importance, treatment challenges, and management strategies
- The immunopathogenesis of sepsis in elderly patients
- Targeting the coagulation cascade in sepsis: Did we find the “magic bullet”?
- A cutaneous manifestation of antiphospholipid antibody syndrome
- CME REVIEWARTICLE
- Pathogenesis of increased risk of thrombosis in cancer
- Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole …
- Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell …
- The anti‐inflammatory actions of antithrombin–a review
- Factor V Leiden: association with venous thromboembolism in pregnancy and screening issues
- Tumor necrosis factor-α is associated with increased protein C activation in nonobese type 2 diabetic patients
- Novel therapeutic agents in the management of hemorrhage and thrombosis
- Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes
- Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial
- The contact system
- Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated)
- Liver transplant surgery and transfusion
- Evaluation of Plasma Protein C Antigen, Protein C Activity and Thrombomodulin Levels in Type 2 Diabetic Patients
- Prevention of endothelial cell injury by activated protein C: the molecular mechanism (s) and therapeutic implications
- Beyond sepsis: activated protein C and ischemia–reperfusion injury
- Treatment of the Antiphospholipid Syndrome
- Sepsis in adults and foals
- Percutaneous mechanical thrombectomy: a new approach in the treatment of acute renal‐vein thrombosis
- Hepatic Veno-Occlusive Disease
- Static and dynamic assessment of biomarkers in surgical patients with severe sepsis
- Sepsis and coagulation
- Hyperhomocysteinemia in patients with Cushing’s syndrome
- Prevalence of hereditary factors predisposing to thrombosis in 260 patients diagnosed as thrombosis and investigated at Hospital Israelita Albert Einstein, São …
- Tissue factor as an evolutionary conserved cytokine receptor: Implications for inflammation and signal transduction
- Bidirectional relation between inflammation and coagulation
- Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature
- Budd‐Chiari syndrome as the first manifestation of polycythemia vera in young women with inherited thrombophilic state: an aggressive form of myeloproliferative …
- Thrombophilic risk factors and homocysteine levels in Behçet’s disease in eastern Spain and their association with thrombotic events
- Increased circulating platelet–leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count
- Impaired factor XIIa–dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications
- Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome
- LDL and cAMP cooperate to regulate the functional expression of the LRP in rat ovarian granulosa cells
- Up-regulation interleukin-6 and interleukin-8 by activated protein C in lipopolysaccharide-treated human umbilical vein endothelial cells
- Basic mechanisms of hemostasis
- 19 Treatment of the Antiphospholipid
- Effects of estrogen and selective estrogen receptor modulators on hemostasis and inflammation: potential differences among drugs
- Risk factors for venous thromboembolism in children
- The complexity of treatment with warfarin
- Radiation toxicity and proteinase‐activated receptors
- Venous thrombosis: the role of genes, environment, and behavior
- Oral anticoagulants in development
- Activated Partial Thromboplastin Time (APTT) Testing
- HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: When Heparin Causes Thrombosis: Significance, Recognition, and Management of Heparin‐Induced …
- Tissue factor pathway inhibitor does not influence inflammatory pathways
- The blood coagulation mechanism in multiple myeloma
- Probing the Hirudin−Thrombin Interaction by Incorporation of Noncoded Amino Acids and Molecular Dynamics Simulation,
- Hemostasis in chronic renal failure
- Lepirudin Dose Recommendations for Treatment of Heparin-Induced Thrombocytopenia in Patients Undergoing Intermittent Hemodialysis
- Genetic analysis of plasma von willebrand factor antigen levels as a risk factor for arterial and venous thrombosis
- Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation
- Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day …
- Recombinant human activated protein C: a system modulator of vascular function for treatment of severe sepsis
- Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation
- Low levels of protein C are associated with poor outcome in severe sepsis
- Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure
- The Acute Dialysis Quality Initiative—part VI: access and anticoagulation in CRRT
- The diagnosis and prognosis of pulmonary embolism
- Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C
- Altered blood coagulation in patients with posttraumatic stress disorder
- Hypercoagulability: too many tests, too much conflicting data
- Update on diagnosis and management of essential thrombocythemia
- Counteracting the effects of anticoagulants and antiplatelet agents during neurosurgical emergencies
- Homocysteine and arterial disease: experimental mechanisms
- Abdominoplasty: Thromboembolic risks for both sexes
- Which antiphospholipid antibody tests are most useful?
- Coagulation disorders in patients with cirrhosis and severe sepsis
- Genetic variations of the hemostatic system as risk factors for venous and arterial thrombotic disease
- Hepatic veno-occlusive disease following hematopoietic stem cell transplantation
- Antiphospholipid syndrome
- Selective inhibition of coagulation factors: advances in antithrombotic therapy
- Catastrophic antiphospholipid syndrome: proposed guidelines for diagnosis and treatment
- Extrahepatic portal vein obstruction
- Cerebral ischemic events after diagnosis of mitral valve prolapse: a community-based study of incidence and predictive factors
- Heparin‐induced thrombocytopenia during renal replacement therapy
- Anticoagulation options for pediatric hemodialysis
- Protein C pathway in infants and children
- Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation
- Bleeding disorders in pregnancy
- FGFR3 DYSREGULATION AND CLINICAL OUTCOME IN MYELOMA
- Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT)
- Quality of life and the duration of treatment with vitamin K antagonists in patients with deep venous thrombosis
- Consumption coagulopathy
- Protein C levels in severe sepsis
- Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia
- Activated protein C and sepsis
- Influence of a 7-day treatment with Ginkgo biloba special extract EGb 761 on bleeding time and coagulation: a randomized, placebo-controlled, double-blind study in …
- Disseminated intravascular coagulation
- Veno-occlusive disease of the liver in renal transplant patients
- Spectrum and classification of inflammatory demyelinating diseases of the central nervous system
- Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders
- Risk factors for thromboembolism in teens: when should I test?
- Coagulation interventions in experimental human endotoxemia
- Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders
- Coagulation, fibrinolysis, and fibrin deposition in acute lung injury
- The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia–reperfusion injury
- Paraoxonase 192 Gln→ Arg Polymorphism
- Thrombophilia: A new potential risk factor for cervical insufficiency
- Animal models to study adult stem cell-derived, in vitro-generated islet implantation
- Prophylaxis and treatment of venous thromboembolism in individuals with inherited thrombophilia
- Recent strategies to overcome the hyperacute rejection in pig to human xenotransplantation.
- Labor analgesia in protein S deficient patient: case report
- Coagulation: consultative hemostasis
- Pharmacoeconomic implications of new therapies in sepsis
- Portal vein thrombosis: etiology, diagnostic strategy, therapy and management
- Tissue factor pathway inhibitor in thrombosis and beyond
- Endothelium-specific loss of murine thrombomodulin disrupts the protein C anticoagulant pathway and causes juvenile-onset thrombosis
- Promoters can contribute to the elucidation of protein function
- Pulmonary thromboembolism in children
- Regulation of Vascular Bed–Specific Prothrombotic Potential
- Development of a biohybrid lung
- Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion
- Advances in treating patients with severe sepsis: role of drotrecogin alfa (activated)
- The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes
- Pathogenesis and treatment of disseminated intravascular coagulation
- Antithrombin deficiency: issues in laboratory diagnosis
- Bivalirudin in percutaneous coronary intervention
- DEBATE-Recurrent miscarriage: Does any treatment help?
- DEBATE-Recurrent miscarriage: Does any treatment help?
- Antiphospholipid syndrome: multiple mechanisms
- Evaluation of the marker of hypercoagulability prothrombin fragment F 1+ 2 in patients with mechanical or biological heart valve prostheses
- Ultrafiltration in diuretic-resistant volume overload in nephrotic syndrome and patients with ascites due to chronic liver disease
- Proteinaceous protease inhibitors: structural features and multiple functional faces
- The protein C pathway
- The usefulness of laboratory data in the differential diagnosis of anemia
- Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration …
- Haematology in pregnancy
- Plasmatic coagulation and fibrinolytic system alterations in PNH: relation to clone size
- Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver
- Drotrecogin alfa (activated) in the treatment of severe sepsis
- New anticoagulants
- The relationship between inflammation and the anticoagulant pathway: the emerging role of endothelial nitric oxide synthase (eNOS)
- The Therapeutic Use and Safety of Common Herbal Beverages
- Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature
- Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease
- UltraRapid Communication
- Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club
- Lipid oxidation enhances the function of activated protein C
- Infection and inflammation and the coagulation system
- Pathogenesis and pathology of different types of xenotransplant rejection
- Thrombin and protease-activated receptors in cancer
- Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways
- Thrombotic microangiopathic antiphospholipid syndromes: a continuum of conditions?
- Chemotherapy-induced thrombosis
- Coagulation and inflammation
- Risk factors for cryptogenic ischaemic stroke
- Bleeding disorders in renal failure
- Use of anticoagulants in diagnostic laboratory investigations
- Cancer and thrombosis in women
- Effect of post-operative analgesia on patient morbidity
- Coagulation disorders
- Successful treatment of mesenterial venous thrombosis with recombinant hirudin—a report of five cases
- Kruppel-Like Factor 2 (KLF2) Regulates Endothelial Thrombotic Function
- Patients with inferior vena caval filters should receive chronic thromboprophylaxis
- Effects of B vitamin supplementation on homocysteine levels in cardiac patients at Rush Preventive Cardiology Center
- Disseminated intravascular coagulation
- Olive oil and haemostasis
- New therapies and vaccines for meningococcal disease
- Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and protein S defects
- The last 100 years of sepsis
- Chronic thrombotic microangiopathy associated with antineoplastic therapy with minimal hematologic effects
- Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia
- Management of sepsis
- Comparison of hepatic coagulant, fibrinolytic, and anticoagulant functions between Banna Minipig Inbred line and humans
- Anticoagulation advances: outpatient treatment of venous thrombosis
- Clinical impact of novel anticoagulation strategies in sepsis
- A case of membranous glomerulonephritis presenting as pulmonary embolism and acute hyperlipidaemia
- Bleeding and thrombotic complications in critically ill patients with cancer
- The high atherosclerotic risk among epileptics: the atheroprotective role of multivitamins
- Learning from peer assessment: the role of the external quality assurance multilaboratory thrombophilia test process
- Evaluation of antiinflammatory and antiadhesive effects of heparins in human endotoxemia
- Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with antiphospholipid antibodies.
- Assessment of the coagulation profile in hemato-oncological patients receiving ATG-based conditioning treatment for allogeneic stem cell transplantation
- Pathogenesis of thrombosis in patients with malignancy
- Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery
- French maritime pine bark extract Pycnogenol dose-dependently lowers glucose in type 2 diabetic patients
- Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin
- Beyond antibody-mediated rejection: hyperacute lung rejection as a paradigm for dysregulated inflammation
- Heparin attenuates symptoms and mast cell degranulation induced by AMP nasal provocation
- RETRACTED ARTICLE: Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal …
- Antithrombotic agents in the treatment of severe sepsis
- Coagulation for the clinician
- Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis
- Tissue factor pathway inhibitor in thrombosis and beyond: role of heparin
- Effects of intravenous infusion of highly purified vitamin B2 on lipopolysaccharide-induced shock and bacterial infection in mice
- Assessment of hemostatic risk factors in predicting arterial thrombotic events
- Pathogenesis of thrombosis in cancer
- Homocysteine plasma concentration is related to severity of lung impairment in scleroderma.
- Homocysteine and neuropsychiatric disorders
- Avoiding hepatic veno-occlusive disease: what do we know and where are we going?
- Low molecular weight heparins in special populations
- Prothrombotic states in HIV disease and stroke complications
- Liver failure, transplantation, and critical care
- Low‐Molecular‐Weight Heparins in Thrombosis and Cancer: Emerging Links
- Predictive value of circulating oxidized LDL for cardiac events in type 2 diabetic patients with coronary artery disease
- Soluble thrombomodulin, plasma-derived unactivated protein C, and recombinant human activated protein C in sepsis
- Porcine hematopoietic cell xenotransplantation in nonhuman primates is complicated by thrombotic microangiopathy
- Pro: Antifibrinolytics are safe and effective in patients undergoing liver transplantation
- Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor
- Evolution, innate immunity and the pathogenesis of septic shock
- Analysis of risk factors: the rationale of the guidelines of the Czech Hematological Society for diagnosis and treatment of chronic myeloproliferative disorders with …
- Calciphylaxis associated with acute, reversible renal failure in the setting of alcoholic cirrhosis
- Adult respiratory distress syndrome
- Antithrombin III prevents early pulmonary dysfunction after lung transplantation in the dog
- The cerebrovascular risks associated with tamoxifen use
- Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality …
- Haemostatic alterations in colorectal cancer: perspectives for future treatment
- Oral administration of geranylgeranylacetone improves survival rate in a rat endotoxin shock model: administration timing and heat shock protein 70 induction
- Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?
- Effect of all‐trans‐Retinoic acid on the hypercoagulable state of patients with breast cancer
- Thrombophilias and recurrent pregnancy loss
- Antiphospholipid syndrome: current diagnostic and therapeutic issues; answers to 6 clinical questions about a complex disorder
- The gene expression profile of human umbilical vein endothelial cells stimulated with lipopolysaccharide using cDNA microarray analysis
- Pasteurization of antithrombin without generation of the prelatent form of antithrombin
- Subsets of the Antiphospholipid Syndrome
- The mechanisms of thrombotic risk induced by hormone replacement therapy
- Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats
- Preventing warfarin-related bleeding
- Oral anticoagulant therapy in venous thromboembolism
- Introduction: rationale for using drotrecogin alfa (activated) in patients with severe sepsis
- Noncirrhotic portal hypertension and portal vein thrombosis
- Coagulopathic States
- INHERITED THROMBOPHILIA AND RECURRENT PREGNANCY LOSS
- Unfractionated heparin: focus on a high‐alert drug
- Recombinant factor VIIa: clinical applications for an intravenous hemostatic agent with broad-spectrum potential
- Separation of latent, prelatent, and native forms of human antithrombin by heparin affinity high-performance liquid chromatography
- Inherited thrombophilia
- Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future …
- A Filipino patient with fulminant type 1 diabetes
- Speculum medicinae: reflections of a medievalist-clinician
- Structural and functional consequences of methionine oxidation in thrombomodulin
- Evaluation of anticoagulant system in Turkish children with Perthes disease
- Antiphospholipid antibodies induce monocyte chemoattractant protein-1 in endothelial cells
- Haemostatic function and cerebrovascular disease
- Delayed recovery of normal hematopoiesis in arsenic trioxide treatment of acute promyelocytic leukemia: a comparison to all-trans retinoic acid treatment
- Antiphospholipid syndrome
- Hemostatic abnormalities
- Speculum medicinae: Reflections of
- The effects of ultrafiltration on e-Aminocaproic acid: An in vitro analysis
- Characterization of a mouse model for thrombomodulin deficiency
- Case 1—2005: Cardiac surgery in congenital afibrinogenemia with thrombo-occlusive disease
- Endothelial cell heterogeneity
- Autoimmune process participation in the oral pathologies
- The spleen of a specially adapted mammal, the little hairy armadillo Chaetophractus vellerosus,(Xenarthra, Dasypodidae). A light and electron microscopic …
- Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-α production through inhibition of Egr-1 expression
- BIRD SCHISTOSOMES: NEW CAUSATIVE AGENT OF THE CNS INJURIES?
- Thrombotic manifestations in the antiphospholipid syndrome
- Antithrombotic Agents in the Management of Sepsis
- Protease-activated receptors in the cardiovascular system
- Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics
- The cancer stem cell: evidence for its origin as an injured autoreactive T cell
- Thrombophilia related issues in women and children
- Recombinant hirudin enhances cardiac output and decreases systemic vascular resistance during reperfusion after cardiopulmonary bypass in a porcine …
- Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life
- Coagulation Abnormalities in Critical Illness
- THE ANTIPHOSPHOLIPID SYNDROME: PATHOGENESIS AND IMPLICATIONS FOR SYSTEMIC LUPUS ERYTHEMATOSUS
- El Bazo de un Mamífero con Adaptaciones Especiales: el” Peludo Chico” Chaetophractus vellerosus,(Xenarthra, Dasypodidae). Estudio con Microscopía de …
- Rapid-SF: a rapid whole-blood screen for soluble fibrin monomer
- 4-2. Fundamental Concepts in the Pharmacokinetics and Pharmacodynamics of Antithrombotic Agents
- Anaesthetic implications of anticancer chemotherapy
- The epidemiology and clinical pathophysiology of thromboembolic disease
- Role of current and emerging antithrombotics in thrombosis and cancer
- Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations
- Blood: principles and practice of hematology
- Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production
- Hemorrhagic Disorders in the Surgical Patient
- Drugs affecting the coagulation process
- Clinical Thrombosis Unit, Department of Haematology, Royal Perth Hospital, University of Western Australia, GPO Box X2213 Perth WA 6001, Tel: 61–9–224–2897 …
- Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese …
- Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective…
- Venous thrombosis in pregnancy
- Tissue factor pathway inhibitor induces expression of JUNB and GADD45B mRNAs
- Relevance of plasma D-dimer measurement in patients with acute peripheral vertigo
- Pig peripheral blood mononuclear cells are directly associated with the thrombotic microangiopathy that complicates the induction of chimerism in pig‐to‐baboon …
- Antiphospholipid syndrome
- Coagulation system abnormalities in human immunodeficiency virus (HIV) positive African (Black) patients with acute upper segment deep vein thrombosis (DVT) of …
- Inhibition of thrombin by iopromide in vitro
- Drotrecogin alfa (activated): a novel therapeutic strategy for severe sepsis
- Exogenous sex hormones and thrombophilia
- Relationship Between the Inflammation and Coagulation Pathways in Patients with Severe Sepsis
- Interplay between the hemostatic and inflammatory systems
- Arterial thromboembolism in pregnancy
- Biomarkers for Placental Abnormality
- Protease-activated receptors
- Study of Sepsis Related Changes in Platelet Adhesion, Aggregation and Angiogenic Growth Factor Release
- Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)
- How to Implement Evidence Into Practice to Improve Diabetes Care: Response to Ilag et al.
- A case-control study examining the association between travel and deep venous thrombosis
- 15th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes
- Therapeutic applications of serine protease inhibitors
- Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: case report and review of the literature
- Normal Physiology (short lection course for the students of dental department)
- Current issues regarding tamoxifen and the genital tract: a review
- Key topics in neonatology
- Utility of B-Type Natriuretic Peptide as a Screen for Left Ventricular Dysfunction in Patients With Diabetes: Response to Liew et al.
- Protein C replacement in severe meningococcemia: rationale and clinical experience
- Comparative biochemical and pharmacological studies on heparin-derived oligosaccharides
- Monogenic causes of ischemic stroke
- Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-α production by inhibiting activation of both nuclear factor …
- Proteinase‐activated receptors (PARs) in the nervous system: Roles in neuroplasticity and neurotrauma
- Plasminogen activation, fibrinolysis, and cell proteolytic activity in antiphospholipid syndrome
- Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure
- New treatments for antiphospholipid syndrome
- The pathogenetic role of apoptosis in hypercoagulable states
- Hypoalbuminemia in the Patient with Renal Disease: Its Causes and Consequences
- Critical care clotting catastrophies
- Dissertation Submitted In Partial Fulfillment Of The
- Quand évoquer un syndrome myéloprolifératif en pathologie vasculaire?
- Factor VIII expression in azoxymethane-induced murine fulminant hepatic failure
- The role of evidence-based medicine in the management of critically ill patients
- Primary’,’Secondary’,’Seronegative’,’Catastrophic’and other Subsets of the Antiphospholipid Syndrome
- Cobalamin and Folate Deficiency and their Relation to Activated Protein C Resistance as Risk Factors for Thrombosis in Diabetic Patients
- The Last 100 Years of Sepsis
- Coordinated increase in albumin, fibrinogen, and muscle protein synthesis during hemodialysis: role of cytokines
- Acute respiratory tract infections and (athero) thrombotic disease
- Thromboembolic complications in children with cancer
- deduced that they represented excess a chains
- A review of the technical, diagnostic, and epidemiologic considerations for protein S assays
- Clinical developments for treating ARDS
- Effects of antithrombin III on myeloperoxidase activity, superoxide dismutase activity, and malondialdehyde levels and histopathological findings after spinal cord …
- Vascular function in hemostasis
- Use of Heparin Preparations in Older Patients
- A Novel Approach to Cancer Treatment
- 6 VENOUS THROMBOEMBOLISM
- P Clark, M Greaves, ID Walker, P Langhorne, I Brenkel, L Regan and IA Greer
- Non Endoscopic Predictors of Oesophageal Varices in Patients with Cirrhosis of the Liver
- THE EXPRESSION OF THROMBOMODULIN, TISSUE FACTOR, TISSUE FACTOR PATHWAY INHIBITOR AND ENDOTHELIAL PROTEIN C RECEPTOR IN NORMAL …
- Haemostatic studies in subarachnoid haemorrhage
- Tamoxifen Induces Hypoxia in MCF-7 Xenografts’
- Sugar Shock!: How Sweets and Simple Carbs Can Derail Your Life, and how You Can Get Back on Track
- Prevalence of antiphospholipid syndrome in Sudanese women with recurrent miscarriage
- Human Physiology: Lectures
- Procoagulant activity of adherent platelets
- Molecular and structural analysis of human Factor X deficiency
- Aetiology and treatment of venous thromboembolism
- The importance of platelets and complement in material-induced leukocyte activation in vitro
- Anticoagulation in severe sepsis and the multiple organ dysfunction syndrome
- Antithrombotic agents under flow conditions
- General practitioners’ reasons for not participating in a pharmacy-initiated randomized comparison of community pharmacy and physician-based warfarin …
- 11. Excretion/Secretion, Ionic and Osmotic Regulation
- Cardiovascular disease in systemic lupus erythematosus
- THERAPEUTIC ENZYMES
- Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
- Vascular regulation of hemostasis and fibrinolysis: with special focus on vein graft disease
- Safety issues surrounding the use of aromatase inhibitors in breast cancer
- Fibrinogen Vlissingen/Frankfurt IV: Studies with recombinant fibrinogen and gene-targeted mice
- 36 Annexins in Antiphospholipid Syndrome
- Essential Thrombocythaemia: Diagnosis, Prognostic Aspects, and the Outcome of Finnish patients
- DISSEMINATED INTRAVASCULAR
- Urinary vitamin E metabolites in sepsis using tandem mass spectrometry
- Blueprints Notes and Cases, Pharmacology
- Hypercoaugulability
- Obstetric Anaesthesia
- Somatostatin receptor-mediated negative modulation of HER2 phosphorylation, signaling, and in vitro invasive potential in breast cancer
- Atherosclerosis; aspects of a multicultural disease
- Identifying nutritional and life-style risk factors associated with the development of osteoporosis in women of Asian origin at the Aga Khan University Hospital, Nairobi …
- Haemostatic variables in African adolescents: the PLAY study
- Analysis of membrane dependent reactions in blood coagulation: Comparison of factor VIIa variants with enhanced membrane affinity
- Measurement of venous blood flow using photoplethysmography.
- The case records and commentaries in obstetrics and gynaecology
- Beyond heparin and warfarin: the new generation of anticoagulants
- Basic mechanisms and pathogenesis of venous thrombosis
- Hemostasis and inflammation: two of a kind?
- The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of …
- Hypercoagulability in chronic kidney disease is associated with coagulation activation but not endothelial function
- Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition?
- A review of pulmonary coagulopathy in acute lung injury, acute respiratory distress syndrome and pneumonia
- Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection
- Plasma-coagulation hemostasis in physically active subjects during adaptation to physical exercise
- Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats
- Coagulant and fibrinolytic status in tuberculous meningitis
- The physiopathology of the catastrophic antiphospholipid (Asherson’s) syndrome: compelling evidence
- Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: report of four cases and review of the literature
- Incidence and risk factors for venous thromboembolism
- Venous thromboembolism: a public health concern
- Clinical significance of anticoagulant proteins detection in patients with thrombotic events
- Hemostatic changes in patients with type 2 diabetes mellitus
- Deficiencies of proteins C, S and antithrombin and activated protein C resistance–their involvement in the occurrence of arterial thromboses
- Protein Z g-42a variant and the risk of pregnancy-related venous thromboembolism in a cohort of Italian patients
- Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors
- Sepsis, coagulation, and antithrombin: old lessons and new insights
- Antithrombin-III as a non-invasive marker of chronic liver disease
- Hereditary combined deficiency of the vitamin K-dependent clotting factors
- Protein C and protein S changes in GH-deficient adults on r-HGH replacement therapy: correlations with PAI-1 and t-PA plasma levels
- Modern concepts of the diagnosis and treatment of purpura fulminans
- A novel mechanism of thrombosis in antiphospholipid antibody syndrome
- The epidemiology of venous thromboembolism in the community: implications for prevention and management
- Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity
- Haemostasis impairment in patients with obstructive jaundice
- Thrombophilia risk factors are associated with intrauterine foetal death and pregnancy‐related venous thromboembolism
- Effect of vilon on the immunity status and coagulation hemostasis in patients of different age with diabetes mellitus
- Synthetic and naturalpeptides as antithrombotic agents—a view on the current development
- Nebulized antithrombin limits bacterial outgrowth and lung injury in Streptococcus pneumoniae pneumonia in rats
- Computationally derived points of fragility of a human cascade are consistent with current therapeutic strategies
- Catastrophic cerebral antiphospholipid syndrome presenting as cerebral infarction with haemorrhagic transformation after sudden withdrawal of warfarin in a patient …
- Hemostasis and thrombosis in critically ill patients
- Laboratory testing in disseminated intravascular coagulation
- Management and investigation of neonatal thromboembolic events: genetic and acquired risk factors
- Therapeutic consequences of thrombophilic testing
- Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin
- Risk factors analysis in 672 hospitalized patients with venous thromboembolism
- Genetic Risk Factors of Thrombosis.
- Warfarin and calcific uremic arteriolopathy
- Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit
- naturalheparinoids isolated from Halymenia sp.(Rhodophyceaes) delivery on the Ceará coast.
- Emerging anticoagulant drugs
- Low levels of protein C and antithrombin III could suggest the presence of microcirculatory dysfunction and predict the severity of sepsis and the appearance of …
- Neutral styrene divinylbenzene copolymers for adsorption of toxins in liver failure
- Activated protein C resistance test using factor VIII-deficient plasma: A new approach to the venous thrombotic risk?
- Alterations of coagulation in metformin intoxication
- New anticoagulants: a replacement for coumadin, heparin?
- Past and future of genetic research in thrombosis
- Antithrombin, Protein C, Protein S and Activated Protein C Resistance in the General Healthy Chinese Population: Normal Plasmatic Ranges and Genetic …
- Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature
- Unexpected outcome (positive or negative) including adverse drug reactions: Catastrophic cerebral antiphospholipid syndrome presenting as cerebral …
- General Introduction and Outline of the Thesis
- Alterations in serum prothrombotic markers induced by treatment with bevacizumab-based chemotherapy regimens
- Inhibitors of coagulation and severe sepsis.
- Use of Autoplasma in the Prevention of Venous Thromboses during Endoprosthetic Replacement of the Hip Joint
- < The> effect of genetically related risk factors on the recurrence rate of acute pulmonary embolism in a tertiary teaching hospital in Jordan
- Inherited thrombophilia is associated with pregnancy losses that occur after 12th gestational week in Serbian population
- Protein C and Protein S Levels Are Correlated with Bleeding Symptoms In Thai Population.
- Portal vein thrombosis and thrombophilia in liver cirrhosis: a role for hyperhomocysteinemia?
- The Mechanism of Protein S as An Anticoagulant Independent of Activated Protein C.
- Analysis of Ordering Practice of Thrombophilia Testing at a Single Large Teaching Hospital
- Genetics of venous thrombosis
- Diagnostic algorithm for thrombophilia screening
- Establishment of reference intervals for kaolin-activated thromboelastography in dogs including an assessment of the effects of sex and anticoagulant use
- Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests
- Laboratory investigation of thrombophilia: the good, the bad, and the ugly
- Tissue Factor− 1208D> I Polymorphism Is Associated with D-dimer Levels in Patients with Inflammatory Bowel Disease
- GlideScope® intubation assisted by fiberoptic scope
- Venous thromboembolism and cancer: a systematic review
- ANTICOAGULANT SYSTEM ACTIVITY IN SPLENECTOMIZED VERSUS NON-SPLENECTOMIZED IRANIAN PATIENTS WITH β-THALASSEMIA MAJOR
- Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease
- Long-term stability of coagulation variables: protein S as a biomarker for preanalytical storage-related variations in human plasma
- Thrombolysis in antiphospholipid syndrome: current hematologic perspectives
- Protein C and protein S deficiencies: similarities and differences between two brothers playing in the same game
- Ultrasonography May Help Guide Decisions to Discontinue Anticoagulation Therapy for Deep Venous Thrombosis
- Low level of factor V is associated with development of deep-vein thrombosis in Japanese patients
- Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection
- Practical hemostasis and thrombosis
- Case reports of the use of immunoadsorption or plasma exchange in high‐risk pregnancies of women with antiphospholipid syndrome
- Activated protein C in the treatment of acute lung injury and acute respiratory distress syndrome
- Growth arrest-specific gene 6 (GAS6)
- Stability of coagulation assays performed in plasma from citrated whole blood transported at ambient temperature
- Effects of leptin replacement on risk factors for cardiovascular disease in genetically leptin-deficient subjects
- Trombosis mesentérica y déficit de proteínas C y S en un paciente con hepatitis C crónica en tratamiento con interferón y ribavirina
- 299: The Relation Between the Frequency of Presence of Thrombophilia and Thromboembolic Complications After Allogeneic Hematopoietic Cell Transplantation …
- 300: Once Daily Busulfan Cyclophosphamide is Well Tolerated and Effective Prior to Allogeneic Hematopoietic Stem Cell Transplantation
- Adjunctive therapies for severe sepsis
- Elevated Red Cell Microparticles (RMP) as Risk Factor for Thrombosis in Patients with Renal Failure.
- Endotoxemia alters nucleotide hydrolysis in platelets of rats
- Assessment of hypercoagulability markers and lipid levels in postmenopausal women undergoing either oral or transdermal hormone replacement therapy
- Snakebite-induced coagulopathy and bleeding disorders
- Clinical review: patency of the circuit in continuous renal replacement therapy
- Antithrombin Inhibits Bronchoalveolar Activation of Coagulation and Limits Lung Injury during
- Editorial [Hot Topic: Sepsis (Guest Editor: David E. Joyce)]
- Antiphospholipid antibodies and syndromes: relevance for the GP
- Medical Journal Watch: Context and Applications
- Hypercoagulable state, pathophysiology, classification and epidemiology
- The coagulant response in sepsis and inflammation
- Hereditary thrombophilic risk factors for recurrent pregnancy loss
- Hypercoagulability after trauma: hemostatic changes and relationship to venous thromboembolism
- Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea
- Clinical variability of haemophilia A and B in Mexican families by factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T/A1298C
- A novel mutation (g2172→ c) in the factor V gene in a Chinese family with hereditary activated protein C resistance
- Outcome of pregnancies in women with thrombophilic disorders
- Combined hormonal contraceptive use during the postpartum period: 26 January 2010, Geneva, Switzerland: statement
- Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium—a register-based case-control study
- A Tribute to Eberhard F. Mammen, MD (1930–2008)
- Testing for Inherited and Acquired Thrombotic Disorders
- 35 Drugs affecting blood coagulation, fibrinolysis, and hemostasis
- Antibodies to heparin–platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis
- Guidelines for the diagnosis and management of disseminated intravascular coagulation
- Effects of exposure to air pollution on blood coagulation
- Association of high tidal volume with postpneumonectomy failure
- Baseline Thrombophilic Alterations and Risk of Venous Thromboembolism in 266 Multiple Myeloma Patients Primarily Treated with Thalidomide and High-Dose …
- Does thrombophilia testing help in the clinical management of patients?
- Vascular thrombosis associated with aprotinin and deep hypothermic circulatory arrest: Where are we in 2006?
- Oral contraception and thrombophilia
- ANTITHROMBIN LEVELS IN HEALTHY PAKISTANI MALES
- Thrombophilic factors in idiopathic intracranial hypertension: a report of 51 patients and a meta-analysis
- MORTALITY IN OUTXOFXHOURS EMERGENCY MEDICAL ADMISSIONS
- Association of High Tidal Volume with Postpneumonectomy Failure
- Impact of Terlipressin on Hepatosplanchnic Perfusion:“Only the Dose Makes a Thing Not a Poison”(Paracelsus)
- Risk factors for umbilical venous catheter‐associated thrombosis in very low birth weight infants
- Prevention and Treatment of Bruising
- Thrombin physiology and pathophysiology
- Sulfated polysaccharide purified from Ecklonia cava accelerates antithrombin III-mediated plasma proteinase inhibition
- The relationship between insulin resistance and hypercoagulability in acute ischemic stroke
- Survival Patterns Without Cardiac Surgery or Interventional Catheterization: A Narrowing Base
- Look on the “air side” in pneumonia
- Altered reference ranges for protein C and protein S during early pregnancy: Implications for the diagnosis of protein C and protein S deficiency during pregnancy
- Fibrinolytic system of the armadillo Chaetophractus villosus (Xenarthra, Dasypodidae)
- The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome
- Venous thrombosis in the elderly
- Thrombophilic conditions in the adolescent: the gynecologic impact
- Haemostasis and thrombosis in liver disease
- Haemostatic changes and acquired activated protein C resistance in normal pregnancy
- Sepsis, coagulation and anticoagulants
- Hypercoagulation testing in ischemic stroke
- Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade
- Retroperitoneal hemorrhagic shock in a patient on warfarin therapy
- Blood coagulation in falciparum malaria—a review
- Is Familial Mediterranean Fever a thrombotic disease or not?
- Genetic basis of thrombosis
- Cerebral Hemodynamics in Asymptomatic Patients with Sickle Cell Disease and Thalassemia: Correlation with Hemostatic State
- Coagulopathy in liver diseases
- Venous thromboembolism and ethnicity
- Asparaginase‐related venous thrombosis in UKALL 2003‐re‐exposure to asparaginase is feasible and safe
- Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients
- Platelets, frozen plasma, and cryoprecipitate: what is the clinical evidence for their use in the neonatal intensive care unit?
- Hemostasis factors and aging
- A Young Man with Chest Pain Following a Knee Injury
- Family history as a risk factor for venous thromboembolism
- Chemotherapy-induced hemostatic activation and thrombosis in cancer
- 17 Diagnosis and Management of Disseminated Intravascular Coagulation
- Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation
- Tissue factor and its measurement in whole blood, plasma, and microparticles
- Thrombin in myocardial ischemia-reperfusion during cardiac surgery
- Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?
- Efficacy and safety of recombinant human soluble thrombomodulin (ART‐123) in disseminated intravascular coagulation: results of a phase III, randomized, double …
- Haemostatic problems in liver surgery: A review
- Nebulized anticoagulants limit pulmonary coagulopathy, but not inflammation, in a model of experimental lung injury
- Venous thromboembolism in women taking hormonal contraceptives
- The psychological impact of testing for thrombophilia: a systematic review
- Thrombelastography
- Early coagulation disorders after severe burn injury: impact on mortality
- Haemostasis
- Effects of isoflavones on the coagulation and fibrinolytic system of postmenopausal women
- Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications
- Pleading for the routine introduction in the investigation of the late spontaneous abortion etiology of the exploration of resistance to activated C protein along …
- Effects of nucleotides and nucleosides on coagulation
- Thrombophilia: grading the risk
- Effect of corticosteroids on hemostasis and pulmonary arterial pressure during chronic obstructive pulmonary disease exacerbation
- Global hemostasis in pregnancy: are we using thromboelastography to its full potential?
- A cell-based model of coagulation and its implications
- Protein C concentrate as adjuvant treatment in neonates with sepsis-induced coagulopathy: a pilot study
- Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein C
- Use of complementary and alternative medicine among adults with skin disease: results from a national survey
- 24 Obstetrics, contraception, and estrogen replacement
- The two tales of coagulation in liver transplantation
- Thrombophilia-A clinical approach to thrombophilia testing
- Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents
- Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo
- Less benefit from warfarin in diabetics after myocardial infarction?
- The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia
- Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings
- Advances in pathogenesis and management of sepsis
- Hemorrhagic complications in pediatric hematologic malignancies
- Thrombophilic variables do not increase the generation or procoagulant activity of thrombin during cardiopulmonary bypass
- Pharmacological treatments for acute respiratory distress syndrome
- Coagulation in pregnancy
- Oral Contraception and Thrombophilia
- The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage
- Statins for community-acquired pneumonia: current state of the science
- Management of recurrent thrombosis in liver transplant recipients: a case report
- Improved body mass index after mesenterico-portal bypass
- Hemostasis and ageing
- Hypercoagulability in sickle cell disease and beta-thalassemia
- Association between factor V Leiden mutation and poor pregnancy outcomes among Palestinian women
- Pancreas allograft thrombosis
- Hemodynamic disorders
- Portal vein thrombosis
- Thrombophilia and venous thromboembolism: implications for testing
- Cancer and thrombosis: an increasingly important association
- Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians
- Late onset ulcerative colitis complicating a patient with Budd–Chiari syndrome: a case report and review of the literature
- Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa …
- Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment
- The role of bronchoalveolar hemostasis in the pathogenesis of acute lung injury
- Impaired binding of thrombin to thrombomodulin is associated with risk of deep vein thrombosis
- The epidemiology of venous thromboembolism in the community
- Effects of anticoagulant strategies on activation of inflammation and coagulation
- Lipoprotein (a) levels in childhood arterial ischemic stroke
- Cytokine gene variants and venous thrombotic risk in the BRATROS (BRAZILIAN THROMBOSIS STUDY)
- Inflammation and hemostasis: a bidirectional interaction
- Thrombophilia and pregnancy complications: cause or association?
- Developing a public health research agenda for women with blood disorders
- Management of pregnant women with thrombophilia or a history of venous thromboembolism
- Coagulation and anticoagulation in acute lung injury, pneumonia, and ventilator-associated lung injury
- Risk assessment for recurrent venous thrombosis
- Transgenic mouse models of venous thrombosis: fulfilling the expectations?
- Calculation of chemical equilibria in CaCl2-heparin-sodium adenosinetriphosphate and MgCl2-heparin-sodium adenosinetriphosphate systems in physiological …
- Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome
- Pathogenesis of venous thromboembolism in cancer
- BEHÇET HASTALIĞINDA TROMBOFİLİK FAKTÖRLER VE KLİNİK BULGULARLA BİRLİKTELİĞİ
- Microvascular thrombosis in sepsis and septic shock: an autopsy study
- A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation
- The hemostatic system through aging and menopause
- Intrahepatic portal cavernoma as an indication for liver transplantation
- The paraoxonase gene polymorphism in stroke patients and lipid profile
- Cerebral venous sinus thrombosis in an adolescent with Ewing sarcoma
- Increased Plasma and Optic Nerve Levels of IL-6, TNF-α, and MIP-2 Following Induction of Ischemic Optic Neuropathy in Mice
- Miscellaneous b leeding d isorders
- #ERROR!
- Combined thrombophilia and obstetric complications
- Subject Index Vol. 36, 2007–08
- Inflammation and coagulation
- Evaluation of polymer matrices for an adsorptive approach to plasma detoxification
- Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development
- Thrombophilia
- The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with β …
- Haemostatic disorders in patients with breast cancer at Kenyatta national hospital, Kenya
- Thrombophilia screening or screaming
- An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: The Women’s Genome Health Study
- Thrombotic risk factors: basic pathophysiology
- Antithrombotic therapy in children with venous thromboembolism
- Design and synthesis of a candidate α-human thrombin irreversible inhibitor containing a hydrophobic carborane pharmacophore
- The role of coagulation in arterial and venous thrombosis
- Coagulopathies and thrombosis: usual and unusual causes and associations, part II
- HEMATOLOGIC CONDITIONS AS CAUSE OF ISCHAEMIC STROKE IN YOUNG ADULTS.
- Correlation of vascular endothelial growth factor with the severity of thalassemia intermedia
- Toxicity assessment of naturaland chemical coagulants using brine shrimp (Artemia salina) bioassay
- Prevalence of anticoagulant rodenticide poisoning in humans and animals in France and substances involved
- Mechanisms of thrombosis related to hormone therapy
- Danaparoid sodium attenuates the increase in inflammatory cytokines and preserves organ function in endotoxemic rats
- Microcirculatory endothelial dysfunction during endotoxemia-insights into pathophysiology, pathologic mechanisms and clinical relevance
- Gender and inter-species influence on coagulation tests of rats and mice
- Anticoagulation for acute dialysis
- Pathogenesis, diagnosis, and management of disseminated intravascular coagulation: a literature review
- HIV disease in thrombocardiology
- Hypercoagulable State and Methylenetetra-hydrofolate Reductase (MTHFR) C677T Mutation in Patients with Beta-Thalassemia Major in Kuwait
- Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile
- The inflammation–coagulation axis as an important intermediate pathway in acute lung injury
- Etiology and naturalhistory: diagnosis and evaluation
- The influence of the age in the risk of the prothrombin G20210A mutation for spontaneous venous thrombosis
- Inherited thrombophilia and early pregnancy
- Thrombin activatable fibrinolysis inhibitor (TAFI): A role in pre-eclampsia?
- Heparin‐like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation
- Role of thrombophilia in adverse obstetric outcomes and their prevention using antithrombotic therapy
- Risk factors for thrombophilia in young adults presenting with thrombosis
- A novel splice site mutation in intron C of PROS1 leads to markedly reduced mutant mRNA level, absence of thrombin-sensitive region, and impaired secretion and …
- Recombinant anticoagulant factors for adjunctive treatment of sepsis
- Is there an overlap between sudden neurosensorial hearing loss and cardiovascular risk factors?
- Antiphospholipid antibodies may impair factor XIIa–dependent activation of fibrinolysis in pregnancy: in vitro evidence with human endothelial cells in culture and …
- Venous stasis and activation of coagulation
- Blood transfusion and the anaesthetist: management of massive haemorrhage
- Tissue factor pathway inhibitor [Tfpi]: a naturalcoagulation inhibitor and potential therapeutic agent–a review
- The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis
- Rickettsiae and rickettsial infections: the current state of knowledge
- The prothrombotic state in rheumatoid arthritis: an additive risk factor for adverse cardiovascular events
- Association between estrogen receptor alpha and beta gene polymorphisms and deep vein thrombosis
- The CAPS Registry: morbidity and mortality of the catastrophic antiphospholipid syndrome
- Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation
- Hereditary and acquired antithrombin deficiency
- Activation and regulation of hemostasis in acute liver failure and acute pancreatitis
- Lemierre syndrome variant: Staphylococcus aureus associated with thrombosis of both the right internal jugular vein and the splenic vein after the exploration of a river …
- Thrombophilia screening–at the right time, for the right patient, with a good reason
- High prevalence of activated protein C resistance and factor V Leiden mutation in an Arab population and patients with venous thrombosis in Kuwait
- Thrombosis in multiple myeloma
- Pleural mesothelioma and venous thrombosis: the eosinophilia link
- High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis
- Therapeutic approaches to coagulopathy in cancer patients
- The protective effect of the arginine-heparin complex under simulation of insulin-dependent diabetes
- Pregnancy failure and heritable thrombophilia
- Gestational thrombocytopenia complicated with macrosomia, failure to progress in active labor, and postpartum hemorrhage
- Sepsis and septic shock: a history
- THROMBOPHILIA: THE LABORATORY ASSESSMENT AND MANAGEMENT
- Ultrasonography-guided oral anticoagulant therapy reduced recurrent venous thromboembolism
- Defective Fibrinolysis and Genetic or Acquired Pro-coagulant Changes Synergistically Increase the Risk of Venous Thrombosis
- Low-molecular-weight heparins: what is their thera-peutic usefulness?
- Subject Index Vol. 64, 2010
- Genetic susceptibility to VTE: A primary care approach
- Genetic variation and susceptibility to venous thrombosis: Etiology and risk assessment
- Thrombophilia ad dies vitae
- Traveller’s Thrombosis’–Does It Exist and Are We Ready to Give Prophylaxis?
- A Case of Superior Mesenteric Vein and Portal Vein Thrombosis Associated with Normal Delivery Presented by Acute Pancreatitis
- Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity
- Genome-wide scan in affected sibling pairs reveals two novel susceptibility regions for venous thromboembolism: The Genetics In Familial Thrombosis (GIFT) …
- 301: The Impact of the Disparities of Short Tandem Repeats (STR) between Doonor-recipient Pair on the Allogeneic Hematopoietic Cell Transplantation (AHCT) …
- Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms
- The protein C pathway: implications for the design of the RESPOND study
- The association between vascular function-related genes and age at naturalmenopause
- Retinal vein occlusion: pathophysiology and treatment options
- Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2–dependent fibrinolysis
- Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates
- Massive pulmonary embolism simulating electrocardiographic pattern of Brugada syndrome
- Screening, testing, or personalized medicine: where do inherited thrombophilias fit best?
- Sepsis and multiple organ failure
- Thrombomodulin and GFC levels in Legg–Calve–Perthes disease
- Heparin and maternal fetal interface: why should it work to prevent pregnancy complications?
- Pharmacological treatment of sepsis
- Congenital and Acquired Hypercoagulable Syndromes
- Thrombophilia and cerebral vein thrombosis
- Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms
- Changes in cardiovascular risk factors associated with wine consumption in intervention studies in humans
- Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome
- Predictive value of D-dimer test, persistent residual venous thrombosis, and thrombophilia for venous thromboembolism recurrence
- Inherited trombophilic states and pulmonary embolism
- Clinical and genetic risk factors for venous thromboembolism in Chinese population
- Fiabilidad de los tests diagnósticos no invasivos en la recurrencia de la trombosis venosa profunda
- rhAPC Inhibits Local and Systemic Activation of Coagulation without Influencing Inflammation during P. aeruginosa
- Venous thromboembolism: risk factors for recurrence
- Protein C deficiency
- Update on Physiological Anticoagulant Factor Concentrates in Patients with Sepsis
- Production of bioactive chitosan oligosaccharides and their potential use as nutraceuticals
- Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis
- Coagulation, platelet activation and thrombosis in xenotransplantation
- Thrombophilia and cancer
- Overview of the postulated mechanisms linking cancer and thrombosis
- Clinical guidelines for testing for heritable thrombophilia
- A new era for oral anticoagulation? Old and new anticoagulant drugs
- Role of the M2 haplotype within the annexin A5 gene in the occurrence of pregnancy-related venous thromboembolism
- Tissue factor as an initiator of coagulation and inflammation in the lung
- Blood coagulation as an intrinsic pathway for proinflammation: a mini review
- Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia
- Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse
- Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry
- Deep vein thrombosis: risks and diagnosis
- Genetic susceptibility to VTE: a primary care approach
- Update on the diagnosis, treatment, and prognosis of the catastrophic antiphospholipid syndrome
- Mechanisms of venous thrombosis and resolution
- The clinical application of CRRT—current status: continuous renal replacement therapies in patients with liver disease
- Inherited antithrombin deficiency: a review
- Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done?
- Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis
- Vitamin K‐dependent actions of Gas6
- Hemostatic and thrombotic markers in patients with hemoglobin E/β‐thalassemia disease
- Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial
- Heparin oligosaccharides as potential therapeutic agents in senile dementia
- Inflammation and coagulation in HIV infection contributes significantly to patient mortality
- The nephrotic syndrome: an unusual case of multiple embolic events
- Protein Z, a protein seeking a pathology
- Venous thromboembolism in HIV-positive women during puerperium: a case series
- Sex-related type of venous thromboembolism in patients with and without thrombophilia
- Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences
- The coagulation cascade in sepsis
- Enterocutaneous fistula secondary to purpura fulminans in a preterm infant
- Retinal vascular disease
- Epidemiology of venous thromboembolism
- Polyphosphate and omptins: novel bacterial procoagulant agents
- Role of recombinant human activated protein C (Drotrecogin Alfa, Activated, Xigris®) for severe sepsis
- The role of thrombophilia in splanchnic vein thrombosis
- Early intravenous unfractionated heparin and mortality in septic shock
- Symptomatic venous thromboembolism and thrombophilic status in adult acute leukemia: a single-center experience of 114 patients at diagnosis
- Understanding haemostasis
- Viral cirrhosis: an overview of haemostatic alterations and clinical consequences
- Tourniquet Use Improves Varicose Vein Stripping
- Molecular basis of protein S deficiency
- Valporic acid: is it safe to use in epileptic pediatric patient
- Thrombophilia: common questions on laboratory assessment and management
- Pleural mesothelioma and venous thrombosis: the eosinophilia link.
- Anticoagulation for Continuous Renal Replacement Therapy-Heparin or Citrate?
- Comparative vertebrate fibrinolysis
- Amyloidosis and vascular thrombosis
- Type 2 diabetes mellitus and heart failure
- Update on hemostasis: neurosurgery
- BCR‐ABL1 tyrosine kinase activity at diagnosis, as determined via the pCrkL/CrkL ratio, is predictive of clinical outcome in chronic myeloid leukaemia
- Diagnosis of inherited thrombophilia in pediatrics
- Cross talk between the inflammation and coagulation systems
- Risk factors for thrombosis in cancer patients
- Biological influence of physical exercise on hemostasis
- Disseminated intravascular coagulation
- Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy
- Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India
- the mind-body configuration to disease is being stressed, the
- Novel Approaches to the Treatment of Sepsis Syndrome
- Anticoagulant heparan sulfate: to not clot—or not?
- Death by clot: acute coronary syndromes, ischemic stroke, pulmonary embolism, and disseminated intravascular coagulation
- Laboratory predictors of dengue shock syndrome during the febrile stage
- Causes of venous thrombosis
- Liver disease, coagulation testing, and hemostasis
- Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism
- In vitro anti-bacterial activities of Ankaferd medicinal plant extract
- Skin autoimmunity and blood coagulation
- Durée optimale du traitement anticoagulant au décours d’un premier épisode de maladie veineuse thromboembolique
- Milestones and perspectives in coagulation and hemostasis
- Coagulation, Inflammation, and Tissue Remodeling
- Current knowledge regarding Asherson’s syndrome
- Chasing clot: thrombophilic states and the interventionalist
- Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations
- Hereditary and acquired thrombophilia
- Antiphospholipid syndrome in dermatology: An update
- Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease
- 12 Disseminated intravascular coagulation and other microangiopathies
- The Hypercoagulable States
- Pathogenesis and risk factors in retinal vein occlusions
- Arterial Insufficiency
- Inherited antithrombin deficiency and pregnancy: maternal and fetal outcomes
- Skin necrosis induced by vitamin K antagonists
- Coagulation Disorders in Acute Lung Injury
- Sepsis: from bench to bedside
- The role of protein C in sepsis
- The promise of systems biology in clinical applications
- Hemostatic dysfunction in paraproteinemias and amyloidosis
- Hemodynamically driven stent strut design
- The naturalHistory of Venous Thromboembolism
- Oryginal article Relationship between inflammatory markers and clinical patterns of atrial fibrillation in patients with congestive heart failure
- Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients: an in vitro study
- Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study
- Venous thrombosis in the elderly: incidence, risk factors and risk groups
- Trypsin and Chymotrypsin Inhibitors in Insects and Gut Leeches: an update
- Sexual dimorphism in the mandible of the armadillo Chaetophractus villosus (Desmarest, 1804)(Dasypodidae) from northern Patagonia, Argentina
- Interruption of the blood supply of femoral head: an experimental study on the pathogenesis of Legg-Calve-Perthes Disease
- Gene variants associated with deep vein thrombosis
- Thrombohemostatic Disorder in HIV Infection
- Thrombosis associated with angiogenesis inhibitors
- Blood coagulation and inflammation in acute lung injury
- Effects of pharmacological intervention on coagulopathy and organ function in xenoperfused kidneys
- Purpura Fulminans Due to Staphylococcus Aureus: An Emerging
- Activated protein C for H1N1 influenza? More work to do!
- Uncoupling of protein C and antithrombin III activity in cerebral ischemia patients associated with cutis marmorata
- Heparin-induced thrombocytopenia in surgical patients
- Coagulopathy of Chronic Liver Disease
- Life threatening chylothorax in a patient with congenital thrombophilia: Case report
- The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapy
- Non-enzymatic glycation in diabetic complications
- Venous thrombosis in patients with chronic liver disease
- HYPERCOAGULATION TESTING
- Cardiovascular events in patients with antiphospholipid antibodies: strategies of prevention
- Thrombin-antithrombin III complex, proinflammatory cytokines, and fibrinolytic indices for assessing the severity of inflammation in pleural effusions
- Modulation of sepsis outcome with variants of activated protein C
- Venous thromboembolism in the neonatal period
- Theories of blood coagulation
- The host response to sepsis and developmental impact
- Factor V Leiden homozygous genotype and pregnancy outcomes
- Ocular vascular thrombotic events: a diagnostic window to familial thrombophilia (compound factor V Leiden and prothrombin gene heterozygosity) and thrombosis
- Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera
- Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma
- The correspondence department ofthe Archives is meant to provide forumfor exchange
- Aneurysmal frontal bone cyst in a child with history of acute lymphoblastic leukemia: a case of rare location and history
- New Aspects of Antiinflammatory Activity of Antithrombin: Molecular Mechanism (s) and Therapeutic Implications
- Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation
- Haematology and neurology
- Deep venous thrombosis in a young woman
- Thrombophilia: 2009 update
- Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism
- How to tackle bleeding and thrombosis in the newborn
- Vascular complications after splenectomy for hematologic disorders
- Management of thromboembolism in hematologic malignancies
- Ischaemic stroke patients with heterozygous factor V Leiden present with multiple brain infarctions and widespread atherothrombotic disease
- Deep vein thrombosis and pulmonary embolism in cirrhosis patients
- Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations
- Identifying women at high risk of venous thrombosis before administration of hormone therapy
- An overview of heparin-induced thrombocytopenia
- Haemostatic Issues in Cancer Development and Progression:” The Role of Coagulation and Haemostatic Factors in cancer Development and Metastasis”
- Host-cell interactions with pathogenic Rickettsia species
- Thrombophilia/prothrombotic disorders
- Thrombophilia states and markers of coagulation activation in the prediction of pediatric venous thromboembolic outcomes: a comparative analysis with respect to …
- Soluble endothelial protein C receptor level in obesity
- von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report …
- Postoperative care
- Portal Vein and Superior Mesenteric Vein Thrombosis in Nephrotic Syndrome: A Case Report and Review of Literature
- Purpura fulminans: a rare presentation of a common disease
- Principles of perioperative coagulopathy
- Preventing thrombophilia-related complications of pregnancy
- Effects of red blood cells on hemostasis
- La Hipertrofia de la Bula Timpánica en Tres Especies de Dasipódidos (Mammalia, Xenarthra) de Argentina
- A model for the formation, growth, and lysis of clots in quiescent plasma. A comparison between the effects of antithrombin III deficiency and protein C deficiency
- 03 Postoperative care
- Sublingual administration of warfarin: a novel form of delivery
- How should we determine length of anticoagulation after proximal deep vein thrombosis of the lower limbs?
- The pulmonary protein C system: preventive or therapeutic target in acute lung injury?
- 298: Higher CD 34 Cell Doses Reduce Non Relapse Mortality (NRM) and do not Increase the Incidence of Graft Versus Host Disease (GVHD) following Unrelated …
- Recanalization and its correlation to outcome after cerebral venous thrombosis
- Randomized Controlled Trials in Sepsis
- Age-related changes in fibrin networks and platelets of individuals over 75: a scanning electron microscopy study showing “thrombotic preparedness”
- Venous Thromboembolism: Mechanisms, Treatment, and Public Awareness
- Long-term prospective study of recurrent venous thromboembolism in a Hispanic population
- The use angiogenesis stimulators for the treatment of chronic ischemia of lower extremities
- Coagulation activity in liver disease
- Combination of a SAW-biosensor with MALDI mass spectrometric analysis
- The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT
- Pharmacogenetics of warfarin: current status and future challenges
- TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus
- In vivo effect of adhesion inhibitor heparin on Legionella pneumophila pathogenesis in a murine pneumonia model
- Thrombophilias: when should we test and how does it help?
- Protective effects of activated protein C in sepsis
- Severe congenital protein C deficiency: the use of protein C concentrates (human) as replacement therapy for life-threatening blood-clotting complications
- An Update on Pathogenic Mechanisms Mediated by Antiphospholipid Antibodies.
- Pathogenesis, immunity, pathology, and pathophysiology in rickettsial diseases
- Pregnancy and thrombophilia
- Laboratory diagnostics in septic disseminated intravascular coagulation
- The effects of tamoxifen on homocysteine levels in breast cancer patients
- Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial
- Does hemodilution by the crystalloid priming solution derange the efficacy of anticoagulation during cardiopulmonary bypass?
- Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?
- Management of Pulmonary Embolism: 2010 State-of-the-Art Update
- Once and only once
- Inherited thrombophilia and the eye
- Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays
- Design implications for endovascular stents and the endothelium
- Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia
- Fondaparinux for the treatment of patients with acute heparininduced thrombocytopenia
- Skin biopsies demonstrate site-specific endothelial activation in mouse models of sepsis
- Oral anticoagulants: Pharmacogenetics: Relationship between genetic and non-genetic factors
- Drugs affecting coagulation
- The use of recombinant tissue plasminogen activator in the management of infective intracardiac thrombi in pre‐term infants with thrombocytopaenia
- CLINICAL CASE
- Atherosclerosis and vascular aging as modifiers of tumor progression, angiogenesis, and responsiveness to therapy
- Old versus new anticoagulants: focus on pharmacology
- Plasma protein C is a useful clinical marker for hepatic veno‐occlusive disease (VOD) in stem cell transplantation
- Kaikov Y, Wadsworth LD, Hall CA et al.(1991) Transcobalamin II deficiency: case report and review of the literature. Eur J Pediatr 150, 841–843. Seeliger MW …
- The sepsis text
- Complement and coagulation: strangers or partners in crime?
- Beyond unfractionated heparin and warfarin: current and future advances
- Darwin, earthworms & circadian rhythms: A fertile field for science fair experiments
- Influence of the factor II G20210A variant or the factor V G1691A mutation on symptomatic recurrent venous thromboembolism in children: an international multicenter …
- Epidemic meningitis, meningococcaemia, and Neisseria meningitidis
- Fatal pulmonary embolism in a premature neonate after twin-to-twin transfusion syndrome
- Thrombohemorrhagic complications of myeloproliferative disorders
- Drotrecogin alfa (activated): the treatment for severe sepsis?
- Accuracy of D-dimers to rule out venous thromboembolism events across age categories
- Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery
- Assessment of thrombotic risk factors predisposing to thromboembolic complications in prosthetic orthopedic surgery
- Heparin-like effect in liver disease and liver transplantation
- Impact of neutrophil apoptosis on haemostatic activation in chronic liver disease patients
- Pulmonary embolism and fever: when should right-sided infective endocarditis be considered?
- Effects of β2-glycoprotein-I on platelet aggregation in cord versus adult whole blood
- FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragm in® a dded to standard t herapy in patients with lung c ancer
- biology: its relevance to medicine
- Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies
- Endothelial cell infection and hemostasis
- Genetics of ischemic stroke
- Quantitative changes in serum IL-8, TNF-α and TGF-β1 levels depending on compensation stage in type 2 diabetic patients
- Evaluation of hypercoagulable states and molecular markers of acute venous thrombosis
- Relation between coagulation/fibrinolysis and lactate in the course of human septic shock
- Prothrombotic status in Myeloproliferative neoplasms: the role of JAK2V617F allele burden and platelets/leukocytes activation
- THE FOLLOWING GUIDELINES ARE NOT MEANT TO REPLACE GOOD SOUND CLINICAL JUDGMENT
- Perioperative coagulation profile in living liver donors as assessed by rotational thromboelastometry
- CHAPTER MYOCARDIAL ISCHEMIA AND INFARCTION
- Heparin-Induced thrombocytopenia (HIT): a case study
- Elevated homocysteine, glutathione and cysteinylglycine concentrations in patients homozygous for the Chuvash polycythemia VHL mutation
- Predictive value of thrombopath determination in women with infertility and pregnancy complications
- Cocaine cardiotoxicity
- 13 The Therapeutic Use and Safety of Common Herbal Beverages
- Study of proinflammatory responses induced by Yersinia pestis in human monocytes using cDNA arrays
- A Simple Tool to Educate Laboratory Staff About Anticoagulation
- Biophysical characterization of anticoagulant hemextin AB complex from the venom of snake Hemachatus haemachatus
- Hypercoagulable states
- Recombinant fibrinogenase from Agkistrodon acutus venom protects against sepsis via direct degradation of fibrin and TNF-α
- Evaluation of protein C in Nigerian patients with sickle cell anaemia in steady state
- Antithrombin prevents reperfusion-induced hepatic apoptosis by enhancing insulin-like growth factor-I production in mice
- Plasma Products and Indications for Their Use
- Thromboelastographic evaluation of coagulation in patients with extrahepatic portal vein thrombosis and non‐cirrhotic portal fibrosis: a pilot study
- Hepatic function after genetically-engineered pig liver transplantation in baboons
- Thrombosis and acute lymphoblastic leukaemia
- Management of venous thromboembolism.
- Glycocalyx protection reduces leukocyte adhesion after ischemia/reperfusion
- Acute venous thrombosis: pathogenesis and evolution
- Physiological changes of pregnancy and monitoring
- I. Palomo1, F. Segovia1, C. Ortega1, S. Pierangeli2
- The role of coagulation in ventilator-associated pneumonia
- TRANSFUSION PRACTICE: Liver donor’s age and recipient’s serum creatinine predict blood component use during liver transplantation
- Shock, blood transfusion and coagulation
- Thalidomide–dexamethasone as up‐front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and …
- A comprehensive review of thrombogenic mechanisms in APS
- Cerebral Venous Thrombosis
- Current role of activated protein C therapy for severe sepsis and septic shock
- Renal and cardiac endothelial heterogeneity impact acute vascular rejection in pig‐to‐baboon xenotransplantation
- The safety profile of drotrecogin alfa (activated)
- Use of defibrotide in the treatment and prevention of veno-occlusive disease
- Portal vein thrombosis in Egyptian patients with liver cirrhosis: Role of methylenetetrahydrofolate reductase C677T gene mutation
- Perioperative haemostasis and coagulation management in cardiac surgery: a European survey
- Beneficial effects of recombinant human activated protein C in a ewe model of septic shock
- Nephrotic syndrome complicated by life-threatening pulmonary embolism in an adult patient
- The phenotypic heterogeneity of severe hemophilia
- Portal vein thrombosis and haematemesis in chronic liver disease. Are P-selectin and PSGL-1 clues?
- Acute venous thrombosis: pathogenesis and
- Thrombophilias and pre-eclampsia
- Stress Hyperglycemia-An independent risk factor for multivessel coronary artery disease in Post Myocardial Infarction Patients.
- Rocky Mountain Fever: A Review
- Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: a meta-analysis
- Role of thrombin in coronary artery bypass grafting
- Combining early coagulation and inflammatory status improves prediction of mortality in burned and nonburned trauma patients
- High availability of intravascular tissue factor in neonates
- What have we Learned Regarding Pregnancy Morbidity and Antiphospholipid Syndrome?
- Thromboembolism in pregnancy: recurrence and its prevention
- Drugs affecting coagulation
- Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with esse…
- Thrombin generation and coagulation factor activities: evaluation and comparison with the international normalized ratio
- Venous thromboembolism
- The coagulant response in sepsis
- Haemostasis in Neurosurgery
- Drug-induced thromboembolic events in patients with malignancy
- Clinical guidelines for testing for heritable thrombophilia
- Lower incidence of procoagulant abnormalities during follow-up after creation of the Fontan circulation in children
- Hematological and coagulation changes in sepsis
- Evaluating the efficacy and safety of unfractionated heparin in patients diagnosed with sepsis
- Antiphospholipid syndrome: a challenging hypercoagulable state with systemic manifestations
- Raised LIGHT levels in pulmonary arterial hypertension: potential role in thrombus formation
- Plasma factor and inhibitor composition contributes to thrombin generation dynamics in patients with acute or previous cerebrovascular events
- A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation
- Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis
- Nadroparine activated fibrinolysis and improvement of glomerular filtration rate in patients with FIGO IIB–IIIB cervical cancer treated with radiochemotherapy
- Computational modeling and simulation of thrombus formation
- A practical approach to diagnosis and treatment of symptomatic thromboembolic events in children with acute lymphoblastic leukemia: recommendations of the “ …
- Urgent warfarin reversal: know your options
- The cost-benefit ratio of screening pregnant women for thrombophilia
- Laboratory evaluation of the antiphospholipid syndrome
- Prevalence, management, and outcomes of critically ill patients with prothrombin time prolongation in United Kingdom intensive care units
- Monitoring high-dose heparinization during cardiopulmonary bypass–A comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti …
- Effect of pregnancy on the hemostatic and metabolic systems
- High factor XI, recurrent pregnancy loss, enoxaparin
- Gene expression profiling in rat liver treated with various hepatotoxic-compounds inducing coagulopathy
- Human protein C concentrates for replacement therapy in congenital and acquired protein C deficiency
- Emerging technologies and quality assurance in hemostasis: a review of findings from the Royal College of Pathologists of Australasia Quality Assurance Program
- Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion
- Tuscan study on the appropriateness of fresh-frozen plasma transfusion (TuSAPlaT)
- Coagulation disorders: Quality in laboratory diagnosis
- Chemotherapy-associated thrombosis
- Activated protein C in sepsis and beyond: update 2006
- Antiphospholipid syndrome: Current diagnostic and therapeutic issues–Answers to 6 clinical questions about a complex disorder
- Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?
- Disseminated intravascular coagulation in obstetric and gynecologic disorders
- Septik şok tedavisinde kullanılan ilaçların şokun patofizyolojisine etkileri
- Tanck MW, Haagsma EB, van Hoek B, Rosendaal FR, Janssen HL, Leebeek FW; Liver and Thrombosis Study Group
- Drug therapy of cardiac diseases in children.
- Venous thromboembolism during pregnancy and the impact of thrombophilia in pregnancy complications
- Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for …
- Thrombophilia and direct thrombin inhibitor lepirudin: clinical and monitoring aspects
- Pulmonary Embolism and vascular injury: What is the role of thrombin?
- Evaluation of Protein-Z and Antithrombin III Plasma Levels in Children with Minimal Change Nephrotic Syndrome
- Coagulation Disorders: Diagnostic Standards of Care
- Renuka Gera, Anjali Pawar, Elna N. Saah
- 25 Noncirrhotic Portal Hypertension and Portal Vein Thrombosis
- Noncirrhotic Portal Hypertension
- Overview of hemostasis and platelet physiology
- Antithrombin deficiency and its laboratory diagnosis
- Endothelial activation and dysfunction in sepsis
- Posttraumatic massive bleeding: a challenging multidisciplinary task
- Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis
- Protein Engineering with Noncoded Amino Acids: Applications to Hirudin
- Prevention of murine antiphospholipid syndrome by BAFF blockade
- Review of the relationship between venous thromboembolism, malignancy and its treatment
- 100 Questions & Answers About Deep Vein Thrombosis and Pulmonary Embolism
- Promising therapeutic agents for sepsis
- Thromboembolic complications in pediatric hematologic malignancies
- A review of the prevention and treatment of venous thromboembolism
- Controversies of surviving sepsis campaign bundles: should we use them?
- Profile of Venous Thromboembolism in India.
- Danaparoid sodium reduces ischemia/reperfusion-induced liver injury in rats by attenuating inflammatory responses
- RNA-binding Protein HuR Interacts with Thrombomodulin 5′ Untranslated Region and Represses Internal Ribosome Entry Site–mediated Translation under IL-1β …
- Blood Diseases and Their Diagnosis (1)
- Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment
- Sauchinone, a lignan from Saururus chinensis, reduces tumor necrosis factor-α production through the inhibition of c-raf/MEK1/2/ERK 1/2 pathway activation
- Overfatness, stunting and physical inactivity are determinants of plasminogen activator inhibitor-1activity, fibrinogen and thrombin–antithrombin complex in African …
- Inhibition of thrombin during reperfusion improves immediate postischemic myocardial function and modulates apoptosis in a porcine model of cardiopulmonary …
- Blue (or purple) toe syndrome
- Venous thromboembolism in cervical cancer
- Drug-induced thrombosis—experimental, clinical, and mechanistic considerations
- Low plasma levels of tissue factor pathway inhibitor in patients with congenital factor V deficiency
- Thromboembolism in hematologic malignancies
- Crosstalk between inflammation and coagulation in acute pancreatitis
- Hepatic Veno-Occlusive Disease
- RNA-binding Protein HuR Interacts with Thrombomodulin 5’UTR and Represses IRES-mediated Translation under IL-1 {beta} treatment
- HIV-associated vascular diseases: structural and functional changes, clinical implications
- Bleeding risks in interventional radiology
- ExoU-induced procoagulant activity in Pseudomonas aeruginosa-infected airway cells
- Surgeon General’s call to action to prevent deep vein thrombosis and pulmonary embolism
- Liposomal formulations of thrombomodulin increase engraftment after intraportal islet transplantation
- Fundamental Mechanisms in Venous Thrombosis
- Antithrombin reduces ischemic volume, ameliorates neurologic deficits, and prolongs animal survival in both transient and permanent focal ischemia
- An investigation into the biochemistry of glycoprotein I and the interaction of the fibrinolytic system with antiphospholipid antibodies
- Genetics of pre-eclampsia and counseling the
- Salutary roles of CD39 in transplantation
- Supernatant of Aged Erythrocytes Causes Lung Inflammation and Coagulopathy in a “Two-Hit”In Vivo Syngeneic Transfusion Model
- Recurrence of venous thromboembolism….. PAGE 3 and its prevention
- Toxicity as a result of immunostimulation by biologics
- Production of bacterial and fungal polysaccharides
- Update on the use of aromatase inhibitors in early-stage breast cancer
- Low-molecular-weight heparin for thromboprophylaxis
- Alveolar but not intravenous S-ketamine inhibits alveolar sodium transport and lung fluid clearance in rats
- Parametri hemostaze u holecistektomiji
- Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model
- Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study
- Essential Thrombocythemia
- Venous thromboembolism
- Rhythm and Conduction Disorders
- Management of acquired bleeding problems in cancer patients
- Evaluation of Novel Laboratory Methods Using Whole Blood Testing in Different Disturbances of Haemostasis
- EVALUATION OF NOVEL LABORATORY METHODS USING WHOLE BLOOD TESTING IN DIFFERENT DISTURBANCES OF HAEMOSTASIS
- Profile of patients with Thrombosis evaluated in a Tertiary Care Center.
- Thromboelastography in the assessment of coagulation changes in peripheral vascular disease
- A Cell Culture Model of Lipopolysaccharide-induced Endothelial Activation
- Molecularly engineered materials for selective albumin binding to reduce the risk of thrombus formation
- A functional polymorphism (− 603A→ G) in the tissue factor gene promoter is associated with adult-onset asthma
- Novel therapies for the antiphospholipid syndrome
- RB119. P375 2009 616.07076–dc22 2008034795 Acquisitions Editor: Jim Merritt Developmental Editor: Barbara Cicalese
- Antithrombotic therapy
- Hemostatic Studies Sudanese Patients with Sickle ceel anemia
- MEDICAL DISORDERS IN PREGNANCY
- 26 Disordered and Renal Disorders Hemostasis
- Thromboembolic disease
- Inflammatory and coagulation disturbances in acute pancreatitis
- Molecular biology of inflammation and sepsis: a primer
- Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss
- Antithrombin reduces ischemic volume, ameliorates neurologic deficits, and prolongs animal survival in both…
- The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair
- Best Practice & Research Clinical Anaesthesiology
- Candidate gene studies on cardiovascular traits
- Pre-operative homocysteine levels and morbidity and mortality following cardiac surgery
- Thrombosis in Children
- Effects of Resistance Training and Ambulation on Cardiovascular Risk Factors in African-American Women
- Leonotis leonurus: The anticoagulant and antidiabetic activity of Leonotis leonurus
- 2008 ASPHO Abstracts
- Atherosclerosis: in vivo characterization
- OS-1-1 Evi1 expression marks long-term repopulating hematopoietic stem cells○ Keisuke Kataoka1, Tomohiko Sato1, Akihide Yoshimi1, Susumu Goyama1, Shunya …
- Factor V Leiden and activated protein C resistance
- Research Activated protein C ameliorates coagulopathy but does not influence outcome in lethal H1N1 influenza: a controlled laboratory study
- Coagulation State In Diabetic Retinopathy In Type 2 Diabetic Sudanese Patients
- Release of Cardiac Biomarkers and Inflammatory Response during Cardiopulmonary Bypass: Comparison of Different Biocompatible Materials Used in …
- Hematological diseases and stroke
- A Practical Approach to the FBC and Hemostatic Screen
- Management of venous thrombo-embolic disease in childhood
- Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy
- THE IMPACT OF THE G58A POLYMORPHISM ON FIBRINOGEN A-CHAIN GENE ON FACTORS V, X AND THROMBIN IN PATIENTS WITH ADVANCED …
- Hemostasis and thrombosis
- Applications in critical care medicine
- Severe sepsis in neutropenic haematological patients
- Molecularly engineered materials for selective albumin binding to reduce the risk of thrombus formation
- Placental Angiogenesis and Angiogenesis Related Risk Factors in Severe Pre-eclampsia
- An introduction to wounds
- Intraoperative cerebral microembolisation and neuropsychological outcome following total hip and knee arthroplasty
- Components of Metabolic Syndrome
- Antiphospholipid antibodies and the protein C pathway
- Hematologic disorders 6
- Pro-thrombotic effects during anthrax pathogenesis
- Genetic Variation and Susceptibility to Venous Trombosis
- Inflammatory signaling in macrophages: Regulation by G-protein coupled receptor kinase-2 and 5
- Darier Disease
- Adjunctive Therapies in a Clinical Relevant Ovine Model of Septic Shock
- The metabolic syndrome in clinical practice
- Mathematics and transfusion medicine
- Design and synthesis of peptides that neutralize bacterial endotoxins as therapeutic agents for the treatment of sepsis
- Extracorporeal membrane oxygenation for severe systemic inflammatory response: development of a rabbit model
- Severe sepsis, coagulation, and fibrinolysis: dead end or one way?
- Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region
- General mechanisms of coagulation and targets of anticoagulants (Section I)
- ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia
- Hemostasis in patients with acute kidney injury secondary to acute liver failure
- Venous thromboembolism in Asia–an unrecognised and under-treated problem?
- Hereditary Thrombophilia and thrombotic events in pregnancy: single-center experience
- Reference values for thrombotic markers in children
- Naturally Occurring anticoagulants and Their Association With Thromboembolism In Patients With β-Thalassemia Major
- Plasma pentraxin-3 and coagulation and fibrinolysis variables during acute Puumala hantavirus infection and associated thrombocytopenia
- Purpura fulminans: recognition, diagnosis and management
- Targeting factor Xa and thrombin: impact on coagulation and beyond
- Thrombophilia testing for prevention of recurrent venous thromboembolism
- Enhanced thrombin generation and depressed anticoagulant function in children with pneumonia
- The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis
- Anticoagulant therapy for sepsis‐associated disseminated intravascular coagulation: the view from Japan
- Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relatives
- Thrombophilia in childhood: to test or not to test
- Should adult patients be routinely tested for heritable thrombophilia after an episode of venous thromboembolism?
- Successful treatment of arterial thrombus in an extremely low-birth-weight preterm neonate
- Protein C and protein S deficiency: practical diagnostic issues
- The optimal duration of anticoagulation in patients with venous thromboembolism: how long is long enough?
- Testing for inherited thrombophilia in recurrent miscarriage
- Protein C, protein S and von Willebrand factor levels correlate with bleeding symptoms: a population‐based study
- Thrombophilia testing and diagnostic dilemma–a tertiary centre experience
- Replacement of specific coagulation factors in patients with burn: a review
- The thromboelastometric criteria of hemostasis disorders correction during liver transplantation
- Heerlen polymorphism associated with type III protein S deficiency and factor V Leiden mutation in a Polish patient with deep vein thrombosis
- CARDIOlOGy PATIENT PAGE
- Protein C and protein S deficiency presenting as Budd-Chiari syndrome
- New therapeutic options for patients with sepsis and disseminated intravascular coagulation
- Familial Mediterranean fever and hypercoagulability
- Evaluation of coagulation and fibrinolytic parameters in adult onset GH deficiency and the effects of GH replacement therapy: a placebo controlled study
- Prophylaxis of thrombotic complications in patients after reconstructive operations on the main arteries of the lower extremities, made for arteriosclerosis obliterans in a …
- Does anticoagulant therapy improve pregnancy outcome equally, regardless of specific thrombophilia type?
- Innate immunity and coagulation
- Non-severe allergic asthma is associated with elevated plasma protein C and protein S
- Procoagulant abnormalities in cirrhosis with portal vein thrombosis
- Hereditary thrombophilia in an unselected cohort of venous thrombosis patients in Singapore
- Microparticles and pregnancy complications
- Perioperative disorders of coagulation and fibrinolysis in patients subjected to colorectal cancer resection
- Study of associated genetic variants in Indian subjects reveals the basis of ethnicity related differences in susceptibility to venous thromboembolism
- Sepsis-Associated Coagulopathy: Diagnosis With Hematologic Biomarkers and Role in the Development of Multiple Organ Dysfunction Syndrome and Mortality
- Platelet function in pre-eclampsia
- The Severity of Sepsis-Associated Coagulopathy Is Linked With the Amount of Dysfunctional Organs and the Overall Outcome of the Patient
- Elderly trauma patients have high circulating noradrenaline levels but attenuated release of adrenaline, platelets, and leukocytes in response to increasing injury …
- A CROSS SECTIONAL STUDY TO ASSESS THE SPECTRUM OF INHERITED THROMBOPHILIA IN ADULT (20 TO 50 YEARS OF AGE)
- The system of hemostasis in patients with diabetic foot syndrome undergoing surgical treatment
- Fresh frozen plasma transfusion fails to alter the hemostatic balance in critically ill patients with a coagulopathy
- Tissue Factor Pathway Inhibitor Modulates Fibrin Deposition In The Brain In a Manner That Is Independent Of Thrombomodulin and Activated Protein C
- The Efficacy and Safety Of Therapeutic Aheresis In Sepsis and Septic Shock: A Systematic Review and Meta-Analysis
- HEMORHEOLOGIC DISTURBANCES IS VTE RISK FACTOR IN CHILDREN WITH ALL
- PS 0078; Cardiology: Changes of Parameters of the Blood Coagulation System in Patients with Essential Arterial Hypertension with Concomitant Microalbuminuria
- 818: THE ADDITION OF PROTEIN-C AND ANTITHROMBIN-III TO THE DIC SCORING SYSTEM MAY BE HELPFUL TO IDENTIFY PATIENTS WITH SEVERE SEPSIS …
- Optimal duration of anticoagulation in patients with venous thromboembolism
- Thrombophilia screening
- Mechanistic view of risk factors for venous thromboembolism
- Haemostatic and fibrinolytic changes in obese subjects undergoing bariatric surgery: The effect of different surgical…
- Inflammatory bowel disease and thrombosis
- Pathology consultation on the laboratory evaluation of thrombophilia: when, how, and why
- The tick-derived anticoagulant madanin is processed by thrombin and factor Xa
- The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options
- In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband
- Distinct frequencies and mutation spectrums of genetic thrombophilia in Korea in comparison with other Asian countries both in patients with …
- Evaluation of coagulation parameters in patients with chronic liver diseases
- A practical approach to thrombophilia testing
- Thrombophilia: From Benchside To Bedside
- Inherited thrombophilic disorders
- Hereditary thrombophilia in Korean patients with idiopathic pulmonary embolism
- Evaluation of the host response to endotoxemia of FVIII and FIX deficient mice
- Frequency of hereditary thrombophilia in women with recurrent pregnancy loss in N orthern P akistan
- Clinical significance of haemostatic tests in chronic liver disease
- Coagulation and sepsis: a winding road ahead
- Venous thromboembolism and thrombophilia testing
- The incidence and magnitude of fibrinolytic activation in trauma patients: a rebuttal
- Aging hemostasis: changes to laboratory markers of hemostasis as we age—a narrative review
- Low Antithrombin Level Correlates With Failing Fontan Circulation and Predicts the Mortality
- DYNAMICS OF PLASMA HEMOSTASIS IN WOMEN WITH THROMBOGENIC PREGNANCY AND DELIVERY COMPLICATIONS.
- Haemostatic Changes Associated with Thrombosis in Long Term Hemodialysis Treatment
- Upregulation of anticoagulant proteins, protein S and tissue factor pathway inhibitor, in the mouse myocardium with cardio-specific TNF-α overexpression
- Delicate balance of bleeding and thrombosis in end-stage liver disease and liver transplantation
- The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism
- Thrombosis: balancing act
- Journal of Gastrointestinal & Digestive System
- Arterial thromboembolic complications may be more common than expected in inflammatory bowel diseases
- Acute traumatic coagulopathy: from endogenous acute coagulopathy to systemic acquired coagulopathy and back
- Blood Coagulation
- Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization
- The clinical significance of coagulation and the inflammatory response in autoimmunity
- Impaired Thrombin Generation in Patients with Dengue.
- Inherited and acquired thrombophilias
- Reduced thrombin formation and excessive fibrinolysis are associated with bleeding complications in patients with dengue fever: a case–control study …
- Pregnancy loss and thrombophilia: the elusive link
- Deep Vein Thrombosis, Tranexamic Acid, and a Negative d-Dimer
- Retinal vein occlusion: genetic predisposition and systemic risk factors
- The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation
- Hemostatic and fibrinolytic changes are related to inflammatory conditions in patients with psoriatic arthritis—effect of different treatments
- Crosstalk between the coagulation and complement systems in sepsis
- Exploring the biological basis of haemophilic joint disease: experimental studies
- Hemostatic markers in congestive heart failure dogs with mitral valve disease
- Rare double heterozygous mutations in antithrombin underlie hereditary thrombophilia in a Chinese family
- Treatment responses for disseminated intravascular coagulation in 25 children treated with recombinant thrombomodulin: a single institution experience
- Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience
- Polymorphonuclear neutrophils from JAK2V617F positive MPD patients do not support hypercoagulability: A study with calibrated automated thrombography (CAT)
- Debate: Should Thromboprophylaxis Be Used in Hereditary Thrombophilias with Recurrent Pregnancy Loss? Yes
- sEPCR Levels in Chronic Myeloproliferative Diseases and Their Association with Thromboembolic Events: A Case-Control Study
- Venous thromboembolism in multiple myeloma
- Chronic hepatopathy: bleeding vs. thrombosis
- The coagulopathy of liver disease: does vitamin K help?
- Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians
- Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation
- Chronic hepatopathy: bleeding vs. thrombosis
- Studies on coagulation incompatibilities for xenotransplantation
- Hereditary thrombophilic risk factors for recurrent pregnancy loss
- Snake Venom and Hemostasis
- Nebulized anticoagulants limit coagulopathy but not inflammation in pseudomonas aeruginosa-induced pneumonia in rats
- Risk of venous thromboembolism during the postpartum period: a systematic review
- Trauma-induced coagulopathy: standard coagulation tests, biomarkers of coagulopathy, and endothelial damage in patients with traumatic brain injury
- Thromboembolism in pregnancy: challenges and controversies in the prevention of pregnancy-associated venous thromboembolism and management of …
- Thrombosis From a Prothrombin Mutation Conveying Antithrombin-Resistance
- Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab
- PROTEIN C IN CHRONIC LIVER DISEASE
- 72.1 INHERITED DISORDERS OF THE COAGULATION CASCADE
- Is there a period of liability with initiation of warfarin in patients with atrial fibrillation?
- Historical perspective and future direction of coagulation research
- The impact of coagulation parameters on the outcomes of patients with severe community-acquired pneumonia requiring intensive care unit admission
- Pregnancy-related venous thromboembolism: risk and the effect of thromboprophylaxis
- Global laboratory assays in hemophilia
- Increased ADAMTS13 activity in patients with venous thromboembolism
- Crystallization and preliminary crystallographic characterization of three peptidic inhibitors in complex with α-thrombin
- Idiopathic venous thromboembolism and thrombophilia
- In vitro anticoagulant activities of Melastoma malabathricum Linn. aqueous leaf extract: A preliminary novel finding
- Pharmacogenetics and the Treatment of Thrombophilia
- Bronchoalveolar hemostasis in lung injury and acute respiratory distress syndrome
- Hypercoagulability in dogs: pathophysiology
- Diagnosis and management of heritable thrombophilias
- Monitoring of dabigatran anticoagulation and its reversal in vitro by thrombelastography
- Live liver donors: Are they at a higher risk for post-operative thrombotic complications?
- Blood transfusion practices in obstetric anaesthesia
- Hemostatic abnormalities in sickle cell disease
- Physiological changes in hematological parameters during pregnancy
- Effect on thrombin generation of the “in vitro” addition of low-dose LMWH to plasma of healthy pregnant and nonpregnant women
- The utility of thrombophilia testing
- Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation
- Oral contraception in women with mild thrombophilia: What have we learned recently?
- Venous thromboembolism and prothrombotic parameters in Klippel-Trenaunay syndrome
- Acute pulmonary embolus in the course of cancer
- Thrombosis from a prothrombin mutation conveying antithrombin resistance
- Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation
- Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery
- Hemostasis in Pregnancy and Obstetric Surgery
- Evaluation of coagulation abnormalities in acute liver failure
- Prothrombotic disorders in abdominal vein thrombosis
- activation [version 1; peer review: 3 approved]
- Citrate anticoagulation for continuous renal replacement therapy in small children
- Evaluation for hypercoagulable states
- Therapeutic plasma exchange in the management of sepsis and multiple organ dysfunction syndrome: a report of three cases
- The emerging role of neutrophils in thrombosis—the journey of TF through NETs
- Pre-eclampsia: relationship between coagulation, fibrinolysis and inflammation
- Inherited and Acquired Thrombophilias
- Inherited thrombophilia in children
- GENETIC AND BIOCHEMICAL THROMBOSIS RISK MARKERS IN PREGNANCY. I. COAGULATION PATHWAYS
- Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor …
- A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome
- Characterisation of changes in the haemostasis system in dogs with thrombosis
- The new direct oral anticoagulants in special indications: rationale and preliminary data in cancer, mechanical heart valves, anti-phospholipid syndrome, and heparin …
- Activated protein C resistance, endogenous anticoagulants and coagulation parameters in recurrent pregnancy loss
- Thromboelastography: New concepts in haemostasis physiology and correlation with trauma associated coagulopathy
- Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency
- Biological activities of carrageenan
- Polymorphisms of plasminogen activator inhibitor-1, angiotensin converting enzyme and coagulation factor XIII genes in patients with recurrent spontaneous abortion
- Plasma haemostatic potential of haemodialysis patients assessed by thrombin generation assay: hypercoagulability in patients with vascular access thrombosis
- Cerebral thrombosis complicating Crohn’s disease: Two cases
- Heparin infusion to prevent umbilical venous catheter related thrombosis in neonates
- Tecarfarin, a novel vitamin K reductase antagonist, is not affected by CYP2C9 and CYP3A4 inhibition following concomitant administration of fluconazole in healthy …
- Venous thrombosis during assisted reproduction: novel risk reduction strategies
- Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state
- Association between early glycemic control and improvements in markers of coagulation and fibrinolysis in patients with septic shock–induced stress hyperglycemia
- A short contemporary history of disseminated intravascular coagulation
- Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis
- Blood component support in acquired coagulopathic conditions: is there a method to the madness?
- Normal reference ranges of antithrombin, protein C and protein S: effect of sex, age and hormonal status
- Exercise perspective on common cardiac medications
- Venous thromboembolism caused by testosterone abuse in a young man with previously undiagnosed genetic thrombophilia
- Bleeding and management of coagulopathy
- Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form
- The influence of thrombophilia on the long-term survival of patients with a history of venous thromboembolism
- Clinical use and the Italian demand for antithrombin
- Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infection
- Evidence-based approach to thrombophilia testing
- The multivalent activity of the tissue factor–thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention
- Thrombin generation and atherosclerosis
- Anticoagulant failure in coagulopathic patients: PTT confounding and other pitfalls
- Hormonal contraception and cardiovascular system
- Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis
- Blood clotting enzymology
- Optimal use of fresh frozen plasma
- Tissue factor and thrombin in sickle cell anemia
- anticoagulants in cirrhotic patients: controversies and certainties in PVT management
- Decreased levels of circulating CD4+ CD25+ Foxp3+ regulatory T cells in patients with primary antiphospholipid syndrome
- Viral infections and mechanisms of thrombosis and bleeding
- Coagulopathy as a therapeutic target for TRALI: rationale and possible sites of action
- Prothrombotic profile in children with peripheral gangrene: a single center experience
- Coagulation and fibrinolytic disturbances are related to carotid intima thickness and arterial blood pressure in Turner syndrome
- Blood and bone marrow pathology e-book
- Coagulation and the vessel wall in thrombosis and atherosclerosis
- Catastrophic antiphospholipid syndrome (CAPS)
- Sex, thrombosis and inherited thrombophilia
- Venous thrombosis: who should be screened for thrombophilia in 2014
- Crystallization and preliminary crystallographic characterization of three peptidic inhibitors in complex with α-thrombin
- Coagulation factor levels in neurosurgical patients with mild prolongation of prothrombin time: effect on plasma transfusion therapy
- Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation
- Thrombotic risk factors in Chinese Budd-Chiari syndrome patients
- Old and new paradigms for cirrhosis associated coagulation abnormalities
- Coagulation and inflammation
- The link between vascular features and thrombosis
- Bullous hemorrhagic dermatosis distant from the site of heparin injection
- Coagulation disorders: risk of thrombosis in the newborn
- Some hemostatic parameters in women with obstetric hemorrhage in Sokoto, Nigeria
- Abnormalities in blood coagulation, fibrinolysis, and platelet activation in adult patients after the Fontan procedure
- Xeno-kidney transplantation: from idea to reality
- Impairment of thrombin generation in the early phases of the host response of sepsis
- Four factor prothrombin complex concentrate (human): review of the pharmacology and clinical application for vitamin K antagonist reversal
- 1 Antithrombin–Heparin
- FIGHTING HEART DISEASE FROM THE KITCHEN—ONE RECIPE AT A TIME
- Endothelial and platelet function alterations in HIV-infected patients
- Seminars in thrombosis & hemostasis 2010: Impact Factor and highest-cited articles from 2008 to 2009
- Coagulation response in dogs with and without systemic inflammatory response syndrome–Preliminary results
- New oral anticoagulants: comparative pharmacology with vitamin K antagonists
- Procoagulant activity in patients with gynaecological malignancies and the effect of neoadjuvant chemotherapy
- Long-term coagulation changes after resection of thoracoabdominal malignancies
- Gender differences in response to chronic treatment with 17β-oestradiol and 17β-aminoestrogen pentolame on hemostasis in rats
- Deficiencies of antithrombin, protein C and protein S–practical experience in genetic analysis of a large patient cohort
- Comparison of the hemostatic effects of a levonorgestrel-releasing intrauterine system and leuprolide acetate in women with endometriosis: A randomized clinical trial
- Expression and shedding of endothelial protein C receptor in prostate cancer cells
- Outcome of modified portal vein anastomosis for recipients with portal vein thrombosis or stenosis before living donor liver transplantation
- Nebulized anticoagulants for acute lung injury-a systematic review of preclinical and clinical investigations
- Clinical characteristics of first venous thrombosis among women under and over 45 years of age
- Reducing inpatient heritable thrombophilia testing using a clinical decision-making tool
- Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma
- Coagulopathy in the intensive care unit
- High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T
- Myocardial infarction and pregnancy
- Factors that influence the bleeding phenotype in severe hemophilic patients
- The new oral anticoagulants and the future of haemostasis laboratory testing
- Mechanisms of hormonal therapy related thrombosis
- Increased prevalence of activated protein C resistance during pregnancy may implicate venous thrombo embolic disorders as a common cause of maternal mortality …
- Contribution of protein Z and protein Z-dependent protease inhibitor in generalized Shwartzman reaction
- Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines
- Role of microparticles in recurrent miscarriages and other adverse pregnancies: a review
- Unique thrombin inhibition mechanism by anophelin, an anticoagulant from the malaria vector
- Ph-Negative Chronic Myeloproliferative Neoplasm (Primary Myelofibrosis)–as One of the Reasons of the Budd-Chiari Syndrome
- Factor V Leiden and inflammation
- Potential usefulness of thrombopoietin receptor agonists in haemophiliacs with thrombocytopaenia due to chronic liver disease
- How does number of risk factors affect prognosis in young patients with ischemic stroke?
- High mobility group B1 levels in sepsis and Disseminated Intravascular Coagulation.
- Current consideration and management of disseminated intravascular coagulation
- Diagnostic and prognostic significance of neutrophil gelatinase-associated lipocalin in disseminated intravascular coagulation
- Global fibrinolytic activity, PAI-1 level, and 4G/5G polymorphism in Thai children with arterial ischemic stroke
- Late onset Warfarin induced skin necrosis in human immunodeficiency virus infected patient with pulmonary tuberculosis
- Genetic Thrombophilias: When to Consider and What to Do
- DIC: which laboratory tests are most useful
- Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias
- Use of tissue plasminogen activator to treat intracardiac thrombosis in extremely low-birth-weight infants
- Pulmonary thromboembolism in a child with sickle cell hemoglobin D disease in the setting of acute chest syndrome
- Heterogeneous lengths of copy number mutations in human coagulopathy revealed by genome-wide high-density SNP array
- Pathogenesis of antiphospholipid syndrome: understanding the antibodies
- Leech Therapy-Why I am doing!
- Hemostasis in acute liver and kidney failure: nothing is as it seems
- Hematologic Changes with Aging
- Haemostatic and cytokine changes in gestational diabetes mellitus
- Engineering novel anticoagulant proteins by motif grafting
- Anti-annexin V IgG and IgM antibodies in sickle cell disease patients with vaso-occlusive crisis
- Antithrombin levels and the risk of a first episode of venous thromboembolism. A case-control study
- Recurrent thrombosis in an HIV-1 infected child
- Physiology of pregnancy: clinical anaesthetic implications
- Anti-phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome
- Recombinant thrombomodulin improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat LPS model
- FUNDAMENTAL MECHANISMS IN VENOUS THROMBOSIS
- Budd-Chiari syndrome in a patient with ulcerative colitis and no inherited coagulopathy
- Laboratory testing of anticoagulants: the present and the future
- Etiology and assessment of hypercoagulability with lessons from heparin-induced thrombocytopenia
- Antithrombin Rybnik: a new point mutation (nt 683 G> T) associated with type I antithrombin deficiency in a patient with venous thromboembolism and recurrent …
- Effect of Factor V Leiden on thrombosis in childhood leukemia
- The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia
- Hypocoagulability, hypercoagulability and the interpretation of ‘normal’kaolin-activated thrombelastographs in the perioperative period
- Preservation of small bowel with the selective use of heparin and second look laparotomy in acute mesenteric ischaemia: A case report
- Update on the catastrophic antiphospholipid syndrome and the “CAPS Registry”
- Functional assay or antigen test for protein C and protein S in ischemic stroke: which shows the greatest change?
- Coagulation factors and antithrombin levels in young and elderly subjects in Pakistani population
- Coagulation abnormalities in diabetes mellitus
- Prohemostatic interventions in obstetric hemorrhage
- Combined deficiency of proteins C and S: ischaemic stroke in young individuals
- Laboratory referral rates of genetic tests for thrombophilia workup in a major referral center
- Family history of VTE: An easy tool to score the individual risk
- Increased transfusion‐free survival following auxiliary pig liver xenotransplantation
- Neonatal renal vein thrombosis
- Evaluation of Protein C and Protein S in Young Patients with Thrombosis
- USE OF ENZYMES IN COMPLEX TREATMENT OF ANTIPHOSPHOLIPID SYNDROME IN WOMEN WITH REPRODUCTIVE LOSSES OF ANDIJAN STATE
- Thrombophilia-related complications in the treatment of a left atrial appendage thrombus: A case report
- AORTIC THROMBOEMBOLISM IN DOGS–SIGNS AND TREATMENT
- Splenic implant assessment in trauma
- A Case of Deep Vein thrombosis due to Protein C, Protein S Deficiency and Hyper-Homocystinaemia, A Rare Genetic Abnormalities
- Thoracentesis and the risks for bleeding: a new era
- Venous thromboembolism and pregnancy
- Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation
- Newer oral anticoagulants: a review of laboratory monitoring options and reversal agents in the hemorrhagic patient
- Inhibition of cellular growth and migration by suppression of endothelial protein C receptor (EPCR) in lung carcinoma cells
- “Why Did My CPAP Beat Me Up?” Bilateral Periorbital Ecchymosis Associated with Continuous Positive Airway Pressure Therapy
- It is time to adopt a strategy of routine some thrombophilias screening in women with a confirmed history of venous thromboembolism or recurrent fetal loss
- Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis
- Low molecular weight heparin in portal vein thrombosis of cirrhotic patients: only therapeutic purposes?
- Pathophysiology of ischemic acute kidney injury
- Inherited and acquired risk factors for venous thromboembolism
- A flare of ulcerative colitis accompanied with cerebral sinus venous thrombosis and bilateral thalamic infarctus: a case report
- Patient safety and quality in laboratory and hemostasis testing: a renewed loop?
- Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity
- Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G> A) mutations in adults with a …
- Factor V Leiden 1691G/A and prothrombin gene 20210G/A polymorphisms as prothrombotic markers in adult Egyptian acute leukemia patients
- Ruolo patogenetico delle alterazioni emocoagulative nell’insorgenza di sindrome poliabortiva e di patologie ostetriche
- Predictive value of anti-annexin V autoantibodies in the follow-up of vaso-occlusive crisis associated with sickle cell disease
- Von Willebrand Factor-Mediated Thrombotic Microangiopathies
- Atypical Clinical Picture Observed in Three Patients with Thrombosis of the Cerebral Sinuses
- John Ross Ainsworth Birmingham Heartlands and Solihull Hospitals U niversity of Birmingham, UK
- Factor V Leiden and prothrombin 20210A mutations among Turkish pediatric leukemia patients
- Hemocoagulative Aspects of Solid Organ Transplantation
- Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism
- Estimation of Fibrinogen level in Pregnant Women at 3rd Trimester in Different Ages in Khartoum State
- Thrombomodulin is silenced in malignant mesothelioma by a poly (ADP-ribose) polymerase-1-mediated epigenetic mechanism
- Coronary artery bypass grafting in a patient with protein S deficiency: perioperative implications
- Silent myocardial ischaemia in diabetic patients after general anaesthesia with 24 h intravenous opioids or with epidural analgesia
- Combination of antithrombin and recombinant thrombomodulin attenuates leukocyte–endothelial interaction and suppresses the increase of intrinsic damage …
- New anticoagulants in the treatment of VTE
- Developmental hemostasis: clinical implications from the fetus to the adolescent
- Factors associated with the development of superficial vein thrombosis in patients with varicose veins
- Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C
- Genome‐wide linkage scan in affected sibling pairs identifies novel susceptibility region for venous thromboembolism: genetics in familial thrombosis study
- From mice to men: Treating sepsis with heparin
- Thrombosis in systemic lupus erythematosus: role of impaired fibrinolysis
- Platelet-rich fibrin (PRF): an autologous packing material for middle ear microsurgery
- Crossroads of coagulation and innate immunity: the case of deep vein thrombosis
- A case of fulminant varicella infection with purpura fulminans, hepatitis, and rhabdomyolysis
- Innumerable studies on single nucleotide polymorphisms: What could be its utility?
- Deficiency of antithrombin and protein C gene in 202 C hinese venous thromboembolism patients
- Effect of gamma irradiation with 30 gy on the coagulation system in leukoreduced fresh frozen plasma
- Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications
- New insights into modulation of thrombin formation
- Thromboembolism risk following recurrent miscarriage
- Venous and arterial thrombosis: associations and risk factors
- Venous thromboembolism in neonates and children
- Venous Thromboembolism—-An Overview
- Impact of reduced levels of protein C, free protein S and antithrombin in normal frozen plasma on the interpretation of patients’ results
- Bilateral and simultaneous central retinal vein occlusion in a patient with obstructive sleep apnea syndrome
- A systematic update on the state of novel anticoagulants and a primer on reversal and bridging
- Venous thrombosis in the nephrotic syndrome
- Question From the ClinicianRisk of Thrombophilia
- Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the “CAPS Registry”
- Plasma alternatives in acquired bleeding disorders—factor concentrates
- Midventricular obstructive hypertrophic cardiomyopathy during pregnancy complicated by pulmonary embolism: a case report
- Thrombotic complications–prevention and treatment of venous thromboembolism in cancer patients
- Systemic versus localized coagulation activation contributing to organ failure in critically ill patients
- Catastrophic antiphospholipid syndrome
- Ocular manifestations of the antiphospholipid syndrome
- Recurrent ischemic cerebrovascular events in a patient with type I antithrombin deficiency caused by 9788 G> A splice site mutation: a case report
- Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum
- Identification of a novel frameshift mutation causing a premature stop codon in a young Nigerian man with type I antithrombin deficiency
- Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases
- Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines
- Thrombophilia and arteriovenous fistula survival in ESRD
- Anticoagulant effect of polyphenols-rich extracts from black chokeberry and grape seeds
- Current concepts in the management of disseminated intravascular coagulation
- Antithrombin-resistant prothrombin Yukuhashi mutation also causes thrombomodulin resistance in fibrinogen clotting but not in protein C activation
- Update on Physiological Anticoagulant Factor
- Prevention of high-mobility group box 1-mediated early loss of transplanted mouse islets in the liver by antithrombin III
- Deep Vein Thrombosis Following Non-myeloablative Allogeneic Stem Cell Transplantation: Presentation of Three Cases and Literature Review
- Deep venous thrombosis in patients with liver cirrhosis: Incidence and management
- Endogenous anticoagulants
- Treatment of warfarin-associated coagulopathy with vitamin K
- Heparin-induced thrombocytopenia
- Seasonality of thrombogenic disorders in coronary atherosclerosis recrudescence
- Coagulopathy of chronic liver disease
- Thrombophilia and venous thromboembolism: RIETE experience
- Effect of antithrombin, protein C and protein S on portal vein thrombosis in liver cirrhosis: a meta-analysis
- Progestin-only contraception and venous thromboembolism
- Perioperative strategies and thrombophilia in children with extrahepatic portal vein obstruction undergoing the meso-Rex bypass
- Unilateral Renal Vein Thrombosis and Adrenal Hemorrhage in A Newborn with Homozygous Factor V Leiden and Heterozygous Of MTHFR-677T, MTHFR-1298C …
- Association of thrombophilia and polycystic ovarian syndrome in women with history of recurrent pregnancy loss
- Pulmonary embolism in intensive care unit “literature review”
- Doping and thrombosis in sports
- Bevacizumab-based therapy for patients with brain metastases from non-small-cell lung cancer: preliminary results
- Plasma anticoagulants or Inhibitors
- Platelet functions and coagulation changes in Indian children with nephrotic syndrome
- Familial Mediterranean fever presenting with pulmonary embolism.
- Controversies in postpartum contraception: when is it safe to start oral contraceptives after childbirth?
- Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis–a concise review
- How to manage children and young adults with myeloproliferative neoplasms
- Bleeding and clotting disorders in pediatric liver disease
- 14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome
- Venous Thromboembolism in Pregnancy
- Common genetic determinants of coagulation and fibrinolysis
- Successful treatment of right-sided heart thrombus with pulmonary embolism with thrombolytic therapy
- Mesenteric vein thrombosis after laparoscopic sleeve gastrectomy
- The risk of postpolypectomy bleeding during colonoscopy in patients with early liver cirrhosis
- Venous thromboembolism in cirrhosis
- Long-term consequences of pregnancy-related venous thrombosis
- Effects of the etonogestrel-releasing contraceptive implant inserted immediately postpartum on maternal hemostasis: a randomized controlled trial
- Coagulation update: what’s new in hemostasis testing?
- A Pragmatic Dilemma: A Case of Lung Adenocarcinoma Presenting as Upper and Lower Extremity Venous Thromboembolism and Protein C and S Deficiency
- Postvaricella thrombosis—report of two cases and literature review
- The role of tissue factor in systemic inflammatory response syndrome
- Livedoid vasculopathy as a coagulation disorder
- Stroke in pregnancy: A rare case of protein C and protein S deficiency
- Treatment with recombinant human activated protein C: one size does not fit all
- Polymorphisms and Mutations in vWF and ADAMTS13 Genes and Their Correlation With Plasma Levels of FVIII and vWF in Patients With Deep Venous Thrombosis
- Presence of antiphospholipid antibody is a risk factor in thrombotic events in patients with antiphospholipid syndrome or relevant diseases
- Retinal vein occlusions: a review for the internist
- Semi‐Synthetic Polysaccharide Sulfates as Anticoagulant Coatings for PET, 1–Cellulose Sulfate
- Venous thromboembolism in pediatric nephrotic syndrome
- The rare inherited coagulation disorders
- The real value of thrombophilia markers in identifying patients at high risk of venous thromboembolism
- Pharmacokinetics and pharmacodynamics of anticoagulants in paediatric patients
- Molecular mechanisms of sepsis
- Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin
- sex, thrombosis and inherited thrombophilia
- Correlation of thromboelastometry with conventional hemostatic tests in critically ill patients with a coagulopathy treated with fresh frozen plasma
- Inherited thrombophilia: diagnosis and anticoagulation treatment in pregnancy
- Causes of adult splanchnic vein thrombosis in the mediterranean area
- Superficial thrombophlebitis in varicose vein disease: the particular role of methylenetetrahydrofolate reductase
- Thrombosis in myeloproliferative neoplasms
- Haemostatic system in inflammatory bowel diseases: new players in gut inflammation
- Calcified right atrial thrombus in HIV infected patient
- Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia
- Increased risks of deep vein thrombosis and pulmonary embolism in Sjögren syndrome: a nationwide cohort study
- Coagulation problems in the critically ill
- Expression and functional characterisation of naturalR147W and K150del variants of protein C in the Chinese population
- Evaluation of Pro-C global for identification of defects in protein C/S anticoagulant pathway
- Medical management of venous thromboembolism: What the interventional radiologist needs to know
- A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis
- Disseminated intravascular coagulation
- Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis
- Elevated plasminogen activator inhibitor type-1 (PAI-1) as contributing factor in pathogenesis of hypercoagulable state in antiphospholipid syndrome
- Inappropriate use of protein C, protein S, and antithrombin testing for hereditary thrombophilia screening: an experience from a large university hospital
- Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation
- Thrombosis as an intravascular effector of innate immunity
- Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects
- Urgent cesarean delivery and prolonged ventilatory support in a parturient with Fontan circulation and undiagnosed pseudocholinesterase deficiency
- Leukocyte-derived microparticles in vascular homeostasis
- Cerebral venous sinus thrombosis in HIV-infected patients: report of 2 cases
- Intensive care unit management of liver-related coagulation disorders
- Changes of coagulation factors in patients with carcinomas and carcinomas of the breast; perioperative influence of local anesthetics
- Prevalence of thrombophilic mutations in patients with unprovoked thromboembolic disease. A comparative analysis regarding arterial and venous disease
- Warfarin resistance-mechanisms and management
- Protein Z, an anticoagulant protein with expanding role in reproductive biology
- Disseminated Intravascular
- Pregnancy-related venous thromboembolism
- Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes
- Venous thromboembolism and hypercoagulable states
- Thrombophilia testing in neonates and infants with thrombosis
- Protein C and acute inflammation: a clinical and biological perspective
- Polycations Selectively Blocking Tissue Factor-Dependent FVII Activation: Collective In Vitro Anticoagulation Studies §
- eComment. Recombinant activated factor VII in pediatric cardiac surgery: possibilities and limitations
- Complement the hemostatic system: an intimate relationship
- Urine Protein Electrophoresis
- Antiphospholipid syndrome: laboratory testing and diagnostic strategies
- Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure
- Fluid management in obstetric patients
- Role of hemostatic factors on the risk of venous thrombosis in people with impaired kidney function
- ADVANCES IN HEMATOLOGY
- Venous thromboembolism in ovarian cancer: incidence, risk factors and impact on survival
- Beta-fibrinogen (-455 G/A) and Integrin beta-3 (PLA1/A2) polymorphisms and recurrent pregnancy loss in Gaza strip-Palestine
- Dermatological signs of the most frequently systemic bacterial infections
- Nanoscale elements of limnology
- The risk of oestrogens in contraceptives
- Disseminated intravascular coagulation as a possible cause of acute coronary stent thrombosis: a case report and literature review
- Revisiting extra hepatic portal vein obstruction in children from the north Indian gangetic plain
- Infection and inflammation as risk factors for thrombosis and atherosclerosis
- Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment
- Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?
- Hypercoagulability risk factors associated with venous thromboembolic events in patients with idiopathic membranous nephropathy and nephrotic syndrome: a …
- Obstetric and vascular APS: same autoantibodies but different diseases?
- Evaluation of hemostatic balance in blood from patients with polycythemia vera by means of thromboelastography: The effect of isovolemic erythrocytapheresis
- Interplay between coagulation and vascular inflammation in sickle cell disease
- Infections, coagulation and thrombosis
- Controlling coagulation dysregulation in xenotransplantation
- Neurologic complications in multiple myeloma and plasmacytoma
- Endogenous heparinoids induced massive hemorrhage postoperatively following THA
- Pregnancy-induced hypertension, but not gestational diabetes mellitus, is a risk factor for venous thromboembolism in pregnancy
- Role of investigating thrombophilic disorders in young stroke
- Disseminated intravascular coagulation as the laboratory hallmark of acute Q fever
- Peripartum pulmonary embolism: Anesthetic and surgical considerations
- Transfusion-related acute lung injury in cardiac surgery patients is characterized by pulmonary inflammation and coagulopathy: a prospective nested case-control …
- Regulation of human platelet aggregation by genetically modified pig endothelial cells and thrombin inhibition
- Inhaled unfractionated heparin improves abnormalities of alveolar coagulation, fibrinolysis and inflammation in endotoxemia-induced lung injury rats
- Polymorphism of clotting factors in Hungarian patients with Raynaud’s phenomenon
- Pregnancy and venous thromboembolism
- New insights into pathways that determine the link between infection and thrombosis
- Pre-analytical variables in coagulation testing associated with diagnostic errors in hemostasis
- Acute and severe coagulopathy in adult mice following silencing of hepatic antithrombin and protein C production
- Hemoptysis in TB Endemic Area. Think Again!
- Internal jugular vein thrombosis associated with venous hypoplasia and protein S deficiency revealed by ultrasonography
- The mechanism of action of rivaroxaban–an oral, direct Factor Xa inhibitor–compared with other anticoagulants
- Therapeutic apheresis in autoimmune diseases
- Apixaban in the prevention of stroke and systemic embolism in nonvalvular atrial fibrillation
- Antithrombin and mortality in severe pneumonia patients with sepsis‐associated disseminated intravascular coagulation: an observational nationwide study
- Diagnosis and prognosis of coagulopathies in horses with colic
- Cytoprotective-selective activated protein C therapy for ischaemic stroke
- Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation
- Clinical applications of 4-factor prothrombin complex concentrate: a practical pathologist’s perspective
- Impact of anticoagulation on the effectiveness of loop diuretics in heart failure with cardiorenal syndrome and venous thromboembolism
- The role of PAR-1, PAR-2 and Tissue factor in the development of hepatic fibrosis
- Thrombotic disease in critically ill children
- Prevention and treatment of venous thromboembolism in pregnancy
- Bleeding and thrombosis in cirrhotic patients: what really matters?
- Comparative fibrinolysis
- Whole Grains, Multiple Grains: Health or Hype
- Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia
- Obesity, non-alcoholic fatty liver disease, and atherothrombosis: a role for the intestinal microbiota?
- Use of saline flush to prevent filter clotting in continuous renal replacement therapy without anticoagulant
- Coagulation Disorders After Central Nervous System Injury
- Regional Difference of Alginates Extracted from Different Brown Seaweeds
- Investigation of Haemostatic Status in the Elderly Male and Female Using Some Parameters; PT, APTT and PC Count (A Case Study in Owerri Metropolis)
- Kidney endothelial dysfunction: ischemia, localized infections and sepsis
- ST-elevation myocardial infarction due to a spontaneous thrombus in the left anterior descending artery in a young HIV-infected patient
- Influence of blood collection technique on platelet function and coagulation variables in dogs
- Update on disseminated intravascular coagulation: when to consider it, when to expect it, when to treat it
- Molecular basis and thrombotic manifestations of antithrombin deficiency in 15 unrelated Chinese patients
- Sonoclot signature analysis in patients with liver disease and its correlation with conventional coagulation studies
- Development of a new laboratory test to evaluate antithrombin resistance in plasma
- Evaluation of coagulation abnormalities among women with vaginal bleeding in the first trimester of pregnancy
- Postpartum contraception
- Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: results of a population‐based cohort study
- Statins role in the prevention and treatment of sepsis
- Relation of soluble endothelial protein C receptor and cytokines after allogeneic hematopoietic stem cell transplantation
- Hematologic failure
- DEFINING SEPSIS AND ITS CLINICAL MANIFESTATIONS
- An integrative approach to the patient with thrombophilia
- New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study
- Antithrombotics
- Interactions between coagulation and complement—their role in inflammation
- Global coagulation in myeloproliferative neoplasms
- Anticoagulant and Fibrinolytic Drugs–Possible Agents in Treatment of Lung Cancer?
- Assessment of the interplay between blood and skin vascular abnormalities in adult purpura fulminans
- The effect of insulin resistance on inflammatory response and oxidative stress in acute cerebral ischemia
- Pro-and anti-angiogenic agents
- Recurrent venous thromboembolism: what is the risk and how to prevent it
- Management of extra hepatic portal venous obstruction (EHPVO): current strategies
- Recurrent pediatric thrombosis: the effect of underlying and/or coexisting factors
- Hemostatic derangement in dengue hemorrhagic fever
- Comparison of Fibrinogen Level Changes between Pregnancy with History of Abortion and Normal Pregnancy
- Left atrium thrombus in an extremely low‐birthweight infant with late‐onset circulatory dysfunction
- Coagulation, Anticoagulation, and Inflammatory Response
- Pregnancy and puerperium-related strokes in Asian women
- Venous thrombosis in athletes
- When and How to Investigate
- Effects of chitin and sepia ink hybrid hemostatic sponge on the blood parameters of mice
- Evaluation and management of a patient with possible cerebral venous thrombosis
- General introduction and outline of this thesis
- Mild Antithrombin Deficiency and the Risk of Recurrent Venous Thromboembolism: A Prospective Cohort Study
- Management of atrial fibrillation: direct factor IIa and Xa inhibitors or “warfarin shotgun”?
- Drug-induced immune thrombocytopenia
- Coffee consumption is associated with a reduced risk of venous thrombosis that is mediated through hemostatic factor levels
- Venous thrombosis: understanding the paradoxes of recurrence
- Therapeutic plasma exchange for the management of refractory systemic autoimmune diseases: report of 31 cases and review of the literature
- Bivalirudin in Combination with Heparin to Control Mesenchymal Cell
- Novel insights in genetics of arterial thrombosis
- Risk factors for venous and arterial thrombosis
- Copy number variations of the F8 gene are associated with venous thromboembolism
- Hemostasis and Thrombosis-Platelet Disorders
- Inherited and acquired thrombophilia in pregnancy
- Early prediction of acute traumatic coagulopathy
- Influence of hereditary or acquired thrombophilias on the treatment of venous thromboembolism
- Evaluation of the presence of hereditary and acquired thrombophilias in Brazilian children and adolescents with diagnoses of portal vein thrombosis
- Sickle cell disease and β‐thalassaemia major in pregnancy
- Superior vena cava syndrome causing chylothoraces in a preterm neonate: a case report and literature review
- Different impact of two mutations of a novel compound heterozygous protein C deficiency with late onset thrombosis
- Clinical profile, common thrombophilia markers and risk factors in 85 young Indian patients with arterial thrombosis
- Climacteric lowers plasma levels of platelet-derived microparticles: a pilot study in pre-versus postmenopausal women
- Republished review: Ocular manifestations of the antiphospholipid syndrome
- Antiphospholipid Antibodies–Detection and Clinical Importance
- Risk factors for thrombosis in an African population
- Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy
- Pulmonary activation of coagulation and inhibition of fibrinolysis after burn injuries and inhalation trauma
- Involvement of coagulation and hemostasis in inflammatory bowel diseases
- Differential diagnosis of heparin-induced thrombocytopenia and scoring systems
- Thrombophilia Issue
- Tamoxifen-associated Budd-Chiari syndrome complicated by heparin-induced thrombocytopenia and thrombosis: a case report and literature review
- Recombinant Factor VIIa in the Treatment of Hemostatic Disorders in Patients with Solid Tumors
- Prophylaxis of thromboembolic events in patients with nephrotic syndrome
- Hemostasis, Bleeding, Blood-sparing Strategies, and Allogeneic Transfusions in Thoraco-Abdominal Aortic Aneurysm Surgery
- Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial …
- A missense mutation G109R in the PROC gene associated with type I protein C deficiency in a young Polish man with acute myocardial infarction
- Effect of combination doses of citrus limon and Punica granatum juice on blood parameters in rabbits
- Managing clotting: a North American perspective
- Fatal pulmonary thromboembolism. A retrospective autopsy study: Searching for genetic thrombophilias (Factor V Leiden (G1691A) and FII (G20210A) gene variants) …
- Inflammatory bowel disease and thromboembolism
- Epidemiology of venous thrombosis in children with cancer
- Haematological problems in intensive care
- Recanalization after acute deep vein thrombosis
- Prevalence of hypercoagulable disorders in inflammatory bowel disease
- Liver Endothelial Cells: Hemostasis, Thrombosis, and Hepatic Vascular Diseases
- An approach to the patient with non-surgical bleeding and a normal coagulation screen
- Thrombosis in children
- Transfusion and coagulation management in liver transplantation
- Thrombosis and occlusion of vascular access in hemodialyzed patients
- Paraneoplastic syndromes in daily clinical practice
- The utility of thromboelastometry (ROTEM) or thromboelastography (TEG) in non-bleeding ICU patients
- Critical determinants of cardiovascular risk in rheumatoid arthritis
- Budd-Chiari Syndrome: A Clinical Approach
- Recommendations for the prevention of pregnancy‐associated venous thromboembolism
- Thromboembolism in children with cancer
- Association between thrombophilia and seated immobility venous thromboembolism
- Inherited and acquired thrombophilic alterations in patients with superficial vein thrombosis of lower limbs
- Venous thromboembolism in women: an assessment of hormonal, genetic and other risk factors
- Role of vitamin K-dependent proteins in the arterial vessel wall
- VKORC1 rs2359612C allele is associated with increased risk of coronary artery disease in the presence of coronary calcification
- Diagnosis of infection in critical care
- The significance of F139V mutation on thrombotic events in compound heterozygous and homozygous protein C deficiency
- Condom tamponade in the management of massive obstetric hemorrhage: an experience at a teaching hospital
- Endothelial dysfunction in sepsis
- Interaction between oral estrogen plus progestogen therapy and ABO blood groups on coagulation activation in postmenopausal women
- Therapeutic translation in acute kidney injury: the epithelial/endothelial axis
- Effects of the gene carrier polyethyleneimines on structure and function of blood components
- Coagulopathy and hemostatic monitoring in cardiac surgery: an update
- VENOUS THROMBOEMBOLISM IN WOMEN
- Current concepts and new trends in the diagnosis and management of recurrent miscarriage
- Haemostatic parameters in patients with Behcet’s disease
- Massive transfusion in children and neonates
- Understanding the biological mechanisms underlying acquired risk factors for venous thrombosis: studies in mice Date: 2012-06-07
- Immunological Causes Associated to Foetal Death: An Update
- Kocher-Debre-Semelaigne syndrome diagnosed by autopsy associated with disseminated intravascular coagulation
- Multiple markers of hypercoagulation in patients with history of venous thromboembolic disease
- Findings that shed new light on the possible pathogenesis of a disease or an adverse effect: Tamoxifen-associated Budd-Chiari syndrome complicated by …
- Thrombophilia: clinical and laboratory assessment and management
- The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities
- Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population
- Characterization of a Kunitz-type protease inhibitor peptide (Rusvikunin) purified from Daboia russelii russelii venom
- A new warfarin dosing algorithm including VKORC1 3730 G> A polymorphism: comparison with results obtained by other published algorithms
- Reducing mortality in severe sepsis and septic shock
- Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences
- Hemostasis and coagulation
- Aetiology of Venous Thrombosis
- A LONGITUDINAL STUDY OF PROTEIN C ACTIVITY IN PREGNANT NIGERIANS IN SOUTH EASTERN NIGERIA
- Perioperative coagulation management in the intensive care unit
- Inflammation markers, D-dimer and the risk of recurrent venous thrombosis
- Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH)–a review of a new treatment paradigm
- Novel insights into genetics of arterial thrombosis
- Hemostasis and complement activation in Puumala hantavirus infection
- Autoantibodies in lupus: culprits or passive bystanders?
- Trans-fatty acids, dangerous bonds for health? A background review paper of their use, consumption, health implications and regulation in France
- Looking again at VTE 2: new oral anticoagulants
- Definitions, epidemiology and pathophysiology
- Preventing thrombophilia-related complications of pregnancy: an update
- Vitamin K1 monitoring in pregnancies after bariatric surgery: a prospective cohort study
- Current challenges in contraception in adolescents and young women
- Modulation of the immuno-coagulative response in a pneumococcal infection in malnourished mice nasally treated with Lactobacillus casei
- Management of pulmonary embolism: state of the art treatment and emerging research
- Resuscitation beyond Advanced Trauma Life Support: damage control
- Hemoglobinopathies in pregnancy
- Post-traumatic pulmonary embolism in the intensive care unit
- Coagulation in kidney disease
- Erythrocytic phosphatidylserine exposure and hemostatic alterations in β-thalassemia intermediate patients
- A moderate aseptic local inflammation does not induce a significant systemic inflammatory response
- Primary nephrotic syndrome in adults as a risk factor for pulmonary embolism: an up-to-date review of the literature
- NEPHROTIC AND ANTI‐PHOSPHOLIPID SYNDROMES: MULTISYSTEM CONDITIONS ASSOCIATED WITH ACUTE MYOCARDIAL INFARCTION IN YOUNG …
- Anti-platelet therapy is associated with decreased transfusion-associated risk of lung dysfunction, multiple organ failure, and mortality in trauma patients
- Prolonged PT
- The role of complement C3 in Diabetes
- Pulmonary embolism associated with oral contraceptive use-case report
- Sepsis, severe sepsis, and septic shock: current evidence for emergency department management
- The effect of heparin administration in animal models of sepsis: a prospective study in Escherichia coli-challenged mice and a systematic review and …
- Is Inherited Thrombphilia in Pregnancy a Risk Factor for Familial Stroke?
- Characterization of a novel variant of the second domain of bikunin with increased leukocyte elastase inhibitory activity
- Thrombosis and Cancer: A Major Complication of Cancer Care
- Antiphospholipid antibodies in relation to sterility/infertility
- Epidemiology and pathophysiology of nephrotic syndrome–associated thromboembolic disease
- Peripartum cardiomyopathy: current state of knowledge, new developments and future directions
- Management of coagulopathy
- Transforming growth factor (TGF)-β levels and unprovoked recurrent venous thromboembolism
- Hemostatic risk factors for pregnancy-related venous thrombosis
- A New Era of Oral Anticoagulation in Atrial Fibrillation: Implications in Clinical Practice
- Perioperative factor concentrate therapy
- Evaluation of coagulation factors and platelet function from an off-line modified ultrafiltration technique for post-cardiopulmonary bypass circuit blood recovery
- Clinical and genetic features of protein C deficiency in 23 unrelated Chinese patients
- Evaluation of platelet aggregation in the presence of antiphospholipid antibodies: Anti-β2GP1 and anticardiolipin
- Comparative evaluation of Tissue factor and Thrombomodulin activity changes during normal and idiopathic early and late foetal loss: The cause of hypercoagulability …
- Comparative, double-blind, retrospective study for the role of heparin in septic shock
- Dabigatran and its reversal with recombinant factor VIIa and prothrombin complex concentrate: A Sonoclot in vitro study
- The protein Z/protein Z-dependent protease inhibitor complex
- Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics
- Coagulation and regional o anesthesia 4
- Thromboembolism and venous thrombosis of the deep veins in surgical children—an increasing challenge?
- Uncommon ophthalmologic disorders in intensive care unit patients
- Fibrin clot properties and their modulation in thrombotic disorders
- Clinical analysis of living donor liver transplantation in patients with portal vein thrombosis
- Disseminated Intravascular Coagulation
- Exploration of the host haemostatic system by group A streptococcus: implications in searching for novel antimicrobial therapies
- 3.4 Clinical predictivity of genetic tests for thromboembolism
- Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism
- Distant Testing in Laboratory Hematology and Flow Cytometry—The Indian Experience
- The significance of antiphospholipid antibodies in liver recipients
- Sleep apnea and risk of deep vein thrombosis: a non-randomized, pair-matched cohort study
- Association of haemostasis activation markers with thrombophilia and venous thromboembolism
- Design of simultaneous antimicrobial and anticoagulant surfaces based on nanoparticles and polysaccharides
- The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A
- Laboratory-monitored fondaparinux and coagulation activity in association with total hip replacement
- Thrombophilias-Pregnancy Related Risk Categories
- Invertebrate models for biomedical research, testing, and education
- Thrombosis and hemostatic abnormalities in hematological malignancies
- Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia
- In vivo profile of the anticoagulant effect of 17ß-amino-1, 3, 5 (10) estratrien-3-ol
- Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis
- African–Caribbean ethnicity is associated with a hypercoagulable state as measured by thrombin generation
- Inside Diagnostics
- SOME HAEMOSTATIC CHANGES IN WOMEN ON HORMONAL CONTRACEPTIVES ATTENDING FAMILY PLANNING CLINIC AT AHMADU BELLO UNIVERSITY …
- Correction of disorders in tissue perfusion, blood coagulation and fibrinolysis with Orbita apparatus on terahertz waves of cell metabolites
- Thromboelastometry and organ failure in trauma patients: a prospective cohort study
- Inflammation, thrombogenesis, fibrinolysis, and vein wall remodeling after deep venous thrombosis
- Biomarkers of ALI/ARDS: pathogenesis, discovery, and relevance to clinical trials
- Thrombophilia in assisted reproductive technology-place and needs for thromboprophylaxis
- Infection-associated platelet dysfunction of canine platelets detected in a flow chamber model
- Thrombin generation and activated protein C resistance in patients with essential thrombocythemia and polycythemia vera
- The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential …
- Evaluation of a new formula for calculating heparin dose for cardiopulmonary bypass patients
- Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease
- The Excessively Clotting Cancer Patient
- Sepsis and pregnancy
- Acute Liver Failure in Intensive Care
- Coagulopathies in the PICU: DIC and liver disease
- Hematologic malignancies and thrombosis
- Activated protein C does not alleviate the course of systemic inflammation in the APCAP trial
- Recurrent venous thrombosis: a disorder of thrombin generation stimulus-response coupling?
- Management of patients with unprovoked venous thromboembolism: an evidence-based and practical approach
- Hemostasis in children
- Prospective study on haematological and coagulation changes in acute pancreatitis.
- Dynamic changes in thrombin generation in abdominal sepsis in mice
- Prevelence of Hyperhomocystenemia deep vein Thrombosis
- Preoperative liver function assessments to estimate the prognosis and safety of liver resections
- Deep Vein Thrombosis-ECAB
- Blood type, lymphadenectomy and blood transfusion predict venous thromboembolic events following radical prostatectomy with pelvic lymphadenectomy
- Recent Insights into the Molecular and Cellular Contributions to Venous Thrombosis
- HAEMOSTATIC PROFILE AND GLYCAEMIC CONTROL OF PATIENTS WITH TYPE TWO DIABETES MELLITUS IN SOUTH SOUTH NIGERIA
- Miscellaneous rare bleeding disorders
- 14.1 SEPSIS IN OBSTETRICS
- Developments in factor Xa inhibitors for the treatment of thromboembolic disorders
- Bacteria under stress by complement and coagulation
- The hemostatic system as a modulator of atherosclerosis
- Vitamin K antagonist therapy can be evaluated by whole blood CAT and results in high plasma levels of factor VIII as well as fibrinogen
- The pathogenesis of nephropathia epidemica: new knowledge and unanswered questions
- Haemostatic challenges in the cancer patient: focus on the perioperative period
- Factor V G1691A (Leiden) and prothrombin G20210A gene mutation status, and thrombosis in patients with chronic myeloproliferative disorders
- Factor IXa as a target for anticoagulation in thrombotic disorders and conditions
- Platelets in pulmonary vascular physiology and pathology
- A brief review of 50 years of perioperative thrombosis and hemostasis management
- Molecular characterization of ph-negative myeloproliferative neoplasms in ukraine
- The rete mirabile of the tail, an effective site for sampling sterile blood from armadillos (Dasypodidae, Xenarthra)
- The mild phenotype in severe hemophilia A with Arg1781His mutation is associated with enhanced binding affinity of factor VIII for factor X
- Transforming growth factor (TGF)-levels and unprovoked recurrent venous thromboembolism.
- Intensive Treatment of the Patient with Hepatic
- Thrombotic complications of neonates and children with congenital nephrotic syndrome
- Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology
- Left ventricular thrombus during cardiopulmonary bypass as the primary manifestation of heparin-induced thrombocytopenia
- Risk factors for thrombosis in Serbian children
- 4Lipid levels do not influence the risk of venous thromboembolism: results of
- The identification and management of heparin-induced thrombocytopenia in the vascular patient
- Pathogenic mechanisms of thrombosis in antiphospholipid syndrome (APS)
- Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy
- The use of anticoagulation proteins in the management of systemic inflammatory response associated with sepsis
- The risk of occurrence of venous thrombosis: focus on protein Z
- Risque de maladie veineuse thromboembolique chez la femme en âge de procréer
- Treatment of acute coagulopathy associated with trauma
- The short term effects of Endovascular Aneurysm Repair (EVAR) on coagulation and cardiovascular morbidity and mortality in patients with infra-renal Abdominal …
- Richard O. Francis, Jeffrey S. Jhang
- Nebulized fibrinolytic agents improve pulmonary fibrinolysis but not inflammation in rat models of direct and indirect acute lung injury
- Venous Thromboembolism among Cancer Patients: A Review
- Bothrops jararaca Venom Metalloproteinases Are Essential for Coagulopathy and Increase Plasma Tissue Factor Levels during Envenomation
- Calcitonin gene-related peptide ameliorates hyperoxia-induced lung injury in neonatal rats
- Venous Thromboembolic Disease
- Age-related differences in plasma proteins: how plasma proteins change from neonates to adults
- Independent and combined effects of prednisone and acetylsalicylic acid on thromboelastography variables in healthy dogs
- Systemic autoimmune diseases and pregnancy
- Pharmacology of hemostasis and thrombosis
- Metabolic effects of combined oral
- A new peptide (Ruviprase) purified from the venom of Daboia russelii russelii shows potent anticoagulant activity via non-enzymatic inhibition of thrombin and factor …
- The M2 haplotype in the ANXA5 gene is an independent risk factor for idiopathic small-for-gestational age newborns
- Guidelines on the diagnosis and treatment for acute promyelocytic leukemia: associação brasileira de hematologia, hemoterapia e terapia celular guidelines …
- Pregnancy-associated venous thromboembolism: prevention and treatment
- VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence …
- Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety
- The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients
- Snakebite envenomation in children: critical care issues
- Danaparoid 16 for the treatment of heparin-induced thrombocytopenia
- 10th International Winter Meeting on Coagulation. Basic, Laboratory and Clinical Aspects of Venous and Arterial Thromboembolic Diseases. Bormio, Italy, April …
- Coagulation activation in an experimental pneumonia model in malnourished mice
- Pediatric thrombophilia
- Transcriptome Profiles Associated to VHSV Infection or DNA Vaccination in Turbot (Scophthalmus maximus)
- Mechanisms of thrombogenesis
- PREVENTION OF RECURRENT MISCARRIAGE
- To Find out the Association of Antiphospholipid Antibody Syndrome and Chronic Leg Ulcers
- Thromboelastometry and multiple organ failure in trauma patients
- Links between allergy and cardiovascular or hemostatic system
- Obstetric haemorrhage
- Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women’s interagency HIV study (WIHS)
- A cross sectional survey on the prevalence of protein c deficiency among patients previously treated for venous Thromboembolism at the kenyatta national hospital
- Coagulation and inflammation in scrub typhus and murine typhus—a prospective comparative study from Laos
- Obstetric Haemorrhage
- Platelet reactivity and thrombogenicity in postmenopausal women
- Familial aggregation of stroke
- Kidney complications of hematopoietic stem cell transplantation
- Endothelium-dependent and independent dilation capability of peripheral arteries in patients with systemic lupus erythematosus and antiphospholipid …
- Effects of tetrastarch administration on hemostatic, laboratory, and hemodynamic variables in healthy dogs and dogs with systemic inflammation
- Pharmacology in pictures and schemes. Vol. 2.
- The link between inflammation and coagulation: influence on the interpretation of diagnostic laboratory tests
- The evolution of drug discovery: from traditional medicines to modern drugs
- Clinical syndromes associated with acquired antithrombin deficiency via microvascular leakage and the related risk of thrombosis
- Liver transplantation in human immunodeficiency virus–infected patients: Procoagulant, but is antithrombotic prophylaxis required?
- Silencing of tissue factor by antisense deoxyoligonucleotide prevents monocrotaline/LPS renal injury in mice
- Designing direct and indirect factor Xa inhibitors
- Neonatal portal vein thrombosis: diagnosis and management
- The future of treatment for antiphospholipid syndrome
- Thrombotic disease in the myeloproliferative neoplasms
- Investigation of inherited thrombophilias in patients with pulmonary embolism
- VENOUS THROMBOEMBOLISM IN WOMEN
- Press review
- In vivo depletion of leukocytes and platelets following injection of T cell-specific antibodies into mice
- Cytokines in sepsis: potent immunoregulators and potential therapeutic targets—an updated view
- Global assays of hemostasis
- Hematological problems in pediatric intensive care
- Main Types of Clinical Appearance of Thrombophilic States During Pregnancy–Target Groups for Thrombophilia Testing
- Venous Thromboembolism in Neonates, Children and Patients with Chronic Renal Disease–Special Considerations
- Venous thromboembolism in women: risk factors and long term follow-up
- Sepsis immunopathology: perspectives of monitoring and modulation of the immune disturbances
- Effects of pegylated interferon α on fibrinolytic parameters in patients with chronic hepatitis C
- Coagulation and thrombotic disorders associated with xenotransplantation
- Elevated numbers and altered subsets of procoagulant microparticles in breast cancer patients using endocrine therapy
- Effects of in vitro fertilization on thrombosis and haemostasis and the relationship between infertility and cardiovascular disease
- Modeling thrombin generation: plasma composition based approach
- Protein C Deficiency
- Laboratory Analysis of Coagulation
- Hemostatic Soluble Plasma Proteins During Acute-Phase Response and Chronic Inflammation
- The role of coagulopathy and blood transfusion in acute respiratory distress syndrome
- Molecular analysis and genotype-phenotype correlation in patients with antithrombin deficiency from Southern Italy
- T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response
- 4 Bleeding in the Neonate
- Recurrent pregnancy loss
- Islet Equivalent’Stem Cells and Diabetes
- Hemostasis, coagulation abnormalities, and liver disease
- Mass spectrometry-based glycomic profiling and its applications to α1, 3-galactosyltransferase gene-knockout pig in xenotransplantation
- f~ nveSt utures
- Herpesvirus mediated activation of coagulation and fibrinolytic proteins
- The Relationship Between HIV Infection and Acute Deep Vein Thromboses
- Studies on physicochemical and biological properties of protease inhibitor from edible mushroom Pleurotus floridanus
- Immunohistochemical examination of placenta in women with thrombophilia and pregnancy loss summary
- Management of hematological malignancies in patients affected by renal failure
- Chapter Q Rare Congenital
- Oxygen transport to tissue XXXIV
- The Effects of vanilloid-like agents on platelet aggregation
- Management of complications related to central venous catheters in cancer patients: an update
- Tamoxifen induces resistance to activated protein C
- Pregnancy complications
- Pulmonary Embolic Disorders
- Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies
- Faculty of Engineering Science Avram and Stella Goldstein-Goren Department of Biotechnology Engineering
- Antagonism by bioactive polyphenols against inflammation: a systematic view
- Age-related differences in thrombin generation using a mathematical model
- Prediction and prevention of venous thrombosis in pregnancy
- Haematological abnormalities in decompensated chronic liver disease
- Hemostasis & Thrombosis
- Fast Facts: Bleeding Disorders
- Pharmacogenetic, clinical and demographic factors in the management of warfarin therapy
- Crosstalk between the sympathetic nervous system, inflammation and coagulation in gestational diabetes: a therapeutic approach in postmenopausal hypertension
- A systematic approach to the bleeding patient: correlation of clinical symptoms and signs with laboratory testing
- Atherogenesis and Atherosclerosis in Primary Antiphospholipid Syndrome
- Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review
- Physiology of aging among healthy, older bottlenose dolphins (Tursiops truncatus): comparisons with aging humans
- Guidelines on the use of therapeutic apheresis in clinical practice—evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …
- The Pathogenesis, Diagnosis, and Treatment of Polycythaemia Vera
- The role of shed GP in Ebola virus pathogenicity
- Role of plasminogen activator inhibitor type 1 in experimental (post-traumatic) sepsis
- Hemoglobin, and Coagulation
- Self-management of oral anticoagulation therapy–methodological and clinical aspects
- The Role of p16INK4a Expression in the Age-related Risk of Venous Thromboembolism
- Shoshana Revel-Vilk Margaret L. Rand
- Acute Phase Proteins in Prototype Rheumatic Inflammatory Diseases
- The Canadian Massive Transfusion Consensus Conference Proceedings
- ANTI-PLATELETS ACTIVITY IN AFRICAN WOMEN ON PROGESTIN INJECTABLE CONTRACEPTIVES
- Factor XI Deficiency: a study of clinical, laboratory and molecular modifiers of bleeding phenotype
- Osteoporosis: Bones in Contention
- A population based cohort study: the epidemiology of pediatric venous thromboembolism in Quebec, Canada
- Network Based Simulation on HPC for Translational Medicine: an Application to Anticoagulation
- Platelet-rich plasma and adipose-derived mesenchymal stem cells for regenerative medicine-associated treatments in bottlenose dolphins (Tursiops truncatus …
- Characteristics, Detection, and Clinical Relevance of Alloantibodies in Kidney Transplantation
- Idiopathic Parkinson’s disease, vascular risk factors and cognition: A critical review
- The effect of inflammatory cytokines and coagulation factors on von Willebrand factor synthesis and cleavage
- Albumin versus an artificial colloid in rectal surgery patients
- CYP2C0, VKORC1 and CYP4F2 variant frequencies in patients on either low or high stable warfarin maintenance therapy in the Ghanaian population
- Neurologic Complications of Organ Transplantation and Immunosuppressive Agents
- Speaker Abstracts (SP01–SP50)
- Inhibitors of blood-clotting mechanisms
- Altered clot formation and anticoagulation in a familial Alzheimer’s disease mouse model
- Characterization of the Functional Roles of Histidine-Rich Glycoprotein in Coagulation
- 16th World Congress on In Vitro Fertilization
- Hereditary Diseases and Blood Transfusion: Proceedings of the Nineteenth International Symposium on Blood Transfusion, Groningen 1994, Organized by …
- Alterations in Coagulation in Dogs with Heart Disease
- Evaluating Risk of Recurrent Venous Thromboembolism During the Anticoagulation Period in Patients with Malignancy
- Evaluating risk of recurrent venous thromboembolism during the anticoagulation period in patients with malignancy
- ISCHEMIC HEART DISEASE
- Effects of hormone therapy and calcium supplementation on morbidity and mortality in postmenopausal women
- Host defenses to extracellularbacteria
- Host defenses to extracellular DavidS.-
- Outcome of Puumala Hantavirus-induced Nephropathia Epidemica
- Cognitive impairment after stroke and TIA: Etiology, diagnosis and prevention
- Mast cells in human epithelial cancers
- Hematology, An Issue of Critical Care Nursing Clinics
- Ultrstructural and flow cytometric analysis of platelets and fibrin networks during the menstrual cycle and pregnancy
- Biomarkers for predicting the outcome of Puumala hantavirus infection
- Novel Translational Strategies to Treat Cardiac Injury and Dysfunction
- Protective Role of Octreotide on the Toxic Effect of L-asparaginase (Elspar) on Pancreas of Rats
- Structural and functional studies of histidine-rich glycoprotein in relation to its roles in angiogenesis and coagulation
- Food Allergy and Gluten-free Weight Loss: Control Your Body Chemistry, Reduce Inflammation, and Improve Your Health
- Hematopoietic Stem Cell Transplantation in the PICU
- Development of a Liver Gene Therapy Strategy for Haemophilia B With Lentiviral Vectors
- Clinical Aspects of Thrombophilia Testing
- Demystifying the prothrombotic role of NETs
- Impact of Erythrocytapheresis on Endogenous anticoagulants in Sickle Cell Disease
- Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy
- Novel alternate hemostatic agents for patients with inhibitors: beyond bypass therapy
- The coagulopathy of acute sepsis
- Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a …
- Should all patients with sepsis receive anticoagulation? Yes
- Direct oral anticoagulants in antiphospholipid syndrome
- The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome
- Can vitamin K synthesis altered by dysbiosis of microbiota be blamed in the etiopathogenesis of venous thrombosis?
- High frequency of decreased antithrombin level in pregnant women with thrombosis
- Coagulopathy and its management in patients with severe burns
- Hemostasis, bleeding and thrombosis in liver disease
- Genetic characterization of antithrombin, protein C and protein S deficiencies in Polish patients
- Aging, hypercoagulability, and leg necrosis in critical limb ischemia
- The levels of tissue factor pathway inhibitor in sepsis patients receiving prophylactic enoxaparin
- Superior sagittal sinus thrombosis after intrathecal chemotherapy and intravenous high-dose cytarabine in an acute myeloid leukemia case with t (8; 21)(q22; q22)
- Thrombophilia in Korean patients with arterial or venous thromboembolisms
- Sepsis-associated coagulopathy: diagnosis with hematologic biomarkers and a novel hemostatic score that may predict the risk of developing a multiple organ …
- Pregnancy-related venous thromboembolism
- Combined thrombophilia in a young male presenting as life threatening pulmonary embolism
- Primary and secondary haemostasis changes related to aging
- Sepsis and septic shock: current treatment strategies and new approaches
- An overview of thrombophilia and associated laboratory testing
- The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms
- Anticoagulation in Patients with Liver Cirrhosis
- Thrombosis in pregnancy and maternal outcomes
- Isolated calf deep vein thrombosis
- Translational aspects of developmental hemostasis: infants and children are not miniature adults and even adults may be different
- Hemostatic and thrombotic issues in cardiac surgery
- Severe Thrombophilia in Idiopathic Fatal Pulmonary Embolism
- Thrombophilic risk factors for chronic thromboembolic pulmonary hypertension (CTEPH) in Korea
- Prothrombotic genetic risk factors in patients with very early ST-segment elevation myocardial infarction
- Etiopathogenesis, prevention, and treatment of thromboembolism in inflammatory bowel disease
- naturalcoagulation inhibitors in liver diseases
- AN Bakulev National Scientific and Practical Center for Cardiovascular Surgery, Moscow, 121552, Russian Federation Background. In patients with IHD, there …
- Hemostatic parameters in Thalassemia patients; a single institute experience
- Haemostatic and fibrinolytic changes in obese subjects undergoing bariatric surgery: the effect of different surgical procedures
- 1073: NEW HEMOSTATIC SCORE ADDING PROTEIN-C AND ANTITHROMBIN MAY BETTER IDENTIFY SEPSIS-INDUCED COAGULOPATHY
- Role of family history of venous thromboembolism and thrombophilia as predictors of recurrence: a prospective follow‐up study
- Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database
- Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches
- Down regulated protein C plasma levels in the absence of factor V leiden mutation in HIV patients: An observational study in Maiduguri, North-Eastern Nigeria
- Warfarin induced skin necrosis–Forgotten Diagnosis
- Variation of factor XIII level during pregnancy
- Prevalence of pulmonary embolism during pregnancy
- Association of Inherited Thrombophilia with Placental Adverse Outcomes and Recurrent Pregnancy Loss.
- INHERITED ANTITHROMBIN DEFICIENCY IN PATIENTS WITH RECURRENT THROMBOTIC EVENTS
- Pattern of deranged haemostatic biomarkers among HIV patients: a descriptive case control cohort study in a tertiary health facility in northeastern Nigeria
- Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is ‘shock liver’the unrecognized provocateur of ischemic limb necrosis?
- Clinical aspects of the haemostasis-inflammation interface
- Genetics in thrombophilia
- Multiple Thrombosis Modifier Loci Identified Using a Sensitized Mutagenesis Screen
- DEFICIENCY OF PROTEIN S AND FACTOR V PRESENTING AS ISCHEMIC STROKE IN A 14 YEARS OLD BOY
- S-261 The clinical manifestation of hereditary thrombophilia in patients with unprovoked venous thrombosis
- Remarks about the study of an unusual presentation of venous thrombosis in a child with idiopathic membranous nephropathy
- Management of Coagulopathies in Liver Cirrhosis
- A Multicenter Prospective Phase II Study of Antithrombin-III Based Treatment for Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation
- Uncertain thrombophilia markers
- Thrombophilia testing in young patients with ischemic stroke
- Markers of coagulation activation in patients with hemoglobinopathy in Western Saudi Arabia
- New products for the treatment of haemophilia
- Enhanced thrombin generation and reduced intact protein S in processed solvent detergent plasma
- Coagulopathy in liver disease: a balancing act
- Coagulation phenotypes in septic shock as evaluated by calibrated automated thrombography
- Endogenous thrombin potential as marker of procoagulant response that can be useful in early stage of sepsis
- Inpatient Hypercoagulable Testing, a Single Institution Experience
- HEREDITARY THROMBOPHILIA-RISK FACTOR FOR OBSTETRIC COMPLICATIONS
- Thrombophilia screening: An artificial neural network approach
- Added Value of Next-Generation Sequencing for Haemostasis Diagnosis
